<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Reminiscence therapy for dementia - Woods, B - 2018 | Cochrane Library</title> <meta content="Reminiscence therapy for dementia - Woods, B - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001120.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Reminiscence therapy for dementia - Woods, B - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001120.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD001120.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Reminiscence therapy for dementia" name="citation_title"/> <meta content="Bob Woods" name="citation_author"/> <meta content="Bangor University" name="citation_author_institution"/> <meta content="b.woods@bangor.ac.uk" name="citation_author_email"/> <meta content="Laura O'Philbin" name="citation_author"/> <meta content="Bangor University" name="citation_author_institution"/> <meta content="Emma M Farrell" name="citation_author"/> <meta content="Bangor University" name="citation_author_institution"/> <meta content="Aimee E Spector" name="citation_author"/> <meta content="University College London" name="citation_author_institution"/> <meta content="Martin Orrell" name="citation_author"/> <meta content="University of Nottingham" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.CD001120.pub3" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/03/01" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001120.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001120.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001120.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Mental Recall; Dementia [*therapy]; Orientation; Psychotherapy, Group [*methods]; Randomized Controlled Trials as Topic; Reality Therapy" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001120.pub3&amp;doi=10.1002/14651858.CD001120.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001120.pub3&amp;doi=10.1002/14651858.CD001120.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001120.pub3&amp;doi=10.1002/14651858.CD001120.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001120.pub3&amp;doi=10.1002/14651858.CD001120.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001120.pub3&amp;doi=10.1002/14651858.CD001120.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001120.pub3&amp;doi=10.1002/14651858.CD001120.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001120.pub3&amp;doi=10.1002/14651858.CD001120.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001120.pub3&amp;doi=10.1002/14651858.CD001120.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001120.pub3&amp;doi=10.1002/14651858.CD001120.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001120.pub3&amp;doi=10.1002/14651858.CD001120.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001120.pub3&amp;doi=10.1002/14651858.CD001120.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001120.pub3&amp;doi=10.1002/14651858.CD001120.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001120.pub3&amp;doi=10.1002/14651858.CD001120.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001120.pub3&amp;doi=10.1002/14651858.CD001120.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001120.pub3&amp;doi=10.1002/14651858.CD001120.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001120.pub3&amp;doi=10.1002/14651858.CD001120.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001120.pub3&amp;doi=10.1002/14651858.CD001120.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001120.pub3&amp;doi=10.1002/14651858.CD001120.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001120.pub3&amp;doi=10.1002/14651858.CD001120.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001120.pub3&amp;doi=10.1002/14651858.CD001120.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001120.pub3&amp;doi=10.1002/14651858.CD001120.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001120.pub3&amp;doi=10.1002/14651858.CD001120.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001120.pub3&amp;doi=10.1002/14651858.CD001120.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="kKvAiZoF";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD001120\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD001120\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001120\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001120\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ms","ja","th","zh_HANS","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD001120.pub3",title:"Reminiscence therapy for dementia",firstPublishedDate:"Mar 1, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Dementia and Cognitive Improvement Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=kKvAiZoF&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001120.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001120.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD001120.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD001120.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001120.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD001120.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD001120.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD001120.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD001120.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD001120.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>58966 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD001120.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001120.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001120.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001120.pub3/full#CD001120-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001120.pub3/full#CD001120-sec-0117"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001120.pub3/full#CD001120-sec-0015"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001120.pub3/full#CD001120-sec-0016"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001120.pub3/full#CD001120-sec-0017"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001120.pub3/full#CD001120-sec-0018"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001120.pub3/full#CD001120-sec-0045"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001120.pub3/full#CD001120-sec-0111"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001120.pub3/appendices#CD001120-sec-0122"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/table_n/CD001120StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/table_n/CD001120StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001120.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001120.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001120.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001120.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001120.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD001120.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Reminiscence therapy for dementia</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001120.pub3/information#CD001120-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Bob Woods</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001120.pub3/information#CD001120-cr-0003">Laura O'Philbin</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001120.pub3/information#CD001120-cr-0004">Emma M Farrell</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001120.pub3/information#CD001120-cr-0005">Aimee E Spector</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001120.pub3/information#CD001120-cr-0006">Martin Orrell</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/information/en#CD001120-sec-0127">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 01 March 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD001120.pub3">https://doi.org/10.1002/14651858.CD001120.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD001120-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001120-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001120-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001120-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/th#CD001120-abs-0008">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD001120-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD001120-abs-0001" lang="en"> <section id="CD001120-sec-0001"> <h3 class="title" id="CD001120-sec-0001">Background</h3> <p>This updated Cochrane Review of reminiscence therapy (RT) for dementia was first published in 1998, and last updated in 2005. RT involves the discussion of memories and past experiences with other people using tangible prompts such as photographs or music to evoke memories and stimulate conversation. RT is implemented widely in a range of settings using a variety of formats. </p> </section> <section id="CD001120-sec-0002"> <h3 class="title" id="CD001120-sec-0002">Objectives</h3> <p>To assess the effects of RT on people living with dementia and their carers, taking into account differences in its implementation, including setting (care home, community) and modality (group, individual). </p> </section> <section id="CD001120-sec-0003"> <h3 class="title" id="CD001120-sec-0003">Search methods</h3> <p>We searched ALOIS (the Cochrane Dementia and Cognitive Improvement Group's Specialized Register) on 6 April 2017 using the search term 'reminiscence.' </p> </section> <section id="CD001120-sec-0004"> <h3 class="title" id="CD001120-sec-0004">Selection criteria</h3> <p>We included all randomised controlled trials of RT for dementia in which the duration of the intervention was at least four weeks (or six sessions) and that had a 'no treatment' or passive control group. Outcomes of interest were quality of life (QoL), cognition, communication, behaviour, mood and carer outcomes. </p> </section> <section id="CD001120-sec-0005"> <h3 class="title" id="CD001120-sec-0005">Data collection and analysis</h3> <p>Two authors (LOP and EF) independently extracted data and assessed risk of bias. Where necessary, we contacted study authors for additional information. We pooled data from all sufficiently similar studies reporting on each outcome. We undertook subgroup analysis by setting (community versus care home) and by modality (individual versus group). We used GRADE methods to assess the overall quality of evidence for each outcome. </p> </section> <section id="CD001120-sec-0006"> <h3 class="title" id="CD001120-sec-0006">Main results</h3> <p>We included 22 studies involving 1972 people with dementia. Meta‐analyses included data from 16 studies (1749 participants). Apart from six studies with risk of selection bias, the overall risk of bias in the studies was low. </p> <p>Overall, moderate quality evidence indicated RT did not have an important effect on QoL immediately after the intervention period compared with no treatment (standardised mean difference (SMD) 0.11, 95% confidence interval (CI) ‐0.12 to 0.33; I<sup>2</sup> = 59%; 8 studies; 1060 participants). Inconsistency between studies mainly related to the study setting. There was probably a slight benefit in favour of RT in care homes post‐treatment (SMD 0.46, 95% CI 0.18 to 0.75; 3 studies; 193 participants), but little or no difference in QoL in community settings (867 participants from five studies). </p> <p>For cognitive measures, there was high quality evidence for a very small benefit, of doubtful clinical importance, associated with reminiscence at the end of treatment (SMD 0.11, 95% CI 0.00 to 0.23; 14 studies; 1219 participants), but little or no difference at longer‐term follow‐up. There was a probable slight improvement for individual reminiscence and for care homes when analysed separately, but little or no difference for community settings or for group studies. Nine studies included the widely used Mini‐Mental State Examination (MMSE) as a cognitive measure, and, on this scale, there was high quality evidence for an improvement at the end of treatment (mean difference (MD) 1.87 points, 95% CI 0.54 to 3.20; 437 participants). There was a similar effect at longer‐term follow‐up, but the quality of evidence for this analysis was low (1.8 points, 95% CI ‐0.06 to 3.65). </p> <p>For communication measures, there may have been a benefit of RT at the end of treatment (SMD ‐0.51 points, 95% CI ‐0.97 to ‐0.05; I<sup>2</sup> = 62%; negative scores indicated improvement; 6 studies; 249 participants), but there was inconsistency between studies, related to the RT modality. At follow‐up, there was probably a slight benefit of RT (SMD ‐0.49 points, 95% CI ‐0.77 to ‐0.21; 4 studies; 204 participants). Effects were uncertain for individual RT, with very low quality evidence available. For reminiscence groups, evidence of moderate quality indicated a probable slight benefit immediately (SMD ‐0.39, 95% CI ‐0.71 to ‐0.06; 4 studies; 153 participants), and at later follow‐up. Community participants probably benefited at end of treatment and follow‐up. For care home participants, the results were inconsistent between studies and, while there may be an improvement at follow‐up, at the end of treatment the evidence quality was very low and effects were uncertain. </p> <p>Other outcome domains examined for people with dementia included mood, functioning in daily activities, agitation/irritability and relationship quality. There were no clear effects in these domains. Individual reminiscence was probably associated with a slight benefit on depression scales, although its clinical importance was uncertain (SMD ‐0.41, 95% CI ‐0.76 to ‐0.06; 4 studies; 131 participants). We found no evidence of any harmful effects on people with dementia. </p> <p>We also looked at outcomes for carers, including stress, mood and quality of relationship with the person with dementia (from the carer's perspective). We found no evidence of effects on carers other than a potential adverse outcome related to carer anxiety at longer‐term follow‐up, based on two studies that had involved the carer jointly in reminiscence groups with people with dementia. The control group carers were probably slightly less anxious (MD 0.56 points, 95% CI ‐0.17 to 1.30; 464 participants), but this result is of uncertain clinical importance, and is also consistent with little or no effect. </p> </section> <section id="CD001120-sec-0007"> <h3 class="title" id="CD001120-sec-0007">Authors' conclusions</h3> <p>The effects of reminiscence interventions are inconsistent, often small in size and can differ considerably across settings and modalities. RT has some positive effects on people with dementia in the domains of QoL, cognition, communication and mood. Care home studies show the widest range of benefits, including QoL, cognition and communication (at follow‐up). Individual RT is associated with probable benefits for cognition and mood. Group RT and a community setting are associated with probable improvements in communication. The wide range of RT interventions across studies makes comparisons and evaluation of relative benefits difficult. Treatment protocols are not described in sufficient detail in many publications. There have been welcome improvements in the quality of research on RT since the previous version of this review, although there still remains a need for more randomised controlled trials following clear, detailed treatment protocols, especially allowing the effects of simple and integrative RT to be compared. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD001120-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001120-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD001120-abs-0004">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD001120-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001120-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ja#CD001120-abs-0006">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD001120-abs-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/th#CD001120-abs-0009">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD001120-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD001120-abs-0003" lang="en"> <h3>Reminiscence therapy for dementia</h3> <p><b>Review question</b> </p> <p>We wanted to find out what effect reminiscence therapy (RT) has on people with dementia. In particular, we were interested in effects on quality of life, communication, cognition (the general ability to think and remember), mood, daily activities and relationships. We were also interested in any effects on carers. </p> <p><b>Background</b> </p> <p>RT involves discussing events and experiences from the past. It aims to evoke memories, stimulate mental activity and improve well‐being. Reminiscence is often assisted by props such as videos, pictures and objects. It can take place in a group or be done with a person on their own, when it often results in some form of life‐story book being created. RT helps older people with depression. It may be suitable for people with dementia both because depression is common in dementia and because people with dementia typically have a better memory for the distant past than for recent events. </p> <p><b>Methods</b> </p> <p>We searched for randomised, controlled trials in which RT was compared with no treatment or with a non‐specific activity, such as time spent in general conversation. Our search covered all trials available up to April 2017. </p> <p><b>Results</b> </p> <p>We found 22 trials with 1972 participants to include in the review. All the participants had dementia, mostly of mild or moderate severity. Some of the participants were living at home and some were in care homes. The length of the trials varied from four weeks to two years, and the overall amount of time spent on therapy varied from three to 39 hours. Overall, we thought most of the trials were well conducted. </p> <p>Looking at all the trials together, there did not seem to be an effect of RT on the quality of life reported by the participants. However, there was probably a slight benefit of treatment in the trials done in care homes, which was not seen in the trials done in the community. </p> <p>People having RT scored slightly better than the control group on tests of cognition immediately after the course of treatment, but not weeks to months later. It was not clear that the effect was large enough to be important. The effect was most evident in care home studies, which used individual RT, but not in community studies, which used group RT. </p> <p>We found that group RT and RT in community settings may have a positive effect on the communication and interaction of the person with dementia immediately after the end of treatment, and probably also weeks to months later, although the effect was small. </p> <p>Apart from a probable slight benefit of individual RT on scales measuring depressed mood, we found no evidence for effects of RT on other outcomes, such as agitation, ability to carry out daily activities or relationships with other people. We found no evidence of harmful effects of RT for the people with dementia themselves. </p> <p>We found no effect of RT on family carers other than a suggestion that it made carers slightly more anxious in two large studies of joint reminiscence work. In this type of RT, the carers and the people with dementia were both directly involved in the reminiscence sessions. </p> <p><b>Conclusions</b> </p> <p>We were encouraged to find that the amount and quality of research on RT for dementia has increased considerably since the last version of this review. We concluded that the effects of RT vary, depending on the way it is given and whether it takes place in care homes or the community. However, there is some evidence that RT can improve quality of life, cognition, communication and possibly mood in people with dementia in some circumstances, although all the benefits were small. More research is needed to understand these differences and to find out who is likely to benefit most from what type of RT. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD001120-sec-0117" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD001120-sec-0117"></div> <h3 class="title" id="CD001120-sec-0118">Implications for practice</h3> <section id="CD001120-sec-0118"> <p>Whilst this updated review has shown that reminiscence therapy (RT) can improve outcomes for people with dementia, its effects are inconsistent, often small in size and can differ considerably across settings and modalities. The outcomes for which some benefit has been identified are cognitive function, communication/interaction, quality of life (QoL) and mood. However, the effects are not consistent across different types of reminiscence work (group or individual, with or without family carer involvement), or across different contexts (care home or community), particularly where QoL is the outcome. The evidence relating to QoL is most promising in care homes; that relating to mood is most promising for individual RT. </p> <p>RT can now be viewed alongside cognitive stimulation as an ecopsychosocial intervention with a credible evidence‐base. Individual and group approaches have some support, although the two large, well‐conducted UK studies of joint reminiscence group work involving family members alongside people with dementia have been the studies showing the smallest effects. Individual work has the potential benefit of resulting in some form of life story book, which provides a platform to enhance person‐centred care. However, to date it has not proven clearly superior to group work, which may have added value in terms of enhancing interaction and communication. </p> <p>The lack of participation in the two UK studies of joint reminiscence work suggests that consideration should be given to offering it as one of a number of approaches, as participation does not appear to be valued by a significant number of people with dementia and carers. Where it is offered, benefits beyond the 'in the moment' enjoyment of a shared social group experience, should not be anticipated as general outcomes. </p> <p>The diversity of approaches to reminiscence seen in the various studies suggests that there is a need for manuals and training to be developed so that approaches can be more readily shared, and common approaches developed, for both individual and group work. It is essential that the different functions of reminiscence and the different types of reminiscence work are recognised, to aid sharing of good practice and understanding of the training, support and resources needed for implementation. </p> </section> <h3 class="title" id="CD001120-sec-0119">Implications for research</h3> <section id="CD001120-sec-0119"> <p>The research agenda in relation to reminiscence work now needs to address some of the discrepancies and uncertainties highlighted by this review, and more fully reflect and identify the differences in function and types of reminiscence work. A large scale randomised controlled trial (RCT) of individual, integrative reminiscence work, producing a conventional or digital life story book, would demonstrate whether the promising results from small studies could be replicated on a larger platform, with greater attention to the detail of randomisation and allocation concealment. Such a study should include enough people living with dementia in care home and community settings, and with a range of severities of impairment, so that more fine‐grained conclusions may be drawn. Research is also needed on the extent to which reminiscence work can drive person‐centred care, so that the person's biography becomes a rich resource for planning and action. </p> <p>There has been increasing interest in digital reminiscence work (e.g. <a href="./references#CD001120-bbs2-0121" title="SubramaniamP , WoodsB . Towards the therapeutic use of information and communication technology in reminiscence work for people with dementia: a systematic review. International Journal of Computers in Healthcare2010;1(2):106‐25. ">Subramaniam 2010</a>; <a href="./references#CD001120-bbs2-0123" title="SubramaniamP , WoodsB . Digital life storybooks for people with dementia living in care homes: an evaluation. Clinical Interventions in Aging2016;11:1263‐76. [DOI: 10.2147/CIA.S111097] ">Subramaniam 2016</a>), but to date there have been no studies meeting the criteria for inclusion in the current review. This is clearly an area where more research is justified, in developing the intervention and then delineating its effects. </p> <p>The research to date has emphasised changes beyond the group, on measures carried out before and after a set number of reminiscence sessions. More emphasis on the experience of people with dementia (and carers) within the reminiscence session may be helpful. Is each session an enjoyable experience in itself, even if the lasting benefits are more elusive? <a href="./references#CD001120-bbs2-0032" title="BrookerD , DuceL . Wellbeing and activity in dementia: a comparison of group reminiscence therapy, structured goal‐directed group activity and unstructured time. Aging &amp; Mental Health2000;4(4):354‐8. ">Brooker 2000</a> used an observational method, Dementia Care Mapping, to demonstrate that people with dementia showed greater well‐being when participating in simple reminiscence groups than when undertaking other activities, and it would be helpful to take this 'in the moment' evaluation approach further. </p> <p>Finally, in view of the significant number of people not taking up reminiscence interventions, research would be helpful delineating who does take it up and why, and what type of approach is beneficial for which people, so there can be better tailoring of interventions to individuals. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD001120-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD001120-sec-0015"></div> <div class="table" id="CD001120-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Reminiscence Therapy compared to no treatment for people living with dementia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Reminiscence Therapy compared to no treatment for people living with dementia</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people living with dementia <br/> <b>Setting:</b> Care home and community settings <br/> <b>Intervention:</b> Reminiscence Therapy <br/> <b>Comparison:</b> no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Reminiscence Therapy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of Life (self‐report) at end of treatment<br/> assessed with: QOL‐AD, SRQoL<br/> follow up: range 1 days to 6 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.11 higher<br/> (0.12 lower to 0.33 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1060<br/> (8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A higher score is indicative of improved quality of life. Subgroup analysis by setting likley explains the variation in effect size across the studies. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cognition at end of treatment<br/> assessed with: MMSE, AMI‐PSS, AMI(E)‐PSS, ADAS‐COG<br/> follow up: range 1 days to 6 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.11 higher<br/> (0 to 0.23 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1219<br/> (14 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A higher score is indicative of improved cognition</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Communication and Interaction at end of treatment<br/> assessed with: Social Engagement Scale, Communication Observation Scale, MOSES Withdrawal sub‐scale, Holden Communication Scale <br/> follow up: range 1 days to 2 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.51 lower<br/> (0.97 lower to 0.05 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>249<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> A lower score is indicative of improved communication</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functional behaviour at end of treatment <br/> assessed with: MDS‐ADL, FIM, ADL, BADLS, ADCS‐ADL, DAD<br/> follow up: range 1 days to 6 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.24 lower<br/> (0.69 higher to 0.21 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1030<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A lower score is indicative of improved functional behaviour</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Agitation/irritability at end of treatment <br/> assessed with: CMAI, MOSES (irritability subscale)<br/> follow up: range 1 days to 6 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.03 higher<br/> (0.17 lower to 0.24 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>359<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A lower score is indicative of improved agitation/irritability</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Depressed mood at end of treatment<br/> assessed with: CSDD, GDS, GDS‐SF,MOSES (depression subscale), HADS (depression subscale), MADRS<br/> follow up: range 1 days to 6 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.03 lower<br/> (0.15 lower to 0.1 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>973<br/> (10 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A lower score is indicative of improved mood</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Stress related to caring (caregiver)<br/> assessed with: ZBI‐SF, RSS, NPI, Modified ZBI, ZBI<br/> follow up: range 1 days to 6 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.03 SD higher<br/> (0.21 lower to 0.14 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1155<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A lower score is indicative of less caregiver stress</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p> *<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded one point for inconsistency due to substantial heterogeneity </p> <p><sup>2</sup> Downgraded one point for imprecision due to small sample size (&lt;400 participants) </p> <p><sup>3</sup> Downgraded one point for imprecision as the confidence interval contains null effect and the lower limit passes ‐0.5 </p> <p><sup>4</sup> Downgraded two points for inconsistency due to considerable heterogeneity </p> <p><sup>5</sup> Downgraded one point for inconsistency due to moderate heterogeneity </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001120-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Reminiscence therapy compared to no treatment for people living with dementia (modality)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Reminiscence therapy compared to no treatment for people living with dementia (modality)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people living with dementia (modality)<br/> <b>Setting:</b> care home and community settings<br/> <b>Intervention:</b> reminiscence therapy<br/> <b>Comparison:</b> no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with reminiscence therapy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Individual: quality of life (self‐reported)</b> at end of treatment<br/> assessed with: QoL‐AD<br/> Scale from: 13 to 52<br/> follow‐up: range 1 to 7 days </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 7.00 points higher</b><br/> (0.14 lower to 14.14 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score on quality of life measures indicated a more positive outcome. 3.0 points may be the minimum clinically important difference. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Individual: cognition</b> at end of treatment<br/> assessed with: MMSE, AMI‐PSS<br/> follow‐up: range 1 day to 2 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SMD 0.32 higher</b><br/> (0.04 higher to 0.61 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>196<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate<sup>2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score on cognitive measures indicated a more positive outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Individual: communication</b> at end of treatment<br/> assessed with: SES, COS<br/> follow‐up: range 1 day to 2 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SMD 0.74 lower</b><br/> (2.38 lower to 0.89 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low<sup>3,4</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score on communication measures indicated a more positive outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Group: quality of life (self‐reported)</b> at end of treatment<br/> assessed with: QoL‐AD, SR‐QoL<br/> follow‐up: range 1 day to 6 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SMD 0.06 higher</b><br/> (0.15 lower to 0.28 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1037<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score on quality of life measures indicated a more positive outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Group: cognition</b> at end of treatment<br/> assessed with: MMSE, AMI‐PSS, ADAS‐Cog<br/> follow‐up: range 1 day to 6 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SMD 0.07 higher</b><br/> (0.05 lower to 0.20 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1023<br/> (9 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score on cognitive measures indicated a more positive outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Group: communication</b> at end of treatment<br/> assessed with: SES, COS, MOSES Withdrawal subscale<br/> follow‐up: range 1 day to 1 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SMD 0.39 lower</b><br/> (0.71 lower to 0.06 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>153<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate<sup>2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score on communication measures indicated a more positive outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>ADAS‐Cog:</b> Alzheimer's Disease Assessment Scale Cognitive subscale; <b>AMI‐PSS:</b> Autobiographical Memory Interview ‐ Perceived Stress Scale; <b>CI:</b> confidence interval; Communication Observation Scale; <b>MD:</b> mean difference; <b>MMSE:</b> Mini‐Mental State Examination; <b>MOSES:</b> Multidimensional Observation Scale for Elderly Subjects; <b>QoL‐AD:</b> Quality of Life in Alzheimer's Disease; <b>RCT:</b> randomised controlled trial; <b>SES:</b> Social Engagement Scale; <b>SMD:</b> standardised mean difference; <b>SR‐QoL:</b> Self‐Report Quality of Life. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded 2 levels for imprecision due to small sample size (&lt; 400 participants) and including both null effect and an upper limit greater than 0.3. </p> <p><sup>2</sup>Downgraded 1 level for imprecision due to small sample size (&lt; 400 participants). </p> <p><sup>3</sup>Downgraded 2 levels for inconsistency due to considerable unexplained heterogeneity. </p> <p><sup>4</sup>Downgraded 2 levels for imprecision due to small sample size (&lt; 400 participants) and both confidence interval limits crossing 0.5. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001120-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Reminiscence therapy compared to no treatment for people living with dementia (setting)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Reminiscence therapy compared to no treatment for people living with dementia (setting)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people living with dementia (setting)<br/> <b>Setting:</b> community and care home settings<br/> <b>Intervention:</b> reminiscence therapy<br/> <b>Comparison:</b> no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with reminiscence therapy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Care home: quality of life (self‐reported)</b> at end of treatment<br/> assessed with: QoL‐AD, SR‐QoL<br/> follow‐up: range 1 day to 6 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SMD 0.46 higher</b><br/> (0.18 higher to 0.75 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>193<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score on quality of life measures indicated a more positive outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Care home: cognition</b> at end of treatment<br/> assessed with: MMSE, AMI‐PSS<br/> follow‐up: range 1 day to 2 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SMD 0.29 higher</b><br/> (0.03 higher to 0.56 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>230<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score on cognitive measures indicated a more positive outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Care home: communication</b> at end of treatment<br/> assessed with: SES, Communication Scale for Cognitively Impaired<br/> follow‐up: range 1 day to 2 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SMD 0.52 lower</b><br/> (1.29 lower to 0.24 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>184<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low<sup>2,3</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score on communication measures indicated a more positive outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Community: quality of life (self‐reported)</b> at end of treatment<br/> assessed with: QoL‐AD (self‐report)<br/> Scale from: 13 to 52<br/> follow‐up: range 1 day to 6 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.57 points lower</b><br/> (1.37 lower to 0.22 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>867<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score on quality of life measures indicated a more positive outcome. 3.0 points may be the minimum clinically important difference. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Community: cognition</b> at end of treatment<br/> assessed with: MMSE, AMI‐PSS, AMI‐E‐PSS, ADAS‐Cog<br/> follow‐up: range 1 day to 6 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SMD 0.07 higher</b><br/> (0.05 lower to 0.20 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>989<br/> (8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score on cognitive measures indicated a more positive outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Community: communication and interaction</b> at end of treatment<br/> assessed with: Holden Communication Scale and MOSES (withdrawal subscale)<br/> follow‐up: range 1 day to 7 days </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SMD 0.57 lower</b><br/> (1.08 lower to 0.06 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score on communication measures indicated a more positive outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>ADAS‐Cog:</b> Alzheimer's Disease Assessment Scale Cognitive subscale; <b>AMI‐PSS:</b> Autobiographical Memory Interview ‐ Perceived Stress Scale; <b>AMI‐E‐PSS:</b> Autobiographical Memory Interview ‐ Extended Version ‐ Perceived Stress Scale; <b>MD:</b> mean difference; <b>MMSE:</b> Mini‐Mental State Examination; <b>MOSES:</b> Multidimensional Observation Scale for Elderly Subjects; <b>QoL‐AD:</b> Quality of Life in Alzheimer's Disease; <b>RCT:</b> randomised controlled trial; <b>SES:</b> Social Engagement Scale; <b>SMD:</b> standardised mean difference; <b>SR‐QoL:</b> Self‐Report Quality of Life. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded 1 level for imprecision because of small sample size (&lt; 400 participants). </p> <p><sup>2</sup>Downgraded 2 levels for imprecision because of small sample size (&lt; 400) and the confidence interval including a null effect and a lower limit crossing ‐0.5. </p> <p><sup>3</sup>Downgraded 2 levels for inconsistency due to considerable unexplained heterogeneity. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD001120-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD001120-sec-0016"></div> <p>Reminiscence therapy (RT) was introduced to dementia care in the late 1970s (<a href="./references#CD001120-bbs2-0107" title="KiernatJM . The use of life review activity with confused nursing home residents. American Journal of Occupational Therapy1979;33:306‐10. ">Kiernat 1979</a>; <a href="./references#CD001120-bbs2-0112" title="NorrisAD . Reminiscence with Elderly People. London (UK): Winslow, 1986. ">Norris 1986</a>), and has taken a variety of forms. At its most basic, it involves the discussion of past activities, events and experiences, usually with the aid of tangible prompts (e.g. photographs, household and other familiar items from the past, music and archive sound recordings). More recently, digital storage and presentation of photographs, music and video clips have become widely used (<a href="./references#CD001120-bbs2-0121" title="SubramaniamP , WoodsB . Towards the therapeutic use of information and communication technology in reminiscence work for people with dementia: a systematic review. International Journal of Computers in Healthcare2010;1(2):106‐25. ">Subramaniam 2010</a>). </p> <p>The development of reminiscence work is usually traced to <a href="./references#CD001120-bbs2-0093" title="ButlerRN . The life review: an interpretation of reminiscence in the aged. Psychiatry1963;26:65‐76. ">Butler 1963</a>'s early work on "Life Review." Butler described Life Review as a naturally occurring process where the person looks back on his/her life and reflects on past experiences, including unresolved difficulties and conflicts. This concept was incorporated in psychotherapy for older people, which emphasises that life review can be helpful in promoting a sense of integrity and adjustment. Butler's seminal work contributed to the change in professional perspectives on reminiscence. Rather than being viewed as a problem, with the older person 'living in the past,' reminiscence was sees as a dynamic process of adjustment. This fitted well with <a href="./references#CD001120-bbs2-0096" title="Erikson , E.H . Childhood and Society. New York: Norton, 1950. ">Erikson 1950</a>'s late‐life stage of development, where the person is seen as reflecting on life, seeking to make sense and find meaning in a life lived. </p> <p>Around the same time, increasing interest in oral history meant that the reminiscences of older people were valued more greatly. In the UK, the development of the 'Recall' tape‐slide package (<a href="./references#CD001120-bbs2-0103" title="Help theAged . Recall. London (UK): Help the Aged, 1981. ">Help the Aged 1981</a>) meant that reminiscence triggers were widely available in day care centres, care homes and hospitals, leading many staff to establish some form of reminiscence work, of variable quality. There was also interest in using reminiscence to guide environmental design on the basis that, for example, a lounge of a care home which resembled a living room from earlier in the person's life would seem more familiar and might lead to better maintenance of independence. </p> <p>It is evident that reminiscence work may take a number of different forms, from psychotherapy through to environmental redesign. There is an extensive literature on the various functions of reminiscence, with numerous classification systems proposed (e.g. <a href="./references#CD001120-bbs2-0117" title="RomaniukM , RomaniukJ . Looking back: an analysis of reminiscence functions and triggers. Experimental Aging Research1981;7:477‐89. ">Romaniuk 1981</a>). Differences have emerged between reminiscence functions in their association with mental health, with seeking identity having a positive association and a focus on bitterness, boredom reduction and loss being associated with worse mental health (<a href="./references#CD001120-bbs2-0118" title="RosL , MelendezJC , WebsterJD , ButlerT , SalesA , LatorreJM , et al. Reminiscence functions scale: factorial structure and its relation with mental health in a sample of Spanish older adults. International Psychogeriatrics / IPA2016;28(9):1521‐32. ">Ros 2016</a>). In one general systematic review of reminiscence work, across a variety of populations, drawing from over 100 studies, <a href="./references#CD001120-bbs2-0114" title="PinquartM , ForstmeierS . Effects of reminiscence interventions on psychosocial outcomes: a meta‐analysis. Aging &amp; Mental Health2012;16(5):541‐58. ">Pinquart 2012</a> categorised the type of 'therapeutic work' undertaken into three broad categories: 'simple reminiscence,' involving the recall and sharing of selected personal and shared memories and stories; 'life review,' seen as a structured, evaluative process, usually conducted individually, covering the whole life story chronologically, seeking to integrate negative and positive memories; and 'life review therapy,' typically aimed at people with depression or other mental health difficulties where the aim is to re‐evaluate negative memories, promoting a more positive view of life. 'Life story work' is becoming increasingly used to describe aspects of reminiscence work, such as life review, where the emphasis is on developing a narrative biography, drawing together past, present and future. Life story books are common tangible outcomes from such work, but other media have also been used, such as a display box, portraying key elements of the person's life. Life story work has been employed with children and young people, people with learning disabilities and people with depression (<a href="./references#CD001120-bbs2-0127" title="WoodsB , SubramaniamP . The evidence base for lifestory work so far. In: KaiserP , EleyR editor(s). Life Story Work with People with Dementia; Ordinary Lives, Extraordinary People. London (UK): Jessica Kingsley, 2016:83‐94. ">Woods 2016</a>). The type of reminiscence work undertaken has important implications for the training, supervision and support needed by those acting as facilitators or therapists. </p> <p>Reminiscence work, including life review, has consistently been helpful for older people with depressed mood (<a href="./references#CD001120-bbs2-0089" title="BohlmeijerE , SmitF , CuijpersP . Effects of reminiscence and life review on late‐life depression: a meta‐analysis. International Journal of Geriatric Psychiatry2003;18:1088‐94. ">Bohlmeijer 2003</a>; <a href="./references#CD001120-bbs2-0113" title="PinquartM , DubersteinPR , LynessJM . Effects of psychotherapy and other behavioral interventions on clinically depressed older adults: a meta‐analysis. Aging &amp; Mental Health2007;11(6):645‐57. ">Pinquart 2007</a>). The effects are comparable to both medication and other psychosocial approaches. Life review may also be helpful in preventing depression in older adults (<a href="./references#CD001120-bbs2-0115" title="PotAM , BohlmeijerET , OnrustS , MelenhorstAS , VeerbeekM , DeVriesW . The impact of life review on depression in older adults: a randomized controlled trial. International Psychogeriatrics / IPA2010;22(4):572‐81. ">Pot 2010</a>), and in improving life satisfaction and quality of life (QoL) in older adults in general (<a href="./references#CD001120-bbs2-0090" title="BohlmeijerET , RoemerM , CuijpersP , SmitF . The effects of reminiscence on psychological well‐being in older adults: a meta‐analysis. Aging &amp; Mental Health2007;11:291‐300. ">Bohlmeijer 2007</a>). The effects are also seen in older people with depressed mood living in long‐term care environments (<a href="./references#CD001120-bbs2-0128" title="ZhangSJ , HwuYJ , WuPI , ChangCW . The effects of reminiscence therapy on depression, self‐esteem and life satisfaction on institutionalized older adults: a meta‐analysis. Journal of Nursing &amp; Healthcare Research2015;11(1):33‐42. ">Zhang 2015</a>). Given that depressed mood is more common in people with dementia, reminiscence work may be helpful in dementia in relation to improving mood. </p> <p>In the context of dementia, reminiscence work can also be seen to have a cognitive rationale. People with dementia often appear able to recall events from their childhood, but not from more recent times, even earlier the same day. Drawing on the apparently preserved store of remote memories appears a sensible strategy, when dementia is typically accompanied by great difficulty in new learning. By linking with the person's cognitive strengths in this way, communication might be enhanced, allowing the person to talk confidently of their earlier life and experiences. In fact, studies of remote memory suggest that recall for specific events is not relatively preserved; performance across the lifespan is impaired but people with dementia, like all older people, have an 'autobiographical memory bump,' recalling more memories from youth and adolescence (<a href="./references#CD001120-bbs2-0111" title="MorrisRG . Recent developments in the neuropsychology of dementia. International Review of Psychiatry1994;6:85‐107. ">Morris 1994</a>). Some of the memories represent well‐rehearsed, much practised items or anecdotes. The almost complete absence of autobiographical memories from the person's middle years could lead to a disconnection of past and present, which could contribute to the person's difficulty in retaining a clear sense of personal identity. From a cognitive standpoint, autobiographical memory and level of communication appear key outcomes. </p> <p>Since the first study on reminiscence work that was conducted with a group of older people with dementia was reported by <a href="./references#CD001120-bbs2-0107" title="KiernatJM . The use of life review activity with confused nursing home residents. American Journal of Occupational Therapy1979;33:306‐10. ">Kiernat 1979</a>, the approach has continued to be implemented widely, in a variety of forms. However, the research literature has developed more slowly. The 2005 version of this review included only four studies, and several of them were of low quality. In a more recent review, <a href="./references#CD001120-bbs2-0094" title="CotelliM , ManentiR , ZanettiO . Reminiscence therapy in dementia: a review [Review]. Maturitas2012;72(3):203‐5. ">Cotelli 2012</a> also highlighted the absence of high quality studies. <a href="./references#CD001120-bbs2-0122" title="SubramaniamP , WoodsB . The impact of individual reminiscence therapy for people with dementia: systematic review [Review]. Expert Review of Neurotherapeutics2012;12(5):545‐55. ">Subramaniam 2012</a> focused on individual reminiscence work in their systematic review, identifying five randomised controlled trials (RCT), mainly with small sample sizes. The distinction between 'simple' reminiscence and 'life review,' often leading to the production of a life story book, appeared salient in these reviews. Simple reminiscence may be on an individual or a group basis, whereas life review is typically conducted individually. The involvement of family carers in reminiscence groups jointly with people with dementia is a further development, using simple reminiscence but potentially having an effect on pre‐existing relationships (<a href="./references#CD001120-bbs2-0091" title="BruceE , GibsonF . Remembering Yesterday, Caring Today: Evaluators' Report. London (UK): Age Exchange, 1998. ">Bruce 1998</a>; <a href="./references#CD001120-bbs2-0019" title="ThorgrimsenL , SchweitzerP , OrrellM . Evaluating reminiscence for people with dementia: a pilot study. The Arts in Psychotherapy2002;29(1):93‐7. ">Thorgrimsen 2002</a>). </p> <p>The implications of this background for the current review are as follows.</p> <p> <ul id="CD001120-list-0001"> <li> <p>The type of reminiscence work and its aims needs to be clearly defined. In considering reminiscence work with people with dementia, the key distinction is between 'simple' reminiscence work that has a focus on the individual making sense of their own life story, which is described as having an integrative function. This has implications for whether the work is carried out individually or in a group; life review/life story reminiscence is almost always individual, whereas simple reminiscence can be sustained in one‐to‐one settings or in a group. Life story work usually requires memory triggers specific to the person, whereas more general triggers may be sufficient to trigger a broad range of stories and memories, in simple reminiscence. </p> </li> <li> <p>Different outcome measures may be appropriate according to the type of reminiscence work and its aims. The range of potential aims include: to enhance communication; to increase a sense of personal identity; to have an enjoyable activity in company with others; to improve mood and QoL; to stimulate memories; to increase the individualisation of care; or a combination of these. This list suggests that improvements in general cognition and behaviour might not be the most prominent of the changes expected, except as an indirect consequence of mood change perhaps. </p> </li> <li> <p>The impact on others, in addition to the person with dementia, may also be important, particularly where family carers are involved in the reminiscence work. For example, <a href="./references#CD001120-bbs2-0004" title="BainesS , SaxbyP , EhlertK . Reality orientation and reminiscence therapy: a controlled cross‐over study of elderly confused people. British Journal of Psychiatry1987;151:222‐31. ">Baines 1987</a> examined staff knowledge of those attending group sessions; this increased in reminiscence groups compared with no treatment. Knowledge regarding the person with dementia is of course a prerequisite for individualised care. </p> </li> <li> <p>Memories from the person's earlier life will not all be sources of pleasure and happiness; indeed some may be distressing or traumatic. Evaluation of any negative impact of this approach is required to monitor whether the recall of such memories occurs, and, if it does, whether these can be managed safely within the particular therapeutic context. </p> </li> </ul> </p> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD001120-sec-0017" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD001120-sec-0017"></div> <p>To assess the effects of RT on people living with dementia and their carers, taking into account differences in its implementation, including setting (care home, community) and modality (group, individual). </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD001120-sec-0018" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD001120-sec-0018"></div> <section id="CD001120-sec-0019"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD001120-sec-0020"> <h4 class="title">Types of studies</h4> <p>Studies had to meet the following criteria.</p> <p> <ul id="CD001120-list-0002"> <li> <p>RCTs including cluster randomised trials and cross‐over trials that used RT of any type as an intervention for people living with dementia. </p> </li> </ul> <ul id="CD001120-list-0003"> <li> <p>Control activity was no treatment, treatment as usual or a passive treatment such as basic social contact. </p> </li> </ul> <ul id="CD001120-list-0004"> <li> <p>Study was written in English and published in a peer‐reviewed journal.</p> </li> </ul> </p> <p>Trials that did not publish (or later supply) adequate information about study design and results were included in the review but not in the meta‐analysis. Details are noted in <a href="./references#CD001120-sec-0133" title="">Characteristics of included studies</a>. </p> </section> <section id="CD001120-sec-0021"> <h4 class="title">Types of participants</h4> <p>We included:</p> <p> <ul id="CD001120-list-0005"> <li> <p>participants were people with a diagnosis of dementia, preferably a formal diagnosis according to the Diagnostic and Statistical Manual of Mental Disorders ‐ fourth edition (<a href="./references#CD001120-bbs2-0095" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition. Washington (DC): APA, 1994. ">DSM‐IV</a>), but other diagnostic criteria were considered and included if appropriate. There were no age limits. The main diagnostic categories were Alzheimer's disease (AD) and vascular dementia (VD). These were combined in the analysis; </p> </li> </ul> <ul id="CD001120-list-0006"> <li> <p>all levels of severity. Severity of dementia was determined by group mean scores or score ranges on standardised scales such as the Clinical Dementia Rating (CDR) (<a href="./references#CD001120-bbs2-0106" title="HughesCP , BergL , DanzigerWL , CobenLA , MartinRL . A new clinical scale for the staging of dementia. British Journal of Psychiatry1982;140:566‐72. ">Hughes 1982</a>) or Mini‐Mental State Examination (MMSE) (<a href="./references#CD001120-bbs2-0097" title="FolsteinMF , FolsteinSE , McHughPR . 'Mini Mental State': a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research1975;12:189‐98. ">Folstein 1975</a>); </p> </li> </ul> <ul id="CD001120-list-0007"> <li> <p>family or professional carers where studies recruited dyads (person with dementia and their carer together); </p> </li> </ul> <ul id="CD001120-list-0008"> <li> <p>trials that investigated the effects of RT on different dementia diagnoses by allocating specific control groups for each diagnosis were analysed as separate studies. </p> </li> </ul> </p> <p>We excluded:</p> <p> <ul id="CD001120-list-0009"> <li> <p>participants with mild cognitive impairment (MCI) where the degree of cognitive impairment did not warrant a diagnosis of dementia. </p> </li> </ul> </p> </section> <section id="CD001120-sec-0022"> <h4 class="title">Types of interventions</h4> <p> <ul id="CD001120-list-0010"> <li> <p>Studies were considered for this review if they described a reminiscence intervention (including life story work) targeting people living with dementia in any of the outcomes of interest. Outcomes of interest are described under <a href="#CD001120-sec-0023">Types of outcome measures</a>. </p> </li> <li> <p>Studies were included if the planned duration of the intervention was four weeks or longer or if at least six sessions were offered over a shorter time frame. There was no restriction on the maximum number of RT sessions. </p> </li> <li> <p>Studies were included if a comparison was made to 'no treatment,' 'treatment as usual' or a basic passive control treatment. Passive treatments could consist of, for example, an equivalent number of sessions in which general conversation with participants took place. Comparisons with other activities or therapies such as music therapy were not considered in this review. 'Treatment as usual' was taken to mean standard health care, or activities in accordance with health or social care services' usual provision. </p> </li> </ul> </p> </section> <section id="CD001120-sec-0023"> <h4 class="title">Types of outcome measures</h4> <p> <ul id="CD001120-list-0011"> <li> <p>Studies included assessments of any of the outcomes of interest, provided they used standardised measures, rating scales or questionnaires. Studies could have presented data on both outcomes for the person with dementia and carer outcomes. </p> </li> </ul> <ul id="CD001120-list-0012"> <li> <p>Outcomes that measured post‐treatment (typically immediately after, or within one month after the intervention), and at follow‐up (typically one to six months' post‐intervention). </p> </li> </ul> <ul id="CD001120-list-0013"> <li> <p>Maintaining the effects of the intervention over time was anticipated to be an issue for studies involving people with dementia, therefore, it was expected that post‐treatment data would be captured as close to the final session as possible, to identify immediate outcomes or changes that may have been lost to longer‐term follow‐up. </p> </li> </ul> <ul id="CD001120-list-0014"> <li> <p>Attrition and the reasons for participants dropping out were noted.</p> </li> </ul> </p> <section id="CD001120-sec-0024"> <h5 class="title">Outcomes for the person with dementia</h5> <section id="CD001120-sec-0025"> <h6 class="title">Primary outcome</h6> <p> <ul id="CD001120-list-0015"> <li> <p>Quality of life.</p> </li> </ul> </p> </section> <section id="CD001120-sec-0026"> <h6 class="title">Secondary outcomes</h6> <p> <ul id="CD001120-list-0016"> <li> <p>Cognition.</p> </li> <li> <p>Communication and interaction.</p> </li> <li> <p>Quality of relationship with carer</p> </li> <li> <p>Behaviour, including agitation and activities of daily living (ADL).</p> </li> <li> <p>Mood‐related outcomes, including apathy, anxiety and depression.</p> </li> </ul> </p> <p>Outcomes of interest for the person with dementia were measured using standardised instruments to determine if changes in these outcomes were observed following the intervention. This included self‐reported ratings, clinical ratings or carer ratings of the outcome. </p> </section> </section> <section id="CD001120-sec-0027"> <h5 class="title">Outcomes for the carer</h5> <p>'Carer' in these contexts refers to family carers and professional carers, although they were considered separately in the review. </p> <p> <ul id="CD001120-list-0017"> <li> <p>Mood.</p> </li> <li> <p>Stress/stain related to caring.</p> </li> <li> <p>Quality of life.</p> </li> <li> <p>Outcomes relating to the dyadic relationship.</p> </li> </ul> </p> </section> <section id="CD001120-sec-0028"> <h5 class="title">Adverse outcomes</h5> <p>There is a potential risk that the process of recalling memories from the past may bring about difficult or emotional (or both) memories, which should be anticipated and managed sensitively by facilitators. The potential for adverse outcomes was monitored by observing negative responses on the outcome measures. Family carers or care staff hold their own perceptions of the intervention and its effect on the participant, as well as on themselves, which will be reflected in their carer‐rated outcome measures. </p> </section> </section> </section> <section id="CD001120-sec-0029"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD001120-sec-0030"> <h4 class="title">Electronic searches</h4> <p>We searched ALOIS (<a href="http://www.medicine.ox.ac.uk/alois" target="_blank">www.medicine.ox.ac.uk/alois</a>), the Cochrane Dementia and Cognitive Improvement Group's Specialized Register on 6 April 2017. The search term used was 'reminiscence.' </p> <p>ALOIS was created in part thanks to a grant from the American Alzheimer's Association and is maintained by the Information Specialists of the Cochrane Dementia and Cognitive Improvement Group. It contains studies in the areas of dementia prevention, dementia treatment and cognitive enhancement in healthy older populations. The studies are identified from:   </p> <p> <ul id="CD001120-list-0018"> <li> <p>monthly searches of major healthcare databases: MEDLINE, Embase, CINAHL, PsycINFO and LILACS; </p> </li> <li> <p>monthly searches of trial registers: ISRCTN; UMIN (Japan's Trial Register); the World Health Organization (WHO) portal (which covers ClinicalTrials.gov; ISRCTN; the Chinese Clinical Trials Register; the German Clinical Trials Register; the Iranian Registry of Clinical Trials and the Netherlands National Trials Register, plus others); </p> </li> <li> <p>quarterly search of Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>six‐monthly searches grey literature sources: ISI Web of Knowledge Conference Proceedings; Index to Theses; Australasian Digital Theses. </p> </li> </ul> </p> <p>To view a list of all sources searched for ALOIS see <a href="http://www.medicine.ox.ac.uk/alois/content/about-alois" target="_blank">About ALOIS</a> on the ALOIS website. </p> <p>Details of the search strategies used for the retrieval of reports of trials from the healthcare databases, CENTRAL and conference proceedings can be viewed in the 'methods used in reviews' section within the editorial information about the <a href="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/DEMENTIA/frame.html" target="_blank">Dementia and Cognitive Improvement Group</a>. </p> <p>Additional searches (6 April 2017) were performed in many of the sources listed above to cover the timeframe from the last searches performed for ALOIS to ensure that the search for the review was as up‐to‐date and comprehensive as possible. See <a href="./appendices#CD001120-sec-0123">Appendix 1</a> for search strategies. </p> </section> <section id="CD001120-sec-0031"> <h4 class="title">Searching other resources</h4> <p> <ul id="CD001120-list-0019"> <li> <p>The Alzheimer's Society library.</p> </li> <li> <p>Letters published in BPS Division of Clinical Psychology Faculty of Psychology of Older People and the BPS (British Psychological Society) magazines, requesting information on any controlled trials that may not have been easily discovered (e.g. unpublished papers). </p> </li> <li> <p>Personal contact with specialists in the field.</p> </li> </ul> </p> <p>Additionally, we searched the reference lists of all papers for further references, and review authors searched personal holdings of references to reports and trials. We sent letters/e‐mails to all authors of included RCTs asking for essential information, where this was not available in the publication (e.g. statistics or details of randomisation, or both). </p> </section> </section> <section id="CD001120-sec-0032"> <h3 class="title" id="CD001120-sec-0032">Data collection and analysis</h3> <section id="CD001120-sec-0033"> <h4 class="title">Selection of studies</h4> <p>Following deduplication, two review authors (LOP and EF) independently reviewed the abstracts and, if necessary, the manuscripts of potential studies identified by the search. These review authors were not involved in any of the studies produced by the searches. We excluded obviously irrelevant studies. We obtained the full text of remaining studies and excluded studies that did not meet the inclusion criteria with reasons outlined in the <a href="./references#CD001120-sec-0134" title="">Characteristics of excluded studies</a> table. If authors disagreed about the inclusion of a particular study, this was referred to another review author (BW or AS) for clarification. We collated multiple reports of the same study, so that each study, rather than each report, was the unit of interest in the review. We recorded the selection process in sufficient detail to complete a PRISMA flow diagram (<a href="#CD001120-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD001120-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD001120-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD001120-sec-0034"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (EF and LOP) independently extracted descriptive characteristics, study methodology data and study results from the included studies, recorded them on a data collection form and entered them into Review Manager 5 (<a href="./references#CD001120-bbs2-0116" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). The form was piloted on ten studies. We compared the data to ensure accuracy. Where data did not match, one review author (LOP) checked the data of both authors and made changes if necessary with the agreement of another review author (EF). </p> <p>For each outcome measure, the authors sought to obtain data on every participant randomised irrespective of whether the participant was excluded or dropped out of the intervention or research (i.e. data from an intention to treat (ITT) analysis). If these data were not available in the published studies, the review authors sought the data of those who completed the trials. </p> <p>Where necessary, we sent emails to trial authors requesting additional information. If this was unsuccessful, we contacted authors through ResearchGate. </p> </section> <section id="CD001120-sec-0035"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (LOP and EF) independently assessed the risk of bias of each trial using the Cochrane 'Risk of bias' tool (<a href="./references#CD001120-bbs2-0104" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We attempted to obtain additional information from study authors when we required further information. Based on the methods detailed in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD001120-bbs2-0104" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>), we classified each category of bias as 'low risk of bias,' 'high risk of bias' or 'unclear risk of bias.' An outline of this can be seen in Table 1 below. The meta‐analysis included only trials with a low or unclear risk of bias, except in the case of random sequence generation where only trials with a low risk of bias were included. Any disagreements regarding risk of bias ratings were referred to an independent review author (AS) for clarification. Overall ratings were assigned with respect to each study's methodological quality and are described in the 'Risk of bias' table, <a href="#CD001120-fig-0002">Figure 2</a>; and <a href="#CD001120-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD001120-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD001120-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD001120-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD001120-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <p> <div class="table" id="CD001120-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Table 1. Risk of bias assessment table</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Domain</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><b>Risk of bias judgement</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Selection bias</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Low</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>High</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Unclear</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Random sequence generation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Assigned if simple randomisation was used (e.g. computer‐generated random sequence, coin tossing). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Assigned if study reported an inadequate randomisation method (e.g. using date of birth or odd/even numbers). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Assigned if there was insufficient detail to judge the risk of bias as low or high.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Assigned if restricted randomisation was used (e.g. block randomisation, provided that within groups randomisation was not affected). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allocation Concealment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Assigned if there was evidence of concealed allocation sequence in which allocations could not have been foreseen in advance of, or during, enrolment. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Assigned if those enrolling participants were aware of the group (or period in a cross‐over trial) to which the next enrolled participant would be allocated. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Assigned if there was insufficient detail to judge the risk of bias as low or high.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Detection bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Unclear</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Blinding of outcome assessors (blinding of participants and facilitators is not possible in psychosocial interventions). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Assigned if outcome assessors were blind to treatment allocation.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Assigned if the outcome assessors were aware of treatment allocation (e.g. if the reminiscence facilitator was also an outcome assessor). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Assigned if there was insufficient detail to judge the risk of bias as low or high.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Attrition bias </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Unclear</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Incomplete outcome data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Assigned if the study reported levels of attrition, reasons for attrition and how missing data were dealt with. Assigned if the impact of missing data was not believed to alter the conclusions and there were acceptable reasons for the missing data. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Assigned if there was inadequate information regarding the level of attrition in each group, reasons for attrition and if missing data were not handled correctly. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Assigned if there was insufficient detail to judge the risk of bias as low or high.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reporting bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Unclear</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Assigned if study reported results of all outcome measures that were detailed in the methods section. If a study protocol was available, low risk of bias was assigned if the outcome assessments reported in the trial paper matched those detailed in the protocol. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Assigned if study did not report results of all outcome measures that were detailed in the methods section. Assigned if all outcome measures detailed in the protocol (if available) were not reported in the study. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Assigned if there was insufficient detail to judge the risk of bias as low or high.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Other bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>High</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Unclear</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Availability of training and supervision</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Assigned if RT sessions were facilitated by people who had received some form of training to ensure the necessary principles of RT were adhered to. The definition of training was inclusive and could range from a brief session to a longer, more intensive course. This also applied to interventions delivered by trained family carers. The opportunity for facilitators to access appropriate supervision was also desirable. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Assigned if there was no evidence of facilitator training or supervision.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Assigned if there was insufficient detail to judge the risk of bias as low or high.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Availability of manual, structure or protocol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Assigned if there was evidence of a documented intervention protocol, structure or manual outlining the content of each session to ensure the principles of RT were adhered to. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Assigned if there was no evidence of a treatment protocol, structure or manual for facilitators to follow. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Assigned if there was insufficient detail to judge the risk of bias as low or high.</p> </td> </tr> </tbody> </table> </div> </p> <p>RT: reminiscence therapy.</p> </section> <section id="CD001120-sec-0036"> <h4 class="title">Measures of treatment effect</h4> <p>Data from all included studies were continuous. This type of data required the mean change scores from baseline, the standard deviation of the mean change and the number of participants for each treatment group at each assessment. The majority of study authors did not report change scores from baseline. The baseline assessment was defined as the latest available assessment prior to randomisation, but no longer than two months prior. Where change scores were not reported, the review authors extracted the mean, standard deviation and number of participants for each treatment group at each time point and calculated the required summary statistics manually. In this case, a zero correlation between the measurements at baseline and assessment time was assumed. This method overestimates the standard deviation of the change from baseline, but this conservative approach is considered to be preferable in a meta‐analysis. </p> <p>The meta‐analyses included the combination of data from trials that may not have used the same rating scale to measure a particular outcome. For example, cognition may have been measured by the MMSE in one study and the Autobiographical Memory Interview (AMI) in another. In this situation, the standardised mean difference (SMD; the absolute mean difference (MD) divided by the standard deviation) was used to measure the treatment difference. Where pooled trials used the same rating scale or test to measure an outcome, the MD was used. </p> <p>To allow comparisons with other scales assessing similar outcomes, it was necessary to reverse the change scores on certain scales. For example, on measures of depression where a low score was indicative of a positive outcome on one scale and a high score was indicative of a positive outcome on another. </p> </section> <section id="CD001120-sec-0037"> <h4 class="title">Unit of analysis issues</h4> <p>In studies using a cross‐over design, only data from the first treatment phase after randomisation were eligible for inclusion. </p> <p>Where studies used cluster randomisation and were large, one review author (LOP) extracted the mean size of each cluster, the mean and standard deviation summary statistics, and the estimated intraclass correlation coefficient (ICC) in order to reduce the size of the trial to its effective sample size. This was carried out following Cochrane guidelines set out in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i>. Where studies were not large enough, this could not be carried out. </p> <p>Cluster trials were also assessed for additional biases associated with clustering, including recruitment bias; baseline imbalance; loss of clusters and comparability with individually randomised trials. </p> </section> <section id="CD001120-sec-0038"> <h4 class="title">Dealing with missing data</h4> <p>Where possible, review authors extracted data on all participants randomised. Data from ITT analyses were preferred to per protocol or compliance analyses. </p> </section> <section id="CD001120-sec-0039"> <h4 class="title">Assessment of heterogeneity</h4> <p>Assessments of heterogeneity were performed using both the Chi<sup>2</sup> and I<sup>2</sup> statistic. Review authors followed guidance in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> to interpret heterogeneity percentages (i.e. 0% to 40% might not be important; 30% to 60% may represent moderate heterogeneity, 50% to 90% may represent substantial heterogeneity; and 75% to 100% is considerable heterogeneity). </p> </section> <section id="CD001120-sec-0040"> <h4 class="title">Assessment of reporting biases</h4> <p>If there were enough studies available, authors created a funnel plot to assess the risk of publication bias. </p> </section> <section id="CD001120-sec-0041"> <h4 class="title">Data synthesis</h4> <p>The meta‐analyses presented overall estimates of the treatment difference using a fixed‐effect model. Where there was evidence of high heterogeneity of the treatment effect between trials, we used a random‐effects model (which results in broader CIs than a fixed‐effect model). </p> </section> <section id="CD001120-sec-0042"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Subgroup analyses were performed where possible to assess for any important differences related to environmental context or the type/modality of the reminiscence intervention. Assessments of heterogeneity were performed using both the Chi<sup>2</sup> test and I<sup>2</sup> statistic. Where heterogeneity was high, we used a random‐effects model (rather than a fixed‐effect model). </p> </section> <section id="CD001120-sec-0043"> <h4 class="title">Sensitivity analysis</h4> <p>Where necessary, sensitivity analyses were carried out. For example, when meta‐analysing carer scores on the Zarit Burden Interview (ZBI), a sensitivity analysis was carried out depending on the level of carer involvement in the intervention. </p> <section id="CD001120-sec-0044"> <h5 class="title">Presentation of results and 'Summary of findings' tables</h5> <p>We used GRADE methods to rate the quality of evidence (high, moderate, low or very low) behind each effect estimate in the review (<a href="./references#CD001120-bbs2-0099" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383‐394. ">Guyatt 2011</a>). This rating referred to our level of confidence that the estimate reflected the true effect, taking account of the risk of bias in the included studies, inconsistency between studies, imprecision in the effect estimate, indirectness in addressing our review question and the risk of publication bias. We produced 'Summary of findings' tables for RT compared to no treatment to show the effect estimate and the quantity and quality of the supporting evidence for the following outcomes: </p> <p> <ol id="CD001120-list-0020"> <li> <p>self‐reported QoL,</p> </li> <li> <p>communication and interaction</p> </li> <li> <p>cognition</p> </li> <li> <p>functional behaviour</p> </li> <li> <p>agitation</p> </li> <li> <p>depressed mood</p> </li> <li> <p>carer stress</p> </li> </ol> </p> <p>We produced additional tables to summarise the effects on QoL, communication and interaction, and cognition for the two different settings for reminiscence work included in this review (community and care home settings) and for the two major modality types (individual reminiscence work and reminiscence groups). We prepared the 'Summary of findings' tables using the GRADEpro GDT 2015 (<a href="http://gradepro.org" target="_blank">gradepro.org</a>). </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD001120-sec-0045" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD001120-sec-0045"></div> <section id="CD001120-sec-0046"> <h3 class="title">Description of studies</h3> <p>See: <a href="./references#CD001120-sec-0133" title="">Characteristics of included studies</a>; <a href="./references#CD001120-sec-0134" title="">Characteristics of excluded studies</a>; and <a href="./references#CD001120-sec-0135" title="">Characteristics of ongoing studies</a> tables. </p> <section id="CD001120-sec-0047"> <h4 class="title">Results of the search</h4> <p>Systematic searches conducted since the previous review up to October 2014 identified 102 potentially eligible trials, of which 11 were included. A further search conducted in April 2015 identified 21 potential trials. One of these met the inclusion criteria, but was only available as a conference paper (<a href="./references#CD001120-bbs2-0086" title="DwolatzkyT , TractinskyN , Sarne‐FleischmannV . Computer‐supported personal interventions for older people with cognitive impairment and dementia. Alzheimer's Association International Conference 2014; 2014 Jul 12‐17; Copenhagen, Denmark2014:P158. ">Dwolatzky 2014</a>). Later, in April 2016 another search returned 25 records, with three eligible for inclusion. A final search in April 2017 yielded 37 results, of which two were eligible for inclusion. This gave a total of 21 trials that met the inclusion criteria. Two trials by the same authors were identified (<a href="./references#CD001120-bbs2-0072" title="TadakaE , KanagawaK . Randomized controlled trial of a group care program for community‐dwelling elderly people with dementia. Japan Journal of Nursing Science2004;1(1):19‐25. ">Tadaka 2004</a>; <a href="./references#CD001120-bbs2-0124" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007;7(2):167‐73. ">Tadaka 2007</a>), and further examination showed that the same data set and outcome measures were used in both papers. As the data from the earlier paper were not in usable form, the more recent paper, which presented the results as a comparison of AD and VD was included (<a href="./references#CD001120-bbs2-0124" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007;7(2):167‐73. ">Tadaka 2007</a>), and the earlier paper (<a href="./references#CD001120-bbs2-0072" title="TadakaE , KanagawaK . Randomized controlled trial of a group care program for community‐dwelling elderly people with dementia. Japan Journal of Nursing Science2004;1(1):19‐25. ">Tadaka 2004</a>) was excluded. Because <a href="./references#CD001120-bbs2-0124" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007;7(2):167‐73. ">Tadaka 2007</a> analysed the two participant groups separately, with a different control group for each disease type, we entered this study into the meta‐analysis as two separate RCTs (<a href="./references#CD001120-bbs2-0017" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (AD)</a>; <a href="./references#CD001120-bbs2-0018" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (VD)</a>), bringing the number of included studies to 22. More information can be found in the study flow diagram (<a href="#CD001120-fig-0001">Figure 1</a>). </p> </section> <section id="CD001120-sec-0048"> <h4 class="title">Included studies</h4> <p>The review included 22 studies, with 1972 participants: 1001 participants were randomised to treatment conditions and 971 participants to control conditions. In addition to the five studies in our previous 2005 review (<a href="./references#CD001120-bbs2-0004" title="BainesS , SaxbyP , EhlertK . Reality orientation and reminiscence therapy: a controlled cross‐over study of elderly confused people. British Journal of Psychiatry1987;151:222‐31. ">Baines 1987</a>; <a href="./references#CD001120-bbs2-0006" title="GoldwasserAN , AuerbachSM , HarkinsSW . Cognitive, affective and behavioural effects of reminiscence group therapy on demented elderly. International Journal of Aging &amp; Human Development1987;25(3):209‐22. ">Goldwasser 1987</a>; <a href="./references#CD001120-bbs2-0011" title="LaiCKY , ChiI , Kayser‐JonesJ . A randomised controlled trial of a specific reminiscence approach to promote the well‐being of nursing home residents with dementia. International Psychogeriatrics / IPA2004;16(1):33‐49. ">Lai 2004</a>; <a href="./references#CD001120-bbs2-0013" title="MorganS , WoodsRT . Life review with people with dementia in care homes: a preliminary randomised controlled trial. Dementia: Non‐Pharmacological Therapies2012;1(1):43‐59. ">Morgan 2012</a>; <a href="./references#CD001120-bbs2-0019" title="ThorgrimsenL , SchweitzerP , OrrellM . Evaluating reminiscence for people with dementia: a pilot study. The Arts in Psychotherapy2002;29(1):93‐7. ">Thorgrimsen 2002</a>) (of which the <a href="./references#CD001120-bbs2-0013" title="MorganS , WoodsRT . Life review with people with dementia in care homes: a preliminary randomised controlled trial. Dementia: Non‐Pharmacological Therapies2012;1(1):43‐59. ">Morgan 2012</a> study is now a published article rather than a doctoral thesis), 17 new studies met the inclusion criteria (<a href="./references#CD001120-bbs2-0001" title="AkanumaK , MeguroK , MeguroM , SasakiE , ChibaK , IshiiH , et al. Improved social interaction and increased anterior cingulate metabolism after group reminiscence with reality orientation approach for vascular dementia. Psychiatry Research2011;192(3):183‐7. ">Akanuma 2011</a>; <a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>; <a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0007" title="GonzalezJ , MayordomoT , TorresM , SalesA , MelendezJC . Reminiscence and dementia: a therapeutic intervention. International Psychogeriatrics / IPA2015; Vol. 27, issue 10:1731‐7. ">Gonzalez 2015</a>; <a href="./references#CD001120-bbs2-0008" title="HaightB , GibsonF , MichelY . The Northern Ireland life review / life storybook project for people with dementia. Alzheimer's &amp; Dementia2006;2(1):56‐8. [DOI: 10.1016/j.jalz.2005.12.003] ">Haight 2006</a>; <a href="./references#CD001120-bbs2-0009" title="HsiehCJ , ChangC , SuSF , HsiaoYL , ShihYW , HanWH , et al. Reminiscence group therapy on depression and apathy in nursing home residents with mild to moderate dementia. Journal of Experimental Clinical Medicine2010;2(2):72‐8. ">Hsieh 2010</a>; <a href="./references#CD001120-bbs2-0010" title="ItoT , MeguroK , AkanumaK , IshiiH , MoriE . A randomized controlled trial of the group reminiscence approach in patients with vascular dementia. Dementia and Geriatric Cognitive Disorders2007; Vol. 24, issue 1:48‐54. ">Ito 2007</a>; <a href="./references#CD001120-bbs2-0012" title="MelendezJC , TorresM , RedondoR , MayordomoT , SalesA . Effectiveness of follow‐up reminiscence therapy on autobiographical memory in pathological ageing. International Journal of Psychology2015; Vol. 52, issue 4:283‐90. [10.1002/ijop. 12217] ">Melendez 2015</a>; <a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a>; <a href="./references#CD001120-bbs2-0015" title="SärkämöT , TervaniemiM , LaitinenS , NumminenA , KurkiM , JohnsonJK , et al. Cognitive, emotional and social benefits of regular musical activities in early dementia: randomised controlled study. Gerontologist2013;54(4):634‐50. ">Särkämö 2013</a>; <a href="./references#CD001120-bbs2-0016" title="SubramaniamP , WoodsB , WhitakerC . Life review and life story books for people with mild to moderate dementia: a randomised controlled trial. Aging &amp; Mental Health2013;18(3):363‐75. ">Subramaniam 2013</a>; <a href="./references#CD001120-bbs2-0017" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (AD)</a>; <a href="./references#CD001120-bbs2-0018" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (VD)</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>; <a href="./references#CD001120-bbs2-0022" title="YamagamiT , TakayamaY , MakiY , YamaguchiH . A randomized controlled trial of brain‐activating rehabilitation for elderly participants with dementia in residential care homes. Dementia and Geriatric Cognitive Disorders2012;2:372‐80. ">Yamagami 2012</a>; <a href="./references#CD001120-bbs2-0020" title="VanBogaertP , TolsonD , EerlingenR , CarversD , WoutersK , PaqueK , et al. SolCos model‐based individual reminiscence for older adults with mild to moderate dementia in nursing homes: a randomized controlled intervention study. Journal of Psychiatric and Mental Health Nursing2016;23(9‐10):568‐75. ">Van Bogaert 2016</a>). </p> <p>We excluded six of the included studies from the meta‐analyses (<a href="./references#CD001120-bbs2-0001" title="AkanumaK , MeguroK , MeguroM , SasakiE , ChibaK , IshiiH , et al. Improved social interaction and increased anterior cingulate metabolism after group reminiscence with reality orientation approach for vascular dementia. Psychiatry Research2011;192(3):183‐7. ">Akanuma 2011</a>; <a href="./references#CD001120-bbs2-0004" title="BainesS , SaxbyP , EhlertK . Reality orientation and reminiscence therapy: a controlled cross‐over study of elderly confused people. British Journal of Psychiatry1987;151:222‐31. ">Baines 1987</a>; <a href="./references#CD001120-bbs2-0006" title="GoldwasserAN , AuerbachSM , HarkinsSW . Cognitive, affective and behavioural effects of reminiscence group therapy on demented elderly. International Journal of Aging &amp; Human Development1987;25(3):209‐22. ">Goldwasser 1987</a>; <a href="./references#CD001120-bbs2-0007" title="GonzalezJ , MayordomoT , TorresM , SalesA , MelendezJC . Reminiscence and dementia: a therapeutic intervention. International Psychogeriatrics / IPA2015; Vol. 27, issue 10:1731‐7. ">Gonzalez 2015</a>; <a href="./references#CD001120-bbs2-0009" title="HsiehCJ , ChangC , SuSF , HsiaoYL , ShihYW , HanWH , et al. Reminiscence group therapy on depression and apathy in nursing home residents with mild to moderate dementia. Journal of Experimental Clinical Medicine2010;2(2):72‐8. ">Hsieh 2010</a>; <a href="./references#CD001120-bbs2-0022" title="YamagamiT , TakayamaY , MakiY , YamaguchiH . A randomized controlled trial of brain‐activating rehabilitation for elderly participants with dementia in residential care homes. Dementia and Geriatric Cognitive Disorders2012;2:372‐80. ">Yamagami 2012</a>). All six studies were at unclear risk of selection bias due to inadequate information about random sequence generation and allocation concealment. This was the main reason they were excluded, although all six were also rated at unclear risk of bias in at least one other domain. The risk of bias details for each study are summarised in the <a href="#CD001120-sec-0059">Risk of bias in included studies</a> tables while <a href="#CD001120-fig-0002">Figure 2</a> depicts the risk of bias summary. </p> <p>Considering that the <a href="./references#CD001120-bbs2-0004" title="BainesS , SaxbyP , EhlertK . Reality orientation and reminiscence therapy: a controlled cross‐over study of elderly confused people. British Journal of Psychiatry1987;151:222‐31. ">Baines 1987</a> and <a href="./references#CD001120-bbs2-0006" title="GoldwasserAN , AuerbachSM , HarkinsSW . Cognitive, affective and behavioural effects of reminiscence group therapy on demented elderly. International Journal of Aging &amp; Human Development1987;25(3):209‐22. ">Goldwasser 1987</a> studies dated from the 1980s, we did not attempt to contact the study authors. Furthermore, in the previous versions of this review, we were unable to get in touch with the authors of the <a href="./references#CD001120-bbs2-0006" title="GoldwasserAN , AuerbachSM , HarkinsSW . Cognitive, affective and behavioural effects of reminiscence group therapy on demented elderly. International Journal of Aging &amp; Human Development1987;25(3):209‐22. ">Goldwasser 1987</a> study. We attempted to contact the authors of the <a href="./references#CD001120-bbs2-0001" title="AkanumaK , MeguroK , MeguroM , SasakiE , ChibaK , IshiiH , et al. Improved social interaction and increased anterior cingulate metabolism after group reminiscence with reality orientation approach for vascular dementia. Psychiatry Research2011;192(3):183‐7. ">Akanuma 2011</a>; <a href="./references#CD001120-bbs2-0007" title="GonzalezJ , MayordomoT , TorresM , SalesA , MelendezJC . Reminiscence and dementia: a therapeutic intervention. International Psychogeriatrics / IPA2015; Vol. 27, issue 10:1731‐7. ">Gonzalez 2015</a>; <a href="./references#CD001120-bbs2-0009" title="HsiehCJ , ChangC , SuSF , HsiaoYL , ShihYW , HanWH , et al. Reminiscence group therapy on depression and apathy in nursing home residents with mild to moderate dementia. Journal of Experimental Clinical Medicine2010;2(2):72‐8. ">Hsieh 2010</a>; and <a href="./references#CD001120-bbs2-0022" title="YamagamiT , TakayamaY , MakiY , YamaguchiH . A randomized controlled trial of brain‐activating rehabilitation for elderly participants with dementia in residential care homes. Dementia and Geriatric Cognitive Disorders2012;2:372‐80. ">Yamagami 2012</a> studies for more information, but there was no response. </p> <p>Full details of included studies are presented in the <a href="./references#CD001120-sec-0133" title="">Characteristics of included studies</a> table and reasons for exclusion of studies in the <a href="./references#CD001120-sec-0134" title="">Characteristics of excluded studies</a> table. </p> <section id="CD001120-sec-0049"> <h5 class="title">Design</h5> <p>All studies were described by their authors as RCTs, although, as noted above, six studies did not provide enough information on the randomisation methods for us to be sure that the risk of selection bias was low. One study was a cross‐over trial (<a href="./references#CD001120-bbs2-0004" title="BainesS , SaxbyP , EhlertK . Reality orientation and reminiscence therapy: a controlled cross‐over study of elderly confused people. British Journal of Psychiatry1987;151:222‐31. ">Baines 1987</a>). There were three cluster randomised trials (<a href="./references#CD001120-bbs2-0007" title="GonzalezJ , MayordomoT , TorresM , SalesA , MelendezJC . Reminiscence and dementia: a therapeutic intervention. International Psychogeriatrics / IPA2015; Vol. 27, issue 10:1731‐7. ">Gonzalez 2015</a>; <a href="./references#CD001120-bbs2-0012" title="MelendezJC , TorresM , RedondoR , MayordomoT , SalesA . Effectiveness of follow‐up reminiscence therapy on autobiographical memory in pathological ageing. International Journal of Psychology2015; Vol. 52, issue 4:283‐90. [10.1002/ijop. 12217] ">Melendez 2015</a>; <a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a>). </p> </section> <section id="CD001120-sec-0050"> <h5 class="title">Diagnosis</h5> <p>All studies recruited participants with a diagnosis of dementia. One study recruited both participants with MCI and dementia due to AD, but we extracted only data from participants with dementia (<a href="./references#CD001120-bbs2-0012" title="MelendezJC , TorresM , RedondoR , MayordomoT , SalesA . Effectiveness of follow‐up reminiscence therapy on autobiographical memory in pathological ageing. International Journal of Psychology2015; Vol. 52, issue 4:283‐90. [10.1002/ijop. 12217] ">Melendez 2015</a>). Four studies did not specify which diagnostic criteria were used (<a href="./references#CD001120-bbs2-0004" title="BainesS , SaxbyP , EhlertK . Reality orientation and reminiscence therapy: a controlled cross‐over study of elderly confused people. British Journal of Psychiatry1987;151:222‐31. ">Baines 1987</a>; <a href="./references#CD001120-bbs2-0006" title="GoldwasserAN , AuerbachSM , HarkinsSW . Cognitive, affective and behavioural effects of reminiscence group therapy on demented elderly. International Journal of Aging &amp; Human Development1987;25(3):209‐22. ">Goldwasser 1987</a>; <a href="./references#CD001120-bbs2-0019" title="ThorgrimsenL , SchweitzerP , OrrellM . Evaluating reminiscence for people with dementia: a pilot study. The Arts in Psychotherapy2002;29(1):93‐7. ">Thorgrimsen 2002</a>; <a href="./references#CD001120-bbs2-0022" title="YamagamiT , TakayamaY , MakiY , YamaguchiH . A randomized controlled trial of brain‐activating rehabilitation for elderly participants with dementia in residential care homes. Dementia and Geriatric Cognitive Disorders2012;2:372‐80. ">Yamagami 2012</a>). Twelve studies specified a diagnosis of dementia according the DSM‐IV (<a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0007" title="GonzalezJ , MayordomoT , TorresM , SalesA , MelendezJC . Reminiscence and dementia: a therapeutic intervention. International Psychogeriatrics / IPA2015; Vol. 27, issue 10:1731‐7. ">Gonzalez 2015</a>; <a href="./references#CD001120-bbs2-0009" title="HsiehCJ , ChangC , SuSF , HsiaoYL , ShihYW , HanWH , et al. Reminiscence group therapy on depression and apathy in nursing home residents with mild to moderate dementia. Journal of Experimental Clinical Medicine2010;2(2):72‐8. ">Hsieh 2010</a>; <a href="./references#CD001120-bbs2-0011" title="LaiCKY , ChiI , Kayser‐JonesJ . A randomised controlled trial of a specific reminiscence approach to promote the well‐being of nursing home residents with dementia. International Psychogeriatrics / IPA2004;16(1):33‐49. ">Lai 2004</a>; <a href="./references#CD001120-bbs2-0012" title="MelendezJC , TorresM , RedondoR , MayordomoT , SalesA . Effectiveness of follow‐up reminiscence therapy on autobiographical memory in pathological ageing. International Journal of Psychology2015; Vol. 52, issue 4:283‐90. [10.1002/ijop. 12217] ">Melendez 2015</a>; <a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a>; <a href="./references#CD001120-bbs2-0016" title="SubramaniamP , WoodsB , WhitakerC . Life review and life story books for people with mild to moderate dementia: a randomised controlled trial. Aging &amp; Mental Health2013;18(3):363‐75. ">Subramaniam 2013</a>; <a href="./references#CD001120-bbs2-0017" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (AD)</a>; <a href="./references#CD001120-bbs2-0018" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (VD)</a>; <a href="./references#CD001120-bbs2-0020" title="VanBogaertP , TolsonD , EerlingenR , CarversD , WoutersK , PaqueK , et al. SolCos model‐based individual reminiscence for older adults with mild to moderate dementia in nursing homes: a randomized controlled intervention study. Journal of Psychiatric and Mental Health Nursing2016;23(9‐10):568‐75. ">Van Bogaert 2016</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). Of these, four also used the CDR to support a diagnosis of dementia (<a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0017" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (AD)</a>; <a href="./references#CD001120-bbs2-0018" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (VD)</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). One study enrolled participants with a diagnosis of AD based on the criteria of the National Institute of Neurological and Communicative Disorders and Stroke‐Alzheimer's Disease and Related Disorders Association (NINCDS‐ADRD) (<a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>). One study reported that participants had undergone assessment and diagnosis at the neurology department of the General Hospital of Valencia and met the study inclusion criteria (<a href="./references#CD001120-bbs2-0007" title="GonzalezJ , MayordomoT , TorresM , SalesA , MelendezJC . Reminiscence and dementia: a therapeutic intervention. International Psychogeriatrics / IPA2015; Vol. 27, issue 10:1731‐7. ">Gonzalez 2015</a>). Two studies recruited participants if they fulfilled the diagnostic criteria of ischaemic vascular disease with reference to computed tomography or magnetic resonance imaging (or both) findings, and if they scored between 10 and 24 on the MMSE (<a href="./references#CD001120-bbs2-0001" title="AkanumaK , MeguroK , MeguroM , SasakiE , ChibaK , IshiiH , et al. Improved social interaction and increased anterior cingulate metabolism after group reminiscence with reality orientation approach for vascular dementia. Psychiatry Research2011;192(3):183‐7. ">Akanuma 2011</a>; <a href="./references#CD001120-bbs2-0010" title="ItoT , MeguroK , AkanumaK , IshiiH , MoriE . A randomized controlled trial of the group reminiscence approach in patients with vascular dementia. Dementia and Geriatric Cognitive Disorders2007; Vol. 24, issue 1:48‐54. ">Ito 2007</a>). One study recruited care home staff volunteered residents who had a diagnosis of dementia (<a href="./references#CD001120-bbs2-0008" title="HaightB , GibsonF , MichelY . The Northern Ireland life review / life storybook project for people with dementia. Alzheimer's &amp; Dementia2006;2(1):56‐8. [DOI: 10.1016/j.jalz.2005.12.003] ">Haight 2006</a>). In one study, staff members selected participants and then completed the Clifton Assessment Procedures for the Elderly (CAPE) scale (<a href="./references#CD001120-bbs2-0004" title="BainesS , SaxbyP , EhlertK . Reality orientation and reminiscence therapy: a controlled cross‐over study of elderly confused people. British Journal of Psychiatry1987;151:222‐31. ">Baines 1987</a>). </p> </section> <section id="CD001120-sec-0051"> <h5 class="title">Dementia type</h5> <p>Six studies recruited participants with a specific type of dementia diagnosis. Four studies only recruited participants with a diagnosis of AD (<a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>; <a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0007" title="GonzalezJ , MayordomoT , TorresM , SalesA , MelendezJC . Reminiscence and dementia: a therapeutic intervention. International Psychogeriatrics / IPA2015; Vol. 27, issue 10:1731‐7. ">Gonzalez 2015</a>; <a href="./references#CD001120-bbs2-0012" title="MelendezJC , TorresM , RedondoR , MayordomoT , SalesA . Effectiveness of follow‐up reminiscence therapy on autobiographical memory in pathological ageing. International Journal of Psychology2015; Vol. 52, issue 4:283‐90. [10.1002/ijop. 12217] ">Melendez 2015</a>), although <a href="./references#CD001120-bbs2-0012" title="MelendezJC , TorresM , RedondoR , MayordomoT , SalesA . Effectiveness of follow‐up reminiscence therapy on autobiographical memory in pathological ageing. International Journal of Psychology2015; Vol. 52, issue 4:283‐90. [10.1002/ijop. 12217] ">Melendez 2015</a> also recruited a separate group of participants with amnesic MCI, and two studies sought only participants with a diagnosis of VD (<a href="./references#CD001120-bbs2-0001" title="AkanumaK , MeguroK , MeguroM , SasakiE , ChibaK , IshiiH , et al. Improved social interaction and increased anterior cingulate metabolism after group reminiscence with reality orientation approach for vascular dementia. Psychiatry Research2011;192(3):183‐7. ">Akanuma 2011</a>; <a href="./references#CD001120-bbs2-0010" title="ItoT , MeguroK , AkanumaK , IshiiH , MoriE . A randomized controlled trial of the group reminiscence approach in patients with vascular dementia. Dementia and Geriatric Cognitive Disorders2007; Vol. 24, issue 1:48‐54. ">Ito 2007</a>). <a href="./references#CD001120-bbs2-0124" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007;7(2):167‐73. ">Tadaka 2007</a> recruited both participants with AD and VD, but analysed the two groups separately, with a different control group for each disease type. </p> </section> <section id="CD001120-sec-0052"> <h5 class="title">Dementia severity</h5> <p>The majority of included studies sought to recruit participants in the mild to moderate stages of dementia. However, <a href="./references#CD001120-bbs2-0007" title="GonzalezJ , MayordomoT , TorresM , SalesA , MelendezJC . Reminiscence and dementia: a therapeutic intervention. International Psychogeriatrics / IPA2015; Vol. 27, issue 10:1731‐7. ">Gonzalez 2015</a> and <a href="./references#CD001120-bbs2-0012" title="MelendezJC , TorresM , RedondoR , MayordomoT , SalesA . Effectiveness of follow‐up reminiscence therapy on autobiographical memory in pathological ageing. International Journal of Psychology2015; Vol. 52, issue 4:283‐90. [10.1002/ijop. 12217] ">Melendez 2015</a> only included people with mild AD as measured by a score of 3 or 4 on the Geriatric Depression Scale (GDS; i.e. mild dementia was the maximum level). Five studies did not specify a particular level of severity in their inclusion/exclusion criteria (<a href="./references#CD001120-bbs2-0006" title="GoldwasserAN , AuerbachSM , HarkinsSW . Cognitive, affective and behavioural effects of reminiscence group therapy on demented elderly. International Journal of Aging &amp; Human Development1987;25(3):209‐22. ">Goldwasser 1987</a>; <a href="./references#CD001120-bbs2-0008" title="HaightB , GibsonF , MichelY . The Northern Ireland life review / life storybook project for people with dementia. Alzheimer's &amp; Dementia2006;2(1):56‐8. [DOI: 10.1016/j.jalz.2005.12.003] ">Haight 2006</a>; <a href="./references#CD001120-bbs2-0011" title="LaiCKY , ChiI , Kayser‐JonesJ . A randomised controlled trial of a specific reminiscence approach to promote the well‐being of nursing home residents with dementia. International Psychogeriatrics / IPA2004;16(1):33‐49. ">Lai 2004</a>; <a href="./references#CD001120-bbs2-0019" title="ThorgrimsenL , SchweitzerP , OrrellM . Evaluating reminiscence for people with dementia: a pilot study. The Arts in Psychotherapy2002;29(1):93‐7. ">Thorgrimsen 2002</a>; <a href="./references#CD001120-bbs2-0022" title="YamagamiT , TakayamaY , MakiY , YamaguchiH . A randomized controlled trial of brain‐activating rehabilitation for elderly participants with dementia in residential care homes. Dementia and Geriatric Cognitive Disorders2012;2:372‐80. ">Yamagami 2012</a>). </p> <p>Six studies used the CDR as a screening measure to assess if participants met the inclusion criteria. Five studies required a score of between 1 and 2 (mild to moderate dementia) to participate (<a href="./references#CD001120-bbs2-0013" title="MorganS , WoodsRT . Life review with people with dementia in care homes: a preliminary randomised controlled trial. Dementia: Non‐Pharmacological Therapies2012;1(1):43‐59. ">Morgan 2012</a>; <a href="./references#CD001120-bbs2-0016" title="SubramaniamP , WoodsB , WhitakerC . Life review and life story books for people with mild to moderate dementia: a randomised controlled trial. Aging &amp; Mental Health2013;18(3):363‐75. ">Subramaniam 2013</a>; <a href="./references#CD001120-bbs2-0017" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (AD)</a>; <a href="./references#CD001120-bbs2-0018" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (VD)</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>), while potential participants in one study needed to score between 0.5 and 2 (questionable to moderate dementia) (<a href="./references#CD001120-bbs2-0015" title="SärkämöT , TervaniemiM , LaitinenS , NumminenA , KurkiM , JohnsonJK , et al. Cognitive, emotional and social benefits of regular musical activities in early dementia: randomised controlled study. Gerontologist2013;54(4):634‐50. ">Särkämö 2013</a>). Nine studies reported baseline CDR scores. <a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a> reported a mean score of 1 and <a href="./references#CD001120-bbs2-0015" title="SärkämöT , TervaniemiM , LaitinenS , NumminenA , KurkiM , JohnsonJK , et al. Cognitive, emotional and social benefits of regular musical activities in early dementia: randomised controlled study. Gerontologist2013;54(4):634‐50. ">Särkämö 2013</a> reported a mean score of 1.35, indicating that participants had mild‐to‐moderate dementia. Seven studies reported (or sent the review authors) the number of participants who achieved each score. Across five studies, approximately 65% of participants obtained a score of 1 on the CDR indicating that they had mild dementia, while 35% scored 2 indicating moderate dementia (<a href="./references#CD001120-bbs2-0009" title="HsiehCJ , ChangC , SuSF , HsiaoYL , ShihYW , HanWH , et al. Reminiscence group therapy on depression and apathy in nursing home residents with mild to moderate dementia. Journal of Experimental Clinical Medicine2010;2(2):72‐8. ">Hsieh 2010</a>; <a href="./references#CD001120-bbs2-0013" title="MorganS , WoodsRT . Life review with people with dementia in care homes: a preliminary randomised controlled trial. Dementia: Non‐Pharmacological Therapies2012;1(1):43‐59. ">Morgan 2012</a>; <a href="./references#CD001120-bbs2-0016" title="SubramaniamP , WoodsB , WhitakerC . Life review and life story books for people with mild to moderate dementia: a randomised controlled trial. Aging &amp; Mental Health2013;18(3):363‐75. ">Subramaniam 2013</a>; <a href="./references#CD001120-bbs2-0017" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (AD)</a>; <a href="./references#CD001120-bbs2-0018" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (VD)</a>). One study used the CDR sum of boxes as an outcome measure and baseline CDR scores indicated that nine participants had 'questionable dementia', 24 had mild dementia, 17 had moderate dementia and four had severe dementia (<a href="./references#CD001120-bbs2-0022" title="YamagamiT , TakayamaY , MakiY , YamaguchiH . A randomized controlled trial of brain‐activating rehabilitation for elderly participants with dementia in residential care homes. Dementia and Geriatric Cognitive Disorders2012;2:372‐80. ">Yamagami 2012</a>). <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a> indicated that 6.2% of his participants scored 0.5, 67.4% scored 1 and 26.5% scored 2. </p> <p>Sixteen studies reported MMSE scores at baseline. This included one study that used the Hasegawa Dementia Scale‐Revised (the authors reported this was similar to the MMSE) (<a href="./references#CD001120-bbs2-0022" title="YamagamiT , TakayamaY , MakiY , YamaguchiH . A randomized controlled trial of brain‐activating rehabilitation for elderly participants with dementia in residential care homes. Dementia and Geriatric Cognitive Disorders2012;2:372‐80. ">Yamagami 2012</a>). One study used the Cantonese version of the MMSE (<a href="./references#CD001120-bbs2-0011" title="LaiCKY , ChiI , Kayser‐JonesJ . A randomised controlled trial of a specific reminiscence approach to promote the well‐being of nursing home residents with dementia. International Psychogeriatrics / IPA2004;16(1):33‐49. ">Lai 2004</a>), while two studies used the Spanish version (<a href="./references#CD001120-bbs2-0007" title="GonzalezJ , MayordomoT , TorresM , SalesA , MelendezJC . Reminiscence and dementia: a therapeutic intervention. International Psychogeriatrics / IPA2015; Vol. 27, issue 10:1731‐7. ">Gonzalez 2015</a>; <a href="./references#CD001120-bbs2-0012" title="MelendezJC , TorresM , RedondoR , MayordomoT , SalesA . Effectiveness of follow‐up reminiscence therapy on autobiographical memory in pathological ageing. International Journal of Psychology2015; Vol. 52, issue 4:283‐90. [10.1002/ijop. 12217] ">Melendez 2015</a>). Although published cut‐off points on the MMSE should be interpreted cautiously, a widely cited study classified an MMSE score of less than 10 as severe impairment, 10 to 20 as moderate impairment and 20 to 25 as mild impairment (<a href="./references#CD001120-bbs2-0097" title="FolsteinMF , FolsteinSE , McHughPR . 'Mini Mental State': a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research1975;12:189‐98. ">Folstein 1975</a>). In 13 studies, the mean MMSE score fell within the moderate range (<a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0006" title="GoldwasserAN , AuerbachSM , HarkinsSW . Cognitive, affective and behavioural effects of reminiscence group therapy on demented elderly. International Journal of Aging &amp; Human Development1987;25(3):209‐22. ">Goldwasser 1987</a>; <a href="./references#CD001120-bbs2-0007" title="GonzalezJ , MayordomoT , TorresM , SalesA , MelendezJC . Reminiscence and dementia: a therapeutic intervention. International Psychogeriatrics / IPA2015; Vol. 27, issue 10:1731‐7. ">Gonzalez 2015</a>; <a href="./references#CD001120-bbs2-0008" title="HaightB , GibsonF , MichelY . The Northern Ireland life review / life storybook project for people with dementia. Alzheimer's &amp; Dementia2006;2(1):56‐8. [DOI: 10.1016/j.jalz.2005.12.003] ">Haight 2006</a>; <a href="./references#CD001120-bbs2-0010" title="ItoT , MeguroK , AkanumaK , IshiiH , MoriE . A randomized controlled trial of the group reminiscence approach in patients with vascular dementia. Dementia and Geriatric Cognitive Disorders2007; Vol. 24, issue 1:48‐54. ">Ito 2007</a>; <a href="./references#CD001120-bbs2-0012" title="MelendezJC , TorresM , RedondoR , MayordomoT , SalesA . Effectiveness of follow‐up reminiscence therapy on autobiographical memory in pathological ageing. International Journal of Psychology2015; Vol. 52, issue 4:283‐90. [10.1002/ijop. 12217] ">Melendez 2015</a>; <a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a>; <a href="./references#CD001120-bbs2-0015" title="SärkämöT , TervaniemiM , LaitinenS , NumminenA , KurkiM , JohnsonJK , et al. Cognitive, emotional and social benefits of regular musical activities in early dementia: randomised controlled study. Gerontologist2013;54(4):634‐50. ">Särkämö 2013</a>; <a href="./references#CD001120-bbs2-0017" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (AD)</a>; <a href="./references#CD001120-bbs2-0018" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (VD)</a>; <a href="./references#CD001120-bbs2-0019" title="ThorgrimsenL , SchweitzerP , OrrellM . Evaluating reminiscence for people with dementia: a pilot study. The Arts in Psychotherapy2002;29(1):93‐7. ">Thorgrimsen 2002</a>; <a href="./references#CD001120-bbs2-0020" title="VanBogaertP , TolsonD , EerlingenR , CarversD , WoutersK , PaqueK , et al. SolCos model‐based individual reminiscence for older adults with mild to moderate dementia in nursing homes: a randomized controlled intervention study. Journal of Psychiatric and Mental Health Nursing2016;23(9‐10):568‐75. ">Van Bogaert 2016</a>; <a href="./references#CD001120-bbs2-0022" title="YamagamiT , TakayamaY , MakiY , YamaguchiH . A randomized controlled trial of brain‐activating rehabilitation for elderly participants with dementia in residential care homes. Dementia and Geriatric Cognitive Disorders2012;2:372‐80. ">Yamagami 2012</a>), and in one study the mean MMSE score fell within the severe range (<a href="./references#CD001120-bbs2-0011" title="LaiCKY , ChiI , Kayser‐JonesJ . A randomised controlled trial of a specific reminiscence approach to promote the well‐being of nursing home residents with dementia. International Psychogeriatrics / IPA2004;16(1):33‐49. ">Lai 2004</a>). </p> </section> <section id="CD001120-sec-0053"> <h5 class="title">Recruitment setting</h5> <p>Included studies recruited participants from a range of settings including residential care facilities, local hospitals, day hospital facilities and outpatient clinics. Fourteen studies recruited participants from residential/hospital care settings, while eight recruited community‐dwelling participants (<a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>; <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0012" title="MelendezJC , TorresM , RedondoR , MayordomoT , SalesA . Effectiveness of follow‐up reminiscence therapy on autobiographical memory in pathological ageing. International Journal of Psychology2015; Vol. 52, issue 4:283‐90. [10.1002/ijop. 12217] ">Melendez 2015</a>; <a href="./references#CD001120-bbs2-0015" title="SärkämöT , TervaniemiM , LaitinenS , NumminenA , KurkiM , JohnsonJK , et al. Cognitive, emotional and social benefits of regular musical activities in early dementia: randomised controlled study. Gerontologist2013;54(4):634‐50. ">Särkämö 2013</a>; <a href="./references#CD001120-bbs2-0017" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (AD)</a>; <a href="./references#CD001120-bbs2-0018" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (VD)</a>; <a href="./references#CD001120-bbs2-0019" title="ThorgrimsenL , SchweitzerP , OrrellM . Evaluating reminiscence for people with dementia: a pilot study. The Arts in Psychotherapy2002;29(1):93‐7. ">Thorgrimsen 2002</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). The interventions took place in the care homes where participants resided or community locations such as day centres. </p> </section> <section id="CD001120-sec-0054"> <h5 class="title">Participant age</h5> <p>The mean age of participants was over 80 years, with the exception of participants in three studies where reported mean ages were 78 years (<a href="./references#CD001120-bbs2-0001" title="AkanumaK , MeguroK , MeguroM , SasakiE , ChibaK , IshiiH , et al. Improved social interaction and increased anterior cingulate metabolism after group reminiscence with reality orientation approach for vascular dementia. Psychiatry Research2011;192(3):183‐7. ">Akanuma 2011</a>), 77 years (<a href="./references#CD001120-bbs2-0015" title="SärkämöT , TervaniemiM , LaitinenS , NumminenA , KurkiM , JohnsonJK , et al. Cognitive, emotional and social benefits of regular musical activities in early dementia: randomised controlled study. Gerontologist2013;54(4):634‐50. ">Särkämö 2013</a>), and 78 years (<a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). One study reported age range of 60 to 99 years (<a href="./references#CD001120-bbs2-0008" title="HaightB , GibsonF , MichelY . The Northern Ireland life review / life storybook project for people with dementia. Alzheimer's &amp; Dementia2006;2(1):56‐8. [DOI: 10.1016/j.jalz.2005.12.003] ">Haight 2006</a>), and one study reported the median participant age and interquartile range (IQR) as 84 years (78 to 90 years) (<a href="./references#CD001120-bbs2-0020" title="VanBogaertP , TolsonD , EerlingenR , CarversD , WoutersK , PaqueK , et al. SolCos model‐based individual reminiscence for older adults with mild to moderate dementia in nursing homes: a randomized controlled intervention study. Journal of Psychiatric and Mental Health Nursing2016;23(9‐10):568‐75. ">Van Bogaert 2016</a>). </p> </section> <section id="CD001120-sec-0055"> <h5 class="title">Length and duration of interventions</h5> <p>The length of reminiscence interventions ranged from four weeks (the minimum number for inclusion in the review) to 24 months. For studies that reported a range of time for each session (e.g. 60 to 90 minutes), we took the median time to calculate exposure time and session length. </p> <p>The intervention delivered at the highest frequency each week was 30 minutes a day, five days a week, for four weeks (<a href="./references#CD001120-bbs2-0004" title="BainesS , SaxbyP , EhlertK . Reality orientation and reminiscence therapy: a controlled cross‐over study of elderly confused people. British Journal of Psychiatry1987;151:222‐31. ">Baines 1987</a>). Six other studies reported session frequencies of more than once a week (<a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0006" title="GoldwasserAN , AuerbachSM , HarkinsSW . Cognitive, affective and behavioural effects of reminiscence group therapy on demented elderly. International Journal of Aging &amp; Human Development1987;25(3):209‐22. ">Goldwasser 1987</a>; <a href="./references#CD001120-bbs2-0012" title="MelendezJC , TorresM , RedondoR , MayordomoT , SalesA . Effectiveness of follow‐up reminiscence therapy on autobiographical memory in pathological ageing. International Journal of Psychology2015; Vol. 52, issue 4:283‐90. [10.1002/ijop. 12217] ">Melendez 2015</a>; <a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a>; <a href="./references#CD001120-bbs2-0020" title="VanBogaertP , TolsonD , EerlingenR , CarversD , WoutersK , PaqueK , et al. SolCos model‐based individual reminiscence for older adults with mild to moderate dementia in nursing homes: a randomized controlled intervention study. Journal of Psychiatric and Mental Health Nursing2016;23(9‐10):568‐75. ">Van Bogaert 2016</a>; <a href="./references#CD001120-bbs2-0022" title="YamagamiT , TakayamaY , MakiY , YamaguchiH . A randomized controlled trial of brain‐activating rehabilitation for elderly participants with dementia in residential care homes. Dementia and Geriatric Cognitive Disorders2012;2:372‐80. ">Yamagami 2012</a>). The greatest possible reminiscence exposure time was 39 hours (<a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>). Participants received 90 minutes of reminiscence a week for 12 weeks, followed by six‐weekly maintenance sessions for the next 21 months. Two studies had a possible exposure time of 38 hours (<a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). In both studies, participants received weekly two‐hour reminiscence sessions for 12 weeks, followed by monthly reminiscence maintenance sessions for seven months, giving a total of 38 potential hours of RT. In the <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a> study, the family carers met separately from the main group for 45 minutes for four sessions, with the aim of developing listening and communication skills, and considering how the activities and strategies in the sessions could continue at home. The least intensive intervention was weekly 30‐minute sessions for six weeks, totalling three hours of possible exposure to reminiscence (<a href="./references#CD001120-bbs2-0011" title="LaiCKY , ChiI , Kayser‐JonesJ . A randomised controlled trial of a specific reminiscence approach to promote the well‐being of nursing home residents with dementia. International Psychogeriatrics / IPA2004;16(1):33‐49. ">Lai 2004</a>). All other studies delivered the intervention once a week for varying lengths of time. For two studies, the length of reminiscence sessions, and, therefore, potential reminiscence exposure time was unclear (<a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a>; <a href="./references#CD001120-bbs2-0019" title="ThorgrimsenL , SchweitzerP , OrrellM . Evaluating reminiscence for people with dementia: a pilot study. The Arts in Psychotherapy2002;29(1):93‐7. ">Thorgrimsen 2002</a>). Across the remaining included studies, the median intervention exposure time was 11.5 hours. The median individual session length was approximately 53 minutes with a range of 30 minutes to two hours per session. </p> </section> <section id="CD001120-sec-0056"> <h5 class="title">Reminiscence therapy activities</h5> <p>Sixteen trials used simple reminiscence (<a href="./references#CD001120-bbs2-0001" title="AkanumaK , MeguroK , MeguroM , SasakiE , ChibaK , IshiiH , et al. Improved social interaction and increased anterior cingulate metabolism after group reminiscence with reality orientation approach for vascular dementia. Psychiatry Research2011;192(3):183‐7. ">Akanuma 2011</a>; <a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>; <a href="./references#CD001120-bbs2-0004" title="BainesS , SaxbyP , EhlertK . Reality orientation and reminiscence therapy: a controlled cross‐over study of elderly confused people. British Journal of Psychiatry1987;151:222‐31. ">Baines 1987</a>; <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0007" title="GonzalezJ , MayordomoT , TorresM , SalesA , MelendezJC . Reminiscence and dementia: a therapeutic intervention. International Psychogeriatrics / IPA2015; Vol. 27, issue 10:1731‐7. ">Gonzalez 2015</a>; <a href="./references#CD001120-bbs2-0006" title="GoldwasserAN , AuerbachSM , HarkinsSW . Cognitive, affective and behavioural effects of reminiscence group therapy on demented elderly. International Journal of Aging &amp; Human Development1987;25(3):209‐22. ">Goldwasser 1987</a>; <a href="./references#CD001120-bbs2-0009" title="HsiehCJ , ChangC , SuSF , HsiaoYL , ShihYW , HanWH , et al. Reminiscence group therapy on depression and apathy in nursing home residents with mild to moderate dementia. Journal of Experimental Clinical Medicine2010;2(2):72‐8. ">Hsieh 2010</a>; <a href="./references#CD001120-bbs2-0010" title="ItoT , MeguroK , AkanumaK , IshiiH , MoriE . A randomized controlled trial of the group reminiscence approach in patients with vascular dementia. Dementia and Geriatric Cognitive Disorders2007; Vol. 24, issue 1:48‐54. ">Ito 2007</a>; <a href="./references#CD001120-bbs2-0012" title="MelendezJC , TorresM , RedondoR , MayordomoT , SalesA . Effectiveness of follow‐up reminiscence therapy on autobiographical memory in pathological ageing. International Journal of Psychology2015; Vol. 52, issue 4:283‐90. [10.1002/ijop. 12217] ">Melendez 2015</a>; <a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a>; <a href="./references#CD001120-bbs2-0015" title="SärkämöT , TervaniemiM , LaitinenS , NumminenA , KurkiM , JohnsonJK , et al. Cognitive, emotional and social benefits of regular musical activities in early dementia: randomised controlled study. Gerontologist2013;54(4):634‐50. ">Särkämö 2013</a>; <a href="./references#CD001120-bbs2-0017" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (AD)</a>; <a href="./references#CD001120-bbs2-0018" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (VD)</a>; <a href="./references#CD001120-bbs2-0019" title="ThorgrimsenL , SchweitzerP , OrrellM . Evaluating reminiscence for people with dementia: a pilot study. The Arts in Psychotherapy2002;29(1):93‐7. ">Thorgrimsen 2002</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>; <a href="./references#CD001120-bbs2-0022" title="YamagamiT , TakayamaY , MakiY , YamaguchiH . A randomized controlled trial of brain‐activating rehabilitation for elderly participants with dementia in residential care homes. Dementia and Geriatric Cognitive Disorders2012;2:372‐80. ">Yamagami 2012</a>), which is a form of unstructured autobiographical story telling (<a href="./references#CD001120-bbs2-0098" title="GerbenJW , BohlmeijerE , WebsterJD . Reminiscence and mental health: a review of recent progress in theory, research and interventions. Ageing and Society2010;30:697‐721. ">Gerben 2010</a>). It involved discussions around specific themes of the past, such as school days, holidays, food and drink, and work, and was carried out in small groups. Five trials used the more structured approach of life review (<a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0008" title="HaightB , GibsonF , MichelY . The Northern Ireland life review / life storybook project for people with dementia. Alzheimer's &amp; Dementia2006;2(1):56‐8. [DOI: 10.1016/j.jalz.2005.12.003] ">Haight 2006</a>; <a href="./references#CD001120-bbs2-0011" title="LaiCKY , ChiI , Kayser‐JonesJ . A randomised controlled trial of a specific reminiscence approach to promote the well‐being of nursing home residents with dementia. International Psychogeriatrics / IPA2004;16(1):33‐49. ">Lai 2004</a>; <a href="./references#CD001120-bbs2-0013" title="MorganS , WoodsRT . Life review with people with dementia in care homes: a preliminary randomised controlled trial. Dementia: Non‐Pharmacological Therapies2012;1(1):43‐59. ">Morgan 2012</a>; <a href="./references#CD001120-bbs2-0016" title="SubramaniamP , WoodsB , WhitakerC . Life review and life story books for people with mild to moderate dementia: a randomised controlled trial. Aging &amp; Mental Health2013;18(3):363‐75. ">Subramaniam 2013</a>), which aimed to reconstruct the participant's life in a sequential manner on a one‐to‐one basis (<a href="./references#CD001120-bbs2-0100" title="HaberD . Life review: implementation, theory, research, and therapy. International Journal of Aging and Human Development2006;63(2):153‐71. ">Haber 2006</a>). One trial used a standardised reminiscence intervention based on the SolCos Model (<a href="./references#CD001120-bbs2-0020" title="VanBogaertP , TolsonD , EerlingenR , CarversD , WoutersK , PaqueK , et al. SolCos model‐based individual reminiscence for older adults with mild to moderate dementia in nursing homes: a randomized controlled intervention study. Journal of Psychiatric and Mental Health Nursing2016;23(9‐10):568‐75. ">Van Bogaert 2016</a>). </p> <p>One study trained staff across several care homes to deliver the interventions in small groups and gave data about their knowledge of the residents they cared for (<a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a>). Three studies carried out reminiscence jointly with participants and their family carers living in the community (<a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0019" title="ThorgrimsenL , SchweitzerP , OrrellM . Evaluating reminiscence for people with dementia: a pilot study. The Arts in Psychotherapy2002;29(1):93‐7. ">Thorgrimsen 2002</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). One study had a music listening group in which participants listened to songs from their past, and were encouraged to join in and share their memories of that period, such as "remembering the childhood through children's songs" (<a href="./references#CD001120-bbs2-0015" title="SärkämöT , TervaniemiM , LaitinenS , NumminenA , KurkiM , JohnsonJK , et al. Cognitive, emotional and social benefits of regular musical activities in early dementia: randomised controlled study. Gerontologist2013;54(4):634‐50. ">Särkämö 2013</a>). </p> </section> <section id="CD001120-sec-0057"> <h5 class="title">Control group activities</h5> <p>Participants in control conditions were either assigned to a 'treatment as usual' condition or a social contact group involving general unstructured conversion. </p> <p>Some trials included additional conditions as well as a no‐treatment control condition. However, we used only the no‐treatment control in our analyses. For example, one study had an additional 'music singing group' (<a href="./references#CD001120-bbs2-0015" title="SärkämöT , TervaniemiM , LaitinenS , NumminenA , KurkiM , JohnsonJK , et al. Cognitive, emotional and social benefits of regular musical activities in early dementia: randomised controlled study. Gerontologist2013;54(4):634‐50. ">Särkämö 2013</a>), while another study had included a counselling condition (<a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>). One study used a factorial design with four conditions, but we included only data from the RT only and treatment as usual groups (<a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>). Similarly, another study had four conditions, but we extracted data only from the reminiscence and control conditions (<a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>). </p> <p>One study had a 'gift' condition whereby a family member of participants in the control group made a life story book for them without their knowledge. We included data from the first follow‐up time point (i.e. before the life story books were given to participants) in the review, as the 'gift' condition was effectively a no treatment control condition until the participants received their life story books (<a href="./references#CD001120-bbs2-0016" title="SubramaniamP , WoodsB , WhitakerC . Life review and life story books for people with mild to moderate dementia: a randomised controlled trial. Aging &amp; Mental Health2013;18(3):363‐75. ">Subramaniam 2013</a>). </p> </section> </section> <section id="CD001120-sec-0058"> <h4 class="title">Excluded studies</h4> <p>In preparing this up‐dated review, we excluded 63 studies that did not meet all necessary inclusion criteria (see <a href="./references#CD001120-sec-0134" title="">Characteristics of excluded studies</a> table). </p> <p>Reasons for the exclusion of studies varied. The most common reasons were no or inadequate randomisation (meaning the study was not an RCT), intervention was not reminiscence or studies did not specifically recruit participants with a diagnosis of dementia. </p> </section> </section> <section id="CD001120-sec-0059"> <h3 class="title">Risk of bias in included studies</h3> <p>Specific details of the risk of bias for each study are outlined in the 'Risk of bias' table and are summarised in <a href="#CD001120-fig-0002">Figure 2</a> and <a href="#CD001120-fig-0003">Figure 3</a>. </p> <section id="CD001120-sec-0060"> <h4 class="title">Allocation</h4> <p>13 studies were at low risk of selection bias, while nine were rated as unclear. Most studies reported randomisation methods although allocation concealment was rarely reported in detail. Where necessary, we contacted authors for clarification. Replies generally stated that adequate concealment of treatment allocation had been applied, without detailing the method. In these cases, good practice has been assumed, though it was regrettable that further details were not available. Three studies used an accredited trials unit to randomise and allocate participants to their respective conditions (<a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0016" title="SubramaniamP , WoodsB , WhitakerC . Life review and life story books for people with mild to moderate dementia: a randomised controlled trial. Aging &amp; Mental Health2013;18(3):363‐75. ">Subramaniam 2013</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). Three studies used cluster randomisation. One large scale study used cluster randomisation stratified by public or private residential units (<a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a>). Two studies recruited participants in two nursing homes and then randomly allocated the nursing homes to the treatment and control conditions (<a href="./references#CD001120-bbs2-0007" title="GonzalezJ , MayordomoT , TorresM , SalesA , MelendezJC . Reminiscence and dementia: a therapeutic intervention. International Psychogeriatrics / IPA2015; Vol. 27, issue 10:1731‐7. ">Gonzalez 2015</a>; <a href="./references#CD001120-bbs2-0012" title="MelendezJC , TorresM , RedondoR , MayordomoT , SalesA . Effectiveness of follow‐up reminiscence therapy on autobiographical memory in pathological ageing. International Journal of Psychology2015; Vol. 52, issue 4:283‐90. [10.1002/ijop. 12217] ">Melendez 2015</a>). </p> </section> <section id="CD001120-sec-0061"> <h4 class="title">Blinding</h4> <section id="CD001120-sec-0062"> <h5 class="title">Performance bias</h5> <p>Participants cannot be blinded to the experience of taking part in an intervention and likewise, control participants will be aware that they have entered a research trial, but are not receiving any treatment. The person's expectations of potential benefits, or otherwise, may well influence outcome measures, which is difficult to control for. </p> </section> <section id="CD001120-sec-0063"> <h5 class="title">Detection bias</h5> <p>Eight studies were at unclear risk of detection bias (<a href="./references#CD001120-bbs2-0006" title="GoldwasserAN , AuerbachSM , HarkinsSW . Cognitive, affective and behavioural effects of reminiscence group therapy on demented elderly. International Journal of Aging &amp; Human Development1987;25(3):209‐22. ">Goldwasser 1987</a>; <a href="./references#CD001120-bbs2-0007" title="GonzalezJ , MayordomoT , TorresM , SalesA , MelendezJC . Reminiscence and dementia: a therapeutic intervention. International Psychogeriatrics / IPA2015; Vol. 27, issue 10:1731‐7. ">Gonzalez 2015</a>; <a href="./references#CD001120-bbs2-0008" title="HaightB , GibsonF , MichelY . The Northern Ireland life review / life storybook project for people with dementia. Alzheimer's &amp; Dementia2006;2(1):56‐8. [DOI: 10.1016/j.jalz.2005.12.003] ">Haight 2006</a>; <a href="./references#CD001120-bbs2-0009" title="HsiehCJ , ChangC , SuSF , HsiaoYL , ShihYW , HanWH , et al. Reminiscence group therapy on depression and apathy in nursing home residents with mild to moderate dementia. Journal of Experimental Clinical Medicine2010;2(2):72‐8. ">Hsieh 2010</a>; <a href="./references#CD001120-bbs2-0013" title="MorganS , WoodsRT . Life review with people with dementia in care homes: a preliminary randomised controlled trial. Dementia: Non‐Pharmacological Therapies2012;1(1):43‐59. ">Morgan 2012</a>; <a href="./references#CD001120-bbs2-0017" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (AD)</a>; <a href="./references#CD001120-bbs2-0018" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (VD)</a>; <a href="./references#CD001120-bbs2-0022" title="YamagamiT , TakayamaY , MakiY , YamaguchiH . A randomized controlled trial of brain‐activating rehabilitation for elderly participants with dementia in residential care homes. Dementia and Geriatric Cognitive Disorders2012;2:372‐80. ">Yamagami 2012</a>). However, fourteen studies took adequate measures to blind outcome assessors and were at low risk of detection bias. Two studies asked assessors to record their prediction of which arm of the trial each participant belonged to, and their confidence in that prediction (<a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). In the <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a> study, in 44% of cases, interviewers felt participants could equally have been assigned to control or treatment group, with 23% making a correct definite judgement. The proportion of correct definite judgements remained low at follow‐up, at about 25%, which reflected the considerable degree of uncertainty around treatment allocation. <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a> reported a similar prediction pattern. Measures of behaviour, functioning and carer‐rated outcomes of mood and QoL were typically completed by a person who knew the participant and could reliably comment. </p> </section> </section> <section id="CD001120-sec-0064"> <h4 class="title">Incomplete outcome data</h4> <p>Eighteen studies were at low risk of attrition bias, while four were at an unclear risk. Data extracted from several studies were from ITT analyses (<a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>; <a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0011" title="LaiCKY , ChiI , Kayser‐JonesJ . A randomised controlled trial of a specific reminiscence approach to promote the well‐being of nursing home residents with dementia. International Psychogeriatrics / IPA2004;16(1):33‐49. ">Lai 2004</a>; <a href="./references#CD001120-bbs2-0012" title="MelendezJC , TorresM , RedondoR , MayordomoT , SalesA . Effectiveness of follow‐up reminiscence therapy on autobiographical memory in pathological ageing. International Journal of Psychology2015; Vol. 52, issue 4:283‐90. [10.1002/ijop. 12217] ">Melendez 2015</a>; <a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). Eight studies used a per protocol analysis where the analysis was completed without data from participants who dropped out (<a href="./references#CD001120-bbs2-0009" title="HsiehCJ , ChangC , SuSF , HsiaoYL , ShihYW , HanWH , et al. Reminiscence group therapy on depression and apathy in nursing home residents with mild to moderate dementia. Journal of Experimental Clinical Medicine2010;2(2):72‐8. ">Hsieh 2010</a>; <a href="./references#CD001120-bbs2-0010" title="ItoT , MeguroK , AkanumaK , IshiiH , MoriE . A randomized controlled trial of the group reminiscence approach in patients with vascular dementia. Dementia and Geriatric Cognitive Disorders2007; Vol. 24, issue 1:48‐54. ">Ito 2007</a>; <a href="./references#CD001120-bbs2-0015" title="SärkämöT , TervaniemiM , LaitinenS , NumminenA , KurkiM , JohnsonJK , et al. Cognitive, emotional and social benefits of regular musical activities in early dementia: randomised controlled study. Gerontologist2013;54(4):634‐50. ">Särkämö 2013</a>; <a href="./references#CD001120-bbs2-0016" title="SubramaniamP , WoodsB , WhitakerC . Life review and life story books for people with mild to moderate dementia: a randomised controlled trial. Aging &amp; Mental Health2013;18(3):363‐75. ">Subramaniam 2013</a>; <a href="./references#CD001120-bbs2-0017" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (AD)</a>; <a href="./references#CD001120-bbs2-0018" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (VD)</a>; <a href="./references#CD001120-bbs2-0020" title="VanBogaertP , TolsonD , EerlingenR , CarversD , WoutersK , PaqueK , et al. SolCos model‐based individual reminiscence for older adults with mild to moderate dementia in nursing homes: a randomized controlled intervention study. Journal of Psychiatric and Mental Health Nursing2016;23(9‐10):568‐75. ">Van Bogaert 2016</a>; <a href="./references#CD001120-bbs2-0022" title="YamagamiT , TakayamaY , MakiY , YamaguchiH . A randomized controlled trial of brain‐activating rehabilitation for elderly participants with dementia in residential care homes. Dementia and Geriatric Cognitive Disorders2012;2:372‐80. ">Yamagami 2012</a>). In the <a href="./references#CD001120-bbs2-0010" title="ItoT , MeguroK , AkanumaK , IshiiH , MoriE . A randomized controlled trial of the group reminiscence approach in patients with vascular dementia. Dementia and Geriatric Cognitive Disorders2007; Vol. 24, issue 1:48‐54. ">Ito 2007</a> study, both a per protocol and ITT analysis were completed, but we could only extract data from the per protocol analysis. Four studies reported zero withdrawals (<a href="./references#CD001120-bbs2-0004" title="BainesS , SaxbyP , EhlertK . Reality orientation and reminiscence therapy: a controlled cross‐over study of elderly confused people. British Journal of Psychiatry1987;151:222‐31. ">Baines 1987</a>; <a href="./references#CD001120-bbs2-0008" title="HaightB , GibsonF , MichelY . The Northern Ireland life review / life storybook project for people with dementia. Alzheimer's &amp; Dementia2006;2(1):56‐8. [DOI: 10.1016/j.jalz.2005.12.003] ">Haight 2006</a>; <a href="./references#CD001120-bbs2-0013" title="MorganS , WoodsRT . Life review with people with dementia in care homes: a preliminary randomised controlled trial. Dementia: Non‐Pharmacological Therapies2012;1(1):43‐59. ">Morgan 2012</a>; <a href="./references#CD001120-bbs2-0019" title="ThorgrimsenL , SchweitzerP , OrrellM . Evaluating reminiscence for people with dementia: a pilot study. The Arts in Psychotherapy2002;29(1):93‐7. ">Thorgrimsen 2002)</a>. In one study, one participant dropped out, so the authors randomly excluded one participant from each of the two other groups (<a href="./references#CD001120-bbs2-0006" title="GoldwasserAN , AuerbachSM , HarkinsSW . Cognitive, affective and behavioural effects of reminiscence group therapy on demented elderly. International Journal of Aging &amp; Human Development1987;25(3):209‐22. ">Goldwasser 1987</a>). All trials, apart from <a href="./references#CD001120-bbs2-0007" title="GonzalezJ , MayordomoT , TorresM , SalesA , MelendezJC . Reminiscence and dementia: a therapeutic intervention. International Psychogeriatrics / IPA2015; Vol. 27, issue 10:1731‐7. ">Gonzalez 2015</a>, reported attrition rates. </p> <p>The largest care home study, which was based in residential care homes across Ireland, reported 25/153 withdrawals (16%) in the intervention group and 27/151 (18%) in the control group, with withdrawals predominantly due to hospitalisation, transfer to a different residential home or the death of the participant (<a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a>). The largest community‐based study reported a slightly higher attrition rate with 137 total withdrawals from the trial (23% from the treatment group and 34% from the control group) (<a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). Reasons cited were wide ranging and included death or illness of participant or carer, not enough time, or no explanation given. A total of 79/291 participants (27%) were lost over the duration of the <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a> study, for varying reasons including carer in poor health and loss to contact. </p> </section> <section id="CD001120-sec-0065"> <h4 class="title">Selective reporting</h4> <p>There was no evidence of selective outcome reporting for any study. All studies reported the same outcome measures in the methods and results sections of papers. Four studies had a protocol and the outcome measures detailed in the protocol were reported in the completed papers (<a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a>; <a href="./references#CD001120-bbs2-0020" title="VanBogaertP , TolsonD , EerlingenR , CarversD , WoutersK , PaqueK , et al. SolCos model‐based individual reminiscence for older adults with mild to moderate dementia in nursing homes: a randomized controlled intervention study. Journal of Psychiatric and Mental Health Nursing2016;23(9‐10):568‐75. ">Van Bogaert 2016</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). </p> </section> <section id="CD001120-sec-0066"> <h4 class="title">Other potential sources of bias</h4> <section id="CD001120-sec-0067"> <h5 class="title">Treatment protocol</h5> <p>The previous version of this review recommended that future trials should follow a clear treatment protocol, so that it is possible to define precisely the key elements of the different approaches to reminiscence work. The presence of a treatment protocol, or at least evidence of a session plan, is imperative to ensure that the intervention is delivered correctly, and to prevent intervention 'drift' (where the theme of the session may drift off‐topic), or introduce unintentional bias. Seventeen studies were at a low risk of bias relating to the presence of a treatment protocol, while five were at an unclear risk. Seven studies used a standardised reminiscence format. Three of these used the <a href="./references#CD001120-bbs2-0101" title="HaightB . The structured life‐review process: a community approach to the ageing client. In: GMMJones , BMLMiesen editor(s). Caregiving in Dementia. London (UK): Routledge, 1992:277‐92. ">Haight 1992</a> Life Review Model and Life Review Experience Form, which provides a structured format for obtaining relevant information from participants (<a href="./references#CD001120-bbs2-0008" title="HaightB , GibsonF , MichelY . The Northern Ireland life review / life storybook project for people with dementia. Alzheimer's &amp; Dementia2006;2(1):56‐8. [DOI: 10.1016/j.jalz.2005.12.003] ">Haight 2006</a>; <a href="./references#CD001120-bbs2-0013" title="MorganS , WoodsRT . Life review with people with dementia in care homes: a preliminary randomised controlled trial. Dementia: Non‐Pharmacological Therapies2012;1(1):43‐59. ">Morgan 2012</a>; <a href="./references#CD001120-bbs2-0016" title="SubramaniamP , WoodsB , WhitakerC . Life review and life story books for people with mild to moderate dementia: a randomised controlled trial. Aging &amp; Mental Health2013;18(3):363‐75. ">Subramaniam 2013</a>). The <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>, <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a> and <a href="./references#CD001120-bbs2-0019" title="ThorgrimsenL , SchweitzerP , OrrellM . Evaluating reminiscence for people with dementia: a pilot study. The Arts in Psychotherapy2002;29(1):93‐7. ">Thorgrimsen 2002</a> studies followed 'Remembering Yesterday, Caring Today' (RYCT; <a href="./references#CD001120-bbs2-0119" title="SchweitzerP , BruceE . Remembering Yesterday, Caring Today. Reminiscence in Dementia Care: a Guide to Good Practice. London (UK): Jessica Kingsley Publishers, 2008. ">Schweitzer 2008</a>), which is a large group‐based approach, bringing people with dementia and family carers together with a focus on active reminiscence.The <a href="./references#CD001120-bbs2-0020" title="VanBogaertP , TolsonD , EerlingenR , CarversD , WoutersK , PaqueK , et al. SolCos model‐based individual reminiscence for older adults with mild to moderate dementia in nursing homes: a randomized controlled intervention study. Journal of Psychiatric and Mental Health Nursing2016;23(9‐10):568‐75. ">Van Bogaert 2016</a> study based their reminiscence intervention on the SolCos model (<a href="./references#CD001120-bbs2-0120" title="SoltysF , CoatsL . The SolCos model: facilitating reminiscence therapy. Journal of Gerontological Nursing1994;20:11‐6. ">Soltys 1994</a>). </p> </section> <section id="CD001120-sec-0068"> <h5 class="title">Facilitator training and supervision</h5> <p>We considered the knowledge of staff delivering the interventions, total training hours and availability of supervision. All studies were at a low risk of bias in relation to facilitator training and supervision. Eleven studies did not specify training (<a href="./references#CD001120-bbs2-0001" title="AkanumaK , MeguroK , MeguroM , SasakiE , ChibaK , IshiiH , et al. Improved social interaction and increased anterior cingulate metabolism after group reminiscence with reality orientation approach for vascular dementia. Psychiatry Research2011;192(3):183‐7. ">Akanuma 2011</a>; <a href="./references#CD001120-bbs2-0006" title="GoldwasserAN , AuerbachSM , HarkinsSW . Cognitive, affective and behavioural effects of reminiscence group therapy on demented elderly. International Journal of Aging &amp; Human Development1987;25(3):209‐22. ">Goldwasser 1987</a>; <a href="./references#CD001120-bbs2-0007" title="GonzalezJ , MayordomoT , TorresM , SalesA , MelendezJC . Reminiscence and dementia: a therapeutic intervention. International Psychogeriatrics / IPA2015; Vol. 27, issue 10:1731‐7. ">Gonzalez 2015</a>; <a href="./references#CD001120-bbs2-0009" title="HsiehCJ , ChangC , SuSF , HsiaoYL , ShihYW , HanWH , et al. Reminiscence group therapy on depression and apathy in nursing home residents with mild to moderate dementia. Journal of Experimental Clinical Medicine2010;2(2):72‐8. ">Hsieh 2010</a>; <a href="./references#CD001120-bbs2-0010" title="ItoT , MeguroK , AkanumaK , IshiiH , MoriE . A randomized controlled trial of the group reminiscence approach in patients with vascular dementia. Dementia and Geriatric Cognitive Disorders2007; Vol. 24, issue 1:48‐54. ">Ito 2007</a>; <a href="./references#CD001120-bbs2-0012" title="MelendezJC , TorresM , RedondoR , MayordomoT , SalesA . Effectiveness of follow‐up reminiscence therapy on autobiographical memory in pathological ageing. International Journal of Psychology2015; Vol. 52, issue 4:283‐90. [10.1002/ijop. 12217] ">Melendez 2015</a>; <a href="./references#CD001120-bbs2-0013" title="MorganS , WoodsRT . Life review with people with dementia in care homes: a preliminary randomised controlled trial. Dementia: Non‐Pharmacological Therapies2012;1(1):43‐59. ">Morgan 2012</a>; <a href="./references#CD001120-bbs2-0015" title="SärkämöT , TervaniemiM , LaitinenS , NumminenA , KurkiM , JohnsonJK , et al. Cognitive, emotional and social benefits of regular musical activities in early dementia: randomised controlled study. Gerontologist2013;54(4):634‐50. ">Särkämö 2013</a>; <a href="./references#CD001120-bbs2-0016" title="SubramaniamP , WoodsB , WhitakerC . Life review and life story books for people with mild to moderate dementia: a randomised controlled trial. Aging &amp; Mental Health2013;18(3):363‐75. ">Subramaniam 2013</a>; <a href="./references#CD001120-bbs2-0017" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (AD)</a>; <a href="./references#CD001120-bbs2-0018" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (VD)</a>), but all were reported to have been delivered by appropriate facilitators such as psychologists or gerontologists. Further details are available in the 'Risk of bias' table. The other studies provided four hours (<a href="./references#CD001120-bbs2-0022" title="YamagamiT , TakayamaY , MakiY , YamaguchiH . A randomized controlled trial of brain‐activating rehabilitation for elderly participants with dementia in residential care homes. Dementia and Geriatric Cognitive Disorders2012;2:372‐80. ">Yamagami 2012</a>), six hours (<a href="./references#CD001120-bbs2-0004" title="BainesS , SaxbyP , EhlertK . Reality orientation and reminiscence therapy: a controlled cross‐over study of elderly confused people. British Journal of Psychiatry1987;151:222‐31. ">Baines 1987</a>), 10 hours <a href="./references#CD001120-bbs2-0008" title="HaightB , GibsonF , MichelY . The Northern Ireland life review / life storybook project for people with dementia. Alzheimer's &amp; Dementia2006;2(1):56‐8. [DOI: 10.1016/j.jalz.2005.12.003] ">Haight 2006</a>, 19.3 hours (<a href="./references#CD001120-bbs2-0011" title="LaiCKY , ChiI , Kayser‐JonesJ . A randomised controlled trial of a specific reminiscence approach to promote the well‐being of nursing home residents with dementia. International Psychogeriatrics / IPA2004;16(1):33‐49. ">Lai 2004</a>), 22 hours (<a href="./references#CD001120-bbs2-0019" title="ThorgrimsenL , SchweitzerP , OrrellM . Evaluating reminiscence for people with dementia: a pilot study. The Arts in Psychotherapy2002;29(1):93‐7. ">Thorgrimsen 2002</a>), 30.4 hours (<a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>), one day (<a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>), two and a half days (<a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>), and three days (<a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>; <a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a>) of training. Facilitators in the <a href="./references#CD001120-bbs2-0020" title="VanBogaertP , TolsonD , EerlingenR , CarversD , WoutersK , PaqueK , et al. SolCos model‐based individual reminiscence for older adults with mild to moderate dementia in nursing homes: a randomized controlled intervention study. Journal of Psychiatric and Mental Health Nursing2016;23(9‐10):568‐75. ">Van Bogaert 2016</a> study received a training programme though the total number of hours was not specified. </p> </section> <section id="CD001120-sec-0069"> <h5 class="title">Contamination</h5> <p>The main risk of contamination arose from trials located in care homes, in which control and intervention participants resided and socialised together. Two studies that included residential care participants seemed to use at least one member of staff or research team to carry out the intervention whilst also working in the home, potentially meaning that themes of reminiscence could be carried over into daily care and contaminate any control conditions (<a href="./references#CD001120-bbs2-0006" title="GoldwasserAN , AuerbachSM , HarkinsSW . Cognitive, affective and behavioural effects of reminiscence group therapy on demented elderly. International Journal of Aging &amp; Human Development1987;25(3):209‐22. ">Goldwasser 1987</a>; <a href="./references#CD001120-bbs2-0008" title="HaightB , GibsonF , MichelY . The Northern Ireland life review / life storybook project for people with dementia. Alzheimer's &amp; Dementia2006;2(1):56‐8. [DOI: 10.1016/j.jalz.2005.12.003] ">Haight 2006</a>). However, correct adherence to the trial protocol would have minimised this risk. </p> </section> <section id="CD001120-sec-0070"> <h5 class="title">Outcome measures</h5> <p>Where more than one measure of a single outcome domain was used in a study, data from the most common or the most extensive measure were included in the meta‐analysis. This was to avoid including data from the same participants more than once in each outcome analysis. </p> <p>Most studies collected outcomes up to two weeks after the final session, but for some larger studies this may have been up to four weeks (<a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). For purposes of this review, the primary end points of the <a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>; <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; and <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a> studies were after the 12 weeks of weekly reminiscence sessions (three months post‐baseline) while the later follow‐up time point was following completion of the monthly maintenance sessions. </p> <p><b>Quality of life</b> </p> <p>Ten studies measured self‐reported QoL at the end of treatment time point, while six measured it at follow‐up. Two were excluded from the meta‐analysis for risk of selection bias (<a href="./references#CD001120-bbs2-0004" title="BainesS , SaxbyP , EhlertK . Reality orientation and reminiscence therapy: a controlled cross‐over study of elderly confused people. British Journal of Psychiatry1987;151:222‐31. ">Baines 1987</a>; <a href="./references#CD001120-bbs2-0007" title="GonzalezJ , MayordomoT , TorresM , SalesA , MelendezJC . Reminiscence and dementia: a therapeutic intervention. International Psychogeriatrics / IPA2015; Vol. 27, issue 10:1731‐7. ">Gonzalez 2015</a>), while the <a href="./references#CD001120-bbs2-0016" title="SubramaniamP , WoodsB , WhitakerC . Life review and life story books for people with mild to moderate dementia: a randomised controlled trial. Aging &amp; Mental Health2013;18(3):363‐75. ">Subramaniam 2013</a> follow‐up data were also not included because the control group condition had changed by then (participants had been given a life story book as a gift). In the meta‐analysis, all studies used the Quality of Life in Alzheimer's Disease (QoL‐AD), except for the <a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a> study, which used the Self‐Report Quality of Life (SR‐QoL) scale. </p> <p>Seven studies measured proxy‐rated QoL. The <a href="./references#CD001120-bbs2-0004" title="BainesS , SaxbyP , EhlertK . Reality orientation and reminiscence therapy: a controlled cross‐over study of elderly confused people. British Journal of Psychiatry1987;151:222‐31. ">Baines 1987</a> and <a href="./references#CD001120-bbs2-0006" title="GoldwasserAN , AuerbachSM , HarkinsSW . Cognitive, affective and behavioural effects of reminiscence group therapy on demented elderly. International Journal of Aging &amp; Human Development1987;25(3):209‐22. ">Goldwasser 1987</a> studies were excluded from the meta‐analysis for risk of selection bias. All used the proxy scale on the QoL‐AD. Three studies went on to measure it at follow‐up. </p> <p>Two studies measured observed QoL using the Well‐being/Ill‐being (WIB) scale at both end of treatment and follow‐up (<a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0011" title="LaiCKY , ChiI , Kayser‐JonesJ . A randomised controlled trial of a specific reminiscence approach to promote the well‐being of nursing home residents with dementia. International Psychogeriatrics / IPA2004;16(1):33‐49. ">Lai 2004</a>). </p> <p><b>Cognition</b> </p> <p>Nineteen studies measured cognition at end of treatment. Five studies at unclear risk of selection bias (<a href="./references#CD001120-bbs2-0001" title="AkanumaK , MeguroK , MeguroM , SasakiE , ChibaK , IshiiH , et al. Improved social interaction and increased anterior cingulate metabolism after group reminiscence with reality orientation approach for vascular dementia. Psychiatry Research2011;192(3):183‐7. ">Akanuma 2011</a>; <a href="./references#CD001120-bbs2-0004" title="BainesS , SaxbyP , EhlertK . Reality orientation and reminiscence therapy: a controlled cross‐over study of elderly confused people. British Journal of Psychiatry1987;151:222‐31. ">Baines 1987</a>; <a href="./references#CD001120-bbs2-0006" title="GoldwasserAN , AuerbachSM , HarkinsSW . Cognitive, affective and behavioural effects of reminiscence group therapy on demented elderly. International Journal of Aging &amp; Human Development1987;25(3):209‐22. ">Goldwasser 1987</a>; <a href="./references#CD001120-bbs2-0007" title="GonzalezJ , MayordomoT , TorresM , SalesA , MelendezJC . Reminiscence and dementia: a therapeutic intervention. International Psychogeriatrics / IPA2015; Vol. 27, issue 10:1731‐7. ">Gonzalez 2015</a>; <a href="./references#CD001120-bbs2-0022" title="YamagamiT , TakayamaY , MakiY , YamaguchiH . A randomized controlled trial of brain‐activating rehabilitation for elderly participants with dementia in residential care homes. Dementia and Geriatric Cognitive Disorders2012;2:372‐80. ">Yamagami 2012</a>), and follow‐up data from <a href="./references#CD001120-bbs2-0016" title="SubramaniamP , WoodsB , WhitakerC . Life review and life story books for people with mild to moderate dementia: a randomised controlled trial. Aging &amp; Mental Health2013;18(3):363‐75. ">Subramaniam 2013</a> were excluded. Eight studies were included in the meta‐analysis at follow‐up. The most commonly used measures in the meta‐analysis were the MMSE (nine studies) and the Autobiographical Memory Interview Extended Version (AMI‐E) (four studies). </p> <p><b>Communication and Interaction</b> </p> <p>Eight studies measured communication and interaction at end of treatment with four assessing it at a later follow‐up time point. Two studies were excluded from the meta‐analysis for risk of selection bias (<a href="./references#CD001120-bbs2-0004" title="BainesS , SaxbyP , EhlertK . Reality orientation and reminiscence therapy: a controlled cross‐over study of elderly confused people. British Journal of Psychiatry1987;151:222‐31. ">Baines 1987</a>; <a href="./references#CD001120-bbs2-0022" title="YamagamiT , TakayamaY , MakiY , YamaguchiH . A randomized controlled trial of brain‐activating rehabilitation for elderly participants with dementia in residential care homes. Dementia and Geriatric Cognitive Disorders2012;2:372‐80. ">Yamagami 2012</a>). The meta‐analysis included data from four outcome measures; the Holden Communication Scale (<a href="./references#CD001120-bbs2-0019" title="ThorgrimsenL , SchweitzerP , OrrellM . Evaluating reminiscence for people with dementia: a pilot study. The Arts in Psychotherapy2002;29(1):93‐7. ">Thorgrimsen 2002</a>), Social Engagement Scale (SES) (<a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0011" title="LaiCKY , ChiI , Kayser‐JonesJ . A randomised controlled trial of a specific reminiscence approach to promote the well‐being of nursing home residents with dementia. International Psychogeriatrics / IPA2004;16(1):33‐49. ">Lai 2004</a>), Multidimensional Observation Scale for Elderly Subjects (MOSES) withdrawal subscale (<a href="./references#CD001120-bbs2-0017" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (AD)</a>; <a href="./references#CD001120-bbs2-0018" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (VD)</a>), and the Communication Observation Scale for Cognitive Impaired (<a href="./references#CD001120-bbs2-0008" title="HaightB , GibsonF , MichelY . The Northern Ireland life review / life storybook project for people with dementia. Alzheimer's &amp; Dementia2006;2(1):56‐8. [DOI: 10.1016/j.jalz.2005.12.003] ">Haight 2006</a>). The follow‐up meta‐analysis was comprised of data from the SES (<a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0011" title="LaiCKY , ChiI , Kayser‐JonesJ . A randomised controlled trial of a specific reminiscence approach to promote the well‐being of nursing home residents with dementia. International Psychogeriatrics / IPA2004;16(1):33‐49. ">Lai 2004</a>) and MOSES (<a href="./references#CD001120-bbs2-0017" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (AD)</a>; <a href="./references#CD001120-bbs2-0018" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (VD)</a>) </p> <section id="CD001120-sec-0071"> <h6 class="title">Quality of caring relationship</h6> <p>Three studies evaluated the quality of the relationship between the carer and the person with dementia (as rated by the person with dementia) at the end of treatment (<a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0016" title="SubramaniamP , WoodsB , WhitakerC . Life review and life story books for people with mild to moderate dementia: a randomised controlled trial. Aging &amp; Mental Health2013;18(3):363‐75. ">Subramaniam 2013</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). All three used the Quality of Carer and Patient Relationship (QCPR), which has two subscales: warmth and absence of conflict. The <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a> and <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a> studies measured this again at a follow‐up time point. </p> <p><b>Behaviour</b> </p> <p>We divided measures of behaviour into measures of function (i.e. daily living skills) and measures of agitation/irritability. Four studies used scales which assess both of these domains (MBS, CAPE, Behavior Rating Scale for the Elderly (BRSE)) (<a href="./references#CD001120-bbs2-0001" title="AkanumaK , MeguroK , MeguroM , SasakiE , ChibaK , IshiiH , et al. Improved social interaction and increased anterior cingulate metabolism after group reminiscence with reality orientation approach for vascular dementia. Psychiatry Research2011;192(3):183‐7. ">Akanuma 2011</a>; <a href="./references#CD001120-bbs2-0004" title="BainesS , SaxbyP , EhlertK . Reality orientation and reminiscence therapy: a controlled cross‐over study of elderly confused people. British Journal of Psychiatry1987;151:222‐31. ">Baines 1987</a>; <a href="./references#CD001120-bbs2-0008" title="HaightB , GibsonF , MichelY . The Northern Ireland life review / life storybook project for people with dementia. Alzheimer's &amp; Dementia2006;2(1):56‐8. [DOI: 10.1016/j.jalz.2005.12.003] ">Haight 2006</a>; <a href="./references#CD001120-bbs2-0019" title="ThorgrimsenL , SchweitzerP , OrrellM . Evaluating reminiscence for people with dementia: a pilot study. The Arts in Psychotherapy2002;29(1):93‐7. ">Thorgrimsen 2002</a>). As the authors were unable to extract scores for each, data from these two outcome measures were not included in the meta‐analysis. </p> <section id="CD001120-sec-0072"> <p><b>Behaviour: function</b></p> <p>Seven studies measured functional behaviour at end of treatment and at follow‐up (<a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>; <a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0006" title="GoldwasserAN , AuerbachSM , HarkinsSW . Cognitive, affective and behavioural effects of reminiscence group therapy on demented elderly. International Journal of Aging &amp; Human Development1987;25(3):209‐22. ">Goldwasser 1987</a>; <a href="./references#CD001120-bbs2-0008" title="HaightB , GibsonF , MichelY . The Northern Ireland life review / life storybook project for people with dementia. Alzheimer's &amp; Dementia2006;2(1):56‐8. [DOI: 10.1016/j.jalz.2005.12.003] ">Haight 2006</a>; <a href="./references#CD001120-bbs2-0011" title="LaiCKY , ChiI , Kayser‐JonesJ . A randomised controlled trial of a specific reminiscence approach to promote the well‐being of nursing home residents with dementia. International Psychogeriatrics / IPA2004;16(1):33‐49. ">Lai 2004</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>) except for the <a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a> study. The <a href="./references#CD001120-bbs2-0006" title="GoldwasserAN , AuerbachSM , HarkinsSW . Cognitive, affective and behavioural effects of reminiscence group therapy on demented elderly. International Journal of Aging &amp; Human Development1987;25(3):209‐22. ">Goldwasser 1987</a> study was excluded from the meta‐analysis for risk of selection bias. The most common outcome measure was the Activities of Daily Living Scale, though all studies used various ADL measures. </p> </section> <section id="CD001120-sec-0073"> <p><b>Behaviour: agitation/irritability</b></p> <p>Four studies measured agitation/irritability (<a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a>; <a href="./references#CD001120-bbs2-0017" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (AD)</a>; <a href="./references#CD001120-bbs2-0018" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (VD)</a>; <a href="./references#CD001120-bbs2-0022" title="YamagamiT , TakayamaY , MakiY , YamaguchiH . A randomized controlled trial of brain‐activating rehabilitation for elderly participants with dementia in residential care homes. Dementia and Geriatric Cognitive Disorders2012;2:372‐80. ">Yamagami 2012</a>), though one was excluded from the meta‐analysis as there was a high risk of selection bias (<a href="./references#CD001120-bbs2-0022" title="YamagamiT , TakayamaY , MakiY , YamaguchiH . A randomized controlled trial of brain‐activating rehabilitation for elderly participants with dementia in residential care homes. Dementia and Geriatric Cognitive Disorders2012;2:372‐80. ">Yamagami 2012</a>). The <a href="./references#CD001120-bbs2-0017" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (AD)</a> and <a href="./references#CD001120-bbs2-0018" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (VD)</a> studies used the irritability subscale of the MOSES at end of treatment and follow‐up, while the <a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a> study used the Cohen Mansfield Agitation Inventory (CMAI) at end of treatment only. The <a href="./references#CD001120-bbs2-0010" title="ItoT , MeguroK , AkanumaK , IshiiH , MoriE . A randomized controlled trial of the group reminiscence approach in patients with vascular dementia. Dementia and Geriatric Cognitive Disorders2007; Vol. 24, issue 1:48‐54. ">Ito 2007</a> study also measured agitation/irritability using the MOSES but did not report the scores obtained on each subscale. Therefore, the MOSES data from this study could not be included in this meta‐analysis. </p> <p><b>Mood‐related outcomes (person with dementia)</b> </p> </section> <section id="CD001120-sec-0074"> <p><b>Depression</b></p> <p>Fifteen studies measured depression at end of treatment with ten contributing data to the meta‐analysis (<a href="./references#CD001120-bbs2-0001" title="AkanumaK , MeguroK , MeguroM , SasakiE , ChibaK , IshiiH , et al. Improved social interaction and increased anterior cingulate metabolism after group reminiscence with reality orientation approach for vascular dementia. Psychiatry Research2011;192(3):183‐7. ">Akanuma 2011</a>; <a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>; <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0006" title="GoldwasserAN , AuerbachSM , HarkinsSW . Cognitive, affective and behavioural effects of reminiscence group therapy on demented elderly. International Journal of Aging &amp; Human Development1987;25(3):209‐22. ">Goldwasser 1987</a>; <a href="./references#CD001120-bbs2-0007" title="GonzalezJ , MayordomoT , TorresM , SalesA , MelendezJC . Reminiscence and dementia: a therapeutic intervention. International Psychogeriatrics / IPA2015; Vol. 27, issue 10:1731‐7. ">Gonzalez 2015</a>; <a href="./references#CD001120-bbs2-0008" title="HaightB , GibsonF , MichelY . The Northern Ireland life review / life storybook project for people with dementia. Alzheimer's &amp; Dementia2006;2(1):56‐8. [DOI: 10.1016/j.jalz.2005.12.003] ">Haight 2006</a>; <a href="./references#CD001120-bbs2-0009" title="HsiehCJ , ChangC , SuSF , HsiaoYL , ShihYW , HanWH , et al. Reminiscence group therapy on depression and apathy in nursing home residents with mild to moderate dementia. Journal of Experimental Clinical Medicine2010;2(2):72‐8. ">Hsieh 2010</a>; <a href="./references#CD001120-bbs2-0013" title="MorganS , WoodsRT . Life review with people with dementia in care homes: a preliminary randomised controlled trial. Dementia: Non‐Pharmacological Therapies2012;1(1):43‐59. ">Morgan 2012</a>; <a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a>; <a href="./references#CD001120-bbs2-0016" title="SubramaniamP , WoodsB , WhitakerC . Life review and life story books for people with mild to moderate dementia: a randomised controlled trial. Aging &amp; Mental Health2013;18(3):363‐75. ">Subramaniam 2013</a>; <a href="./references#CD001120-bbs2-0017" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (AD)</a>; <a href="./references#CD001120-bbs2-0018" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (VD)</a>; <a href="./references#CD001120-bbs2-0020" title="VanBogaertP , TolsonD , EerlingenR , CarversD , WoutersK , PaqueK , et al. SolCos model‐based individual reminiscence for older adults with mild to moderate dementia in nursing homes: a randomized controlled intervention study. Journal of Psychiatric and Mental Health Nursing2016;23(9‐10):568‐75. ">Van Bogaert 2016</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>; <a href="./references#CD001120-bbs2-0022" title="YamagamiT , TakayamaY , MakiY , YamaguchiH . A randomized controlled trial of brain‐activating rehabilitation for elderly participants with dementia in residential care homes. Dementia and Geriatric Cognitive Disorders2012;2:372‐80. ">Yamagami 2012</a>). Four used the Cornell Scale for Depression in Dementia (CSDD), which was the most common measure (<a href="./references#CD001120-bbs2-0008" title="HaightB , GibsonF , MichelY . The Northern Ireland life review / life storybook project for people with dementia. Alzheimer's &amp; Dementia2006;2(1):56‐8. [DOI: 10.1016/j.jalz.2005.12.003] ">Haight 2006</a>; <a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a>; <a href="./references#CD001120-bbs2-0020" title="VanBogaertP , TolsonD , EerlingenR , CarversD , WoutersK , PaqueK , et al. SolCos model‐based individual reminiscence for older adults with mild to moderate dementia in nursing homes: a randomized controlled intervention study. Journal of Psychiatric and Mental Health Nursing2016;23(9‐10):568‐75. ">Van Bogaert 2016</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). Other measures utilised were the Montgomery‐Åsberg Depression Rating Scale (MADRS), MOSES depression subscale, Geriatric Depression Scale ‐ Short Form (GDS‐SF), and 30‐question Geriatric Depression Scale (GDS‐30). Six of these studies also measured depression at follow‐up time points (<a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>; <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0013" title="MorganS , WoodsRT . Life review with people with dementia in care homes: a preliminary randomised controlled trial. Dementia: Non‐Pharmacological Therapies2012;1(1):43‐59. ">Morgan 2012</a>; <a href="./references#CD001120-bbs2-0017" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (AD)</a>; <a href="./references#CD001120-bbs2-0018" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (VD)</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). </p> </section> <section id="CD001120-sec-0075"> <p><b>Anxiety</b></p> <p>Two studies measured anxiety at end of treatment and follow‐up using the Hospital Anxiety and Depression Scale (HADS) ‐ Anxiety subscale (<a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>) and Rating Anxiety In Dementia (RAID) scale (<a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). </p> </section> <section id="CD001120-sec-0076"> <p><b>Apathy</b></p> <p>Two studies measured apathy at end of treatment; <a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a> used a carer rated Apathy Index and <a href="./references#CD001120-bbs2-0009" title="HsiehCJ , ChangC , SuSF , HsiaoYL , ShihYW , HanWH , et al. Reminiscence group therapy on depression and apathy in nursing home residents with mild to moderate dementia. Journal of Experimental Clinical Medicine2010;2(2):72‐8. ">Hsieh 2010</a> used the Apathy Evaluation Scale, but the latter study was excluded from the meta‐analysis for risk of selection bias. </p> <p><b>Carer outcomes</b> </p> <p>Carer outcomes were divided into outcomes measuring stress related to caring, carer anxiety and depression, carer QoL, and the quality of the caring relationship. </p> </section> <section id="CD001120-sec-0077"> <p><b>Stress related to caring</b></p> <p>Seven studies measured stress related to caring at end of treatment (<a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>; <a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a>; <a href="./references#CD001120-bbs2-0015" title="SärkämöT , TervaniemiM , LaitinenS , NumminenA , KurkiM , JohnsonJK , et al. Cognitive, emotional and social benefits of regular musical activities in early dementia: randomised controlled study. Gerontologist2013;54(4):634‐50. ">Särkämö 2013</a>; <a href="./references#CD001120-bbs2-0019" title="ThorgrimsenL , SchweitzerP , OrrellM . Evaluating reminiscence for people with dementia: a pilot study. The Arts in Psychotherapy2002;29(1):93‐7. ">Thorgrimsen 2002</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>) with five also measuring it at follow‐up (<a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>; <a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0015" title="SärkämöT , TervaniemiM , LaitinenS , NumminenA , KurkiM , JohnsonJK , et al. Cognitive, emotional and social benefits of regular musical activities in early dementia: randomised controlled study. Gerontologist2013;54(4):634‐50. ">Särkämö 2013</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). The most popular measures were the ZBI or Zarit Burden Interview ‐ Short Form (ZBI‐SF). </p> </section> <section id="CD001120-sec-0078"> <p><b>Carer depression and anxiety</b></p> <p>Two studies measured carer depression and anxiety at end of treatment and follow‐up (<a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). Both studies used the HADS. These subscales were analysed separately. </p> </section> <section id="CD001120-sec-0079"> <p><b>Carer well‐being and quality of life</b></p> <p>Four studies measured carer well‐being and QoL at end of treatment (<a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0015" title="SärkämöT , TervaniemiM , LaitinenS , NumminenA , KurkiM , JohnsonJK , et al. Cognitive, emotional and social benefits of regular musical activities in early dementia: randomised controlled study. Gerontologist2013;54(4):634‐50. ">Särkämö 2013</a>; <a href="./references#CD001120-bbs2-0019" title="ThorgrimsenL , SchweitzerP , OrrellM . Evaluating reminiscence for people with dementia: a pilot study. The Arts in Psychotherapy2002;29(1):93‐7. ">Thorgrimsen 2002</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). Only the <a href="./references#CD001120-bbs2-0019" title="ThorgrimsenL , SchweitzerP , OrrellM . Evaluating reminiscence for people with dementia: a pilot study. The Arts in Psychotherapy2002;29(1):93‐7. ">Thorgrimsen 2002</a> study did not include a follow‐up measure. The meta‐analysis comprised of data from the 12‐item General Health Questionnaire (GHQ‐12), 28‐item General Health Questionnaire (GHQ‐28) and the 12‐item Short Form (SF‐12) Mental component. </p> </section> <section id="CD001120-sec-0080"> <p><b>Quality of caring relationship</b></p> <p>Three studies evaluated the quality of the relationship between the carer and the person with dementia (as rated by the carer) at the end of treatment (<a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0016" title="SubramaniamP , WoodsB , WhitakerC . Life review and life story books for people with mild to moderate dementia: a randomised controlled trial. Aging &amp; Mental Health2013;18(3):363‐75. ">Subramaniam 2013</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). All three used the Quality of Carer and Patient Relationship (QCPR), which has two subscales: warmth and absence of conflict. The <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a> and <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a> studies measured this again at a follow‐up time point. </p> </section> </section> </section> </section> </section> <section id="CD001120-sec-0081"> <h3 class="title" id="CD001120-sec-0081">Effects of interventions</h3> <p>See: <a href="./full#CD001120-tbl-0001"><b>Summary of findings for the main comparison</b> Reminiscence Therapy compared to no treatment for people living with dementia</a>; <a href="./full#CD001120-tbl-0002"><b>Summary of findings 2</b> Reminiscence therapy compared to no treatment for people living with dementia (modality)</a>; <a href="./full#CD001120-tbl-0003"><b>Summary of findings 3</b> Reminiscence therapy compared to no treatment for people living with dementia (setting)</a> </p> <section id="CD001120-sec-0082"> <h4 class="title">Effect sizes</h4> <p>Evaluating the clinical meaningfulness of changes on the outcome measures used in studies of reminiscence interventions is challenging, as there are no internationally agreed standards to apply in this context. For SMDs, we have adopted the rule that an SMD of 0.5 or greater reflects an important difference, with SMDs less than 0.10 being negligible. For analyses using the MMSE, we judged a difference of 1.5 points or more as clinically important. The rate of decline on this measure has been estimated, in mild to moderate dementia, to be between 2 and 4 points per annum (<a href="./references#CD001120-bbs2-0110" title="MohsR . Neuropsychological assessment of patients with Alzheimer’s disease. In: BloomFE , KupferDJ editor(s). Psychopharmacology: 4th Generation of Progress. Brentwood (TN): American College of Neuropsychopharmacology, 2000. [www.acnp.org/publications/psycho4generation.aspx] ">Mohs 2000</a>), and so 1.5 points is broadly equivalent to preventing six months of decline in cognition. For other measures, we did not have parallel criteria, so have applied the 0.5 of a standard deviation rule, taking the standard deviation from the baseline evaluations. Thus, for the QoL‐AD, we have taken a difference of 3 points or more to be clinically meaningful, reflecting approximately half the typical standard deviation in samples of people with mild to moderate dementia (e.g. <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). For the SR‐QoL, this translates to 2.2 points or more (<a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>); for the WIB, 0.3 points or more (<a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0011" title="LaiCKY , ChiI , Kayser‐JonesJ . A randomised controlled trial of a specific reminiscence approach to promote the well‐being of nursing home residents with dementia. International Psychogeriatrics / IPA2004;16(1):33‐49. ">Lai 2004</a>); for the MOSES Withdrawal Scale, 3.1 points or more (<a href="./references#CD001120-bbs2-0124" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007;7(2):167‐73. ">Tadaka 2007</a>); for the SES, 0.75 points or more (<a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>); for the QCPR warmth and absence of conflict scales, rated by the person with dementia, 1.8 points; for the MOSES Irritability Scale, 2.2 points or more (<a href="./references#CD001120-bbs2-0124" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007;7(2):167‐73. ">Tadaka 2007</a>); for the ZBI 3 points or more (<a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>); for HADS ‐ Anxiety, 2.2 points or more; for HADS ‐ Depression, 1.8 points or more (<a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>); for the QCPR rated by the carer: warmth 2.7 points or more, absence of conflict 2.2 points or more. </p> <section id="CD001120-sec-0083"> <h5 class="title">Outcomes for the person with dementia</h5> <section id="CD001120-sec-0084"> <h6 class="title">Quality of life</h6> <p>(See <a href="#CD001120-fig-0004">Figure 4</a>.) </p> <div class="figure" id="CD001120-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Reminiscence therapy versus no treatment, outcome: 1.1 Self‐reported quality of life post‐treatment." data-id="CD001120-fig-0004" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Reminiscence therapy versus no treatment, outcome: 1.1 Self‐reported quality of life post‐treatment. </p> </div> </div> </div> <p>For the overall evaluation of the effects of reminiscence on QoL at the end of treatment, eight studies reporting a self‐report QoL measure were included in the meta‐analysis (<a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>; <a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a>; <a href="./references#CD001120-bbs2-0015" title="SärkämöT , TervaniemiM , LaitinenS , NumminenA , KurkiM , JohnsonJK , et al. Cognitive, emotional and social benefits of regular musical activities in early dementia: randomised controlled study. Gerontologist2013;54(4):634‐50. ">Särkämö 2013</a>; <a href="./references#CD001120-bbs2-0016" title="SubramaniamP , WoodsB , WhitakerC . Life review and life story books for people with mild to moderate dementia: a randomised controlled trial. Aging &amp; Mental Health2013;18(3):363‐75. ">Subramaniam 2013</a>; <a href="./references#CD001120-bbs2-0019" title="ThorgrimsenL , SchweitzerP , OrrellM . Evaluating reminiscence for people with dementia: a pilot study. The Arts in Psychotherapy2002;29(1):93‐7. ">Thorgrimsen 2002</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). This included 1060 participants living with dementia; 595 received a reminiscence intervention and 465 received no treatment. Where studies used more than one measure of QoL, the analysis was conducted on the most common or extensive self‐report assessment; seven studies used the QoL‐AD (self‐report) and one study used the SR‐QoL. A random‐effects analysis resulted in a small overall effect size (SMD 0.11, 95% CI ‐0.12 to 0.33; I<sup>2</sup> = 59%; moderate quality evidence; <a href="./references#CD001120-fig-0009" title="">Analysis 1.1</a>). This indicated that, across the eight included studies, reminiscence did not have an important effect on self‐reported QoL. </p> <p>Five studies (all involving reminiscence groups) went on to measure the effects of reminiscence on QoL at later follow‐up of six to 21 months (<a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>; <a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0015" title="SärkämöT , TervaniemiM , LaitinenS , NumminenA , KurkiM , JohnsonJK , et al. Cognitive, emotional and social benefits of regular musical activities in early dementia: randomised controlled study. Gerontologist2013;54(4):634‐50. ">Särkämö 2013</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). This analysis involved 499 participants who received a reminiscence intervention and 375 who received a control intervention. We could not determine whether reminiscence was associated with any effect on self‐reported QoL at follow‐up. The results were inconsistent between studies and the result of the meta‐analysis was imprecise and compatible with either an improvement or a small detrimental effect (random‐effects analysis; SMD 0.35, 95% CI ‐0.11 to 0.80; I<sup>2</sup> = 89%; moderate quality evidence; <a href="./references#CD001120-fig-0025" title="">Analysis 1.17</a>). </p> <p>At both end of treatment and follow‐up there was substantial heterogeneity, which appeared to relate to different modalities and (particularly) contexts of reminiscence work being analysed together. Analyses were accordingly undertaken for different modalities and contexts separately. </p> <section id="CD001120-sec-0085"> <p><b>Modality</b></p> <p>One small study reported self‐report QoL outcomes for individual reminiscence interventions at end of treatment (<a href="./references#CD001120-bbs2-0016" title="SubramaniamP , WoodsB , WhitakerC . Life review and life story books for people with mild to moderate dementia: a randomised controlled trial. Aging &amp; Mental Health2013;18(3):363‐75. ">Subramaniam 2013</a>). This involved 23 participants, and indicated life story work may have improved self‐reported QoL‐AD (mean difference (MD) 7.00 points, 95% CI ‐0.14 to 14.14; low quality evidence). </p> <p>Of the seven studies that implemented group reminiscence interventions, including 1037 participants, six used the self‐report QoL‐AD. There was little or no difference between the reminiscence and control groups (random‐effects analysis; SMD 0.06, 95% CI ‐0.15 to 0.28; I<sup>2</sup> = 56%; high quality evidence). The different settings (community versus care home) appeared to be responsible for the substantial level of inconsistency identified in this analysis. The findings for reminiscence groups at longer‐term follow‐up were detailed in the previous section. </p> </section> <section id="CD001120-sec-0086"> <p><b>Setting</b></p> <p>Three studies including 193 participants living in care home settings were included in the meta‐analysis of self‐report QoL indices (<a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a>; <a href="./references#CD001120-bbs2-0016" title="SubramaniamP , WoodsB , WhitakerC . Life review and life story books for people with mild to moderate dementia: a randomised controlled trial. Aging &amp; Mental Health2013;18(3):363‐75. ">Subramaniam 2013</a>). The analysis suggested that there was probably an improvement in self‐reported QoL following a reminiscence intervention in care homes, but we could not be sure that this was large enough to be clinically important (fixed‐effect analysis; SMD 0.46, 95% CI 0.18 to 0.75; I<sup>2</sup> = 0%; moderate quality evidence). The single care‐home study that reported longer‐term (six months) follow‐up, with 88 participants, also showed a probable improvement on the SR‐QoL (9.8 points, 95% CI 7.05 to 12.55; moderate quality evidence) (<a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>). </p> <p>Five studies with 867 participants included only community‐resident people with dementia (<a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>; <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0015" title="SärkämöT , TervaniemiM , LaitinenS , NumminenA , KurkiM , JohnsonJK , et al. Cognitive, emotional and social benefits of regular musical activities in early dementia: randomised controlled study. Gerontologist2013;54(4):634‐50. ">Särkämö 2013</a>; <a href="./references#CD001120-bbs2-0019" title="ThorgrimsenL , SchweitzerP , OrrellM . Evaluating reminiscence for people with dementia: a pilot study. The Arts in Psychotherapy2002;29(1):93‐7. ">Thorgrimsen 2002</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). All used the self‐report QoL‐AD. There was little or no difference between the reminiscence and control groups (fixed‐effect analysis; MD ‐0.57 points, 95% CI ‐1.37 to 0.22; I<sup>2</sup> = 0%; high quality evidence). Four of these studies measured the effects of reminiscence on QoL of 786 participants living in the community at follow‐up time points of six to 21 months (<a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>; <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0015" title="SärkämöT , TervaniemiM , LaitinenS , NumminenA , KurkiM , JohnsonJK , et al. Cognitive, emotional and social benefits of regular musical activities in early dementia: randomised controlled study. Gerontologist2013;54(4):634‐50. ">Särkämö 2013</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). There was little or no difference between the reminiscence and control groups (QoL‐AD) (fixed‐effect analysis; MD 0.17 points, 95% CI ‐0.79 to 1.13; I<sup>2</sup> = 0%; high quality evidence). </p> </section> <section id="CD001120-sec-0087"> <p><b>Proxy ratings</b></p> <p>The above findings on QoL were based on self‐report measures. Five studies of reminiscence groups with 763 participants used proxy measures, where a family carer or member of care staff rated the person's QoL (<a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a>; <a href="./references#CD001120-bbs2-0015" title="SärkämöT , TervaniemiM , LaitinenS , NumminenA , KurkiM , JohnsonJK , et al. Cognitive, emotional and social benefits of regular musical activities in early dementia: randomised controlled study. Gerontologist2013;54(4):634‐50. ">Särkämö 2013</a>; <a href="./references#CD001120-bbs2-0019" title="ThorgrimsenL , SchweitzerP , OrrellM . Evaluating reminiscence for people with dementia: a pilot study. The Arts in Psychotherapy2002;29(1):93‐7. ">Thorgrimsen 2002</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). All used the QoL‐AD proxy version. There was little or no difference in outcomes at the end of treatment (random‐effects analysis; MD 0.35 points, 95% CI ‐1.23 to 1.94; I<sup>2</sup> = 45%; moderate quality evidence; <a href="./references#CD001120-fig-0010" title="">Analysis 1.2</a>). At longer‐term follow‐up of six to seven months postintervention, three studies with 505 participants, all community based and involving reminiscence groups, reported findings on the QoL‐AD proxy version (<a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0015" title="SärkämöT , TervaniemiM , LaitinenS , NumminenA , KurkiM , JohnsonJK , et al. Cognitive, emotional and social benefits of regular musical activities in early dementia: randomised controlled study. Gerontologist2013;54(4):634‐50. ">Särkämö 2013</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). There was little or no difference between the reminiscence and control groups (MD ‐0.15 points, 95% CI ‐1.14 to 0.83; I<sup>2</sup> = 25%; high quality evidence; <a href="./references#CD001120-fig-0026" title="">Analysis 1.18</a>). </p> </section> <section id="CD001120-sec-0088"> <p><b>Observed quality of life</b></p> <p>Two studies used the WIB, an observational measure of QoL, which was completed during a minimum of six hours' observation of the person undertaking their usual activities (<a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0011" title="LaiCKY , ChiI , Kayser‐JonesJ . A randomised controlled trial of a specific reminiscence approach to promote the well‐being of nursing home residents with dementia. International Psychogeriatrics / IPA2004;16(1):33‐49. ">Lai 2004</a>). The studies included 154 care home participants, and there was probably little or no difference on WIB scores at end of treatment (MD 0.00 points, 95% CI ‐0.17 to 0.18; I<sup>2</sup> = 0%; moderate quality evidence). At longer‐term follow‐up of six to 24 weeks' postintervention, due to the imprecision of the results and the development of inconsistency between the studies, we were unable to determine whether there was any effect of reminiscence on observed QoL (random‐effects analysis; MD ‐0.40 points, 95% CI ‐1.34 to 0.54; I<sup>2</sup> = 93%; very low quality evidence; <a href="./references#CD001120-fig-0027" title="">Analysis 1.19</a>). </p> </section> </section> <section id="CD001120-sec-0089"> <h6 class="title">Cognition</h6> <p>(See <a href="#CD001120-fig-0005">Figure 5</a>.) </p> <div class="figure" id="CD001120-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Reminiscence therapy versus no treatment, outcome: 1.5 Cognition (overall) post‐treatment." data-id="CD001120-fig-0005" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Reminiscence therapy versus no treatment, outcome: 1.5 Cognition (overall) post‐treatment. </p> </div> </div> </div> <p>For cognition, we analysed data from 14 studies involving 1219 people living with dementia, in which 679 received some form of reminiscence and 540 were assigned to control groups. Where studies used more than one measure of cognition, we used the most common or extensive assessment (for the AMI and AMI‐E this was the Personal Semantic Memory Sub‐scale (PSS)). There was a slight improvement in cognition immediately following a reminiscence intervention, but the effect was small and of uncertain clinical importance (change scores between reminiscence and control conditions: SMD 0.11, 95% CI 0.00 to 0.23; I<sup>2</sup> = 9%; high quality evidence; <a href="./references#CD001120-fig-0013" title="">Analysis 1.5</a>). </p> <p>The MMSE was the most widely used cognitive measure, used in nine studies involving 437 participants. A fixed‐effect analysis found an improvement following reminiscence compared to the control group (MD 1.87 points, 95% CI 0.54 to 3.20; I<sup>2</sup> = 0%; high quality evidence). </p> <p>Nine studies measured the difference in cognition scores between reminiscence and control groups over a longer follow‐up period of six to 84 weeks postintervention. This involved 983 participants with 561 in the intervention groups and 422 in the control groups. There was little or no difference in outcome between groups (SMD 0.04, 95% CI ‐0.09 to 0.17; I<sup>2</sup> = 3%; high quality evidence; <a href="./references#CD001120-fig-0029" title="">Analysis 1.21</a>). For the five studies reporting MMSE, there may have been an improvement at follow‐up of six to 36 weeks (MD 1.8 points, 95% CI ‐0.06 to 3.65; I<sup>2</sup> = 0%; 282 participants; low quality evidence), with the quality rating reduced due to the relatively low sample size and imprecision. </p> <section id="CD001120-sec-0090"> <p><b>Modality</b></p> <p>There was a probable slight improvement with individual reminiscence compared with the control group in five studies with 196 participants, but we could not be sure that this was large enough to be clinically important (SMD 0.32, 95% CI 0.04 to 0.61; I<sup>2</sup> = 6%; moderate quality evidence). For individual reminiscence, two studies (both in care homes) with 83 participants reported results at six weeks' follow‐up. There may have been some benefit, but the results were so imprecise that we could not be certain of this, or whether any effect was large enough to be clinically important (SMD 0.35, 95% CI ‐0.08 to 0.79; I<sup>2</sup> = 0%; low quality evidence). </p> <p>For the nine studies with 1023 participants of group reminiscence, there was little or no difference in cognition at the end of treatment between reminiscence and control groups (SMD 0.07, 95% CI ‐0.05 to 0.20; I<sup>2</sup> = 0%; high quality evidence). For the six group reminiscence studies with 281 participants using the MMSE, there was a probable improvement in favour of reminiscence (MD 1.81 points, 95% CI 0.17 to 3.46; I<sup>2</sup> = 0%; moderate quality evidence). For group reminiscence (all community‐based studies), there was little or no difference in cognition at longer‐term follow‐up of six to 84 weeks (SMD 0.01, 95% CI ‐0.12 to 0.14; I<sup>2</sup> = 0%; 7 studies; 900 participants; high quality evidence). </p> </section> <section id="CD001120-sec-0091"> <p><b>Setting</b></p> <p>Six studies in care homes, involving 230 participants, reported cognitive outcomes at end of treatment (<a href="./references#CD001120-bbs2-0008" title="HaightB , GibsonF , MichelY . The Northern Ireland life review / life storybook project for people with dementia. Alzheimer's &amp; Dementia2006;2(1):56‐8. [DOI: 10.1016/j.jalz.2005.12.003] ">Haight 2006</a>; <a href="./references#CD001120-bbs2-0010" title="ItoT , MeguroK , AkanumaK , IshiiH , MoriE . A randomized controlled trial of the group reminiscence approach in patients with vascular dementia. Dementia and Geriatric Cognitive Disorders2007; Vol. 24, issue 1:48‐54. ">Ito 2007</a>; <a href="./references#CD001120-bbs2-0011" title="LaiCKY , ChiI , Kayser‐JonesJ . A randomised controlled trial of a specific reminiscence approach to promote the well‐being of nursing home residents with dementia. International Psychogeriatrics / IPA2004;16(1):33‐49. ">Lai 2004</a>; <a href="./references#CD001120-bbs2-0013" title="MorganS , WoodsRT . Life review with people with dementia in care homes: a preliminary randomised controlled trial. Dementia: Non‐Pharmacological Therapies2012;1(1):43‐59. ">Morgan 2012</a>; <a href="./references#CD001120-bbs2-0016" title="SubramaniamP , WoodsB , WhitakerC . Life review and life story books for people with mild to moderate dementia: a randomised controlled trial. Aging &amp; Mental Health2013;18(3):363‐75. ">Subramaniam 2013</a>; <a href="./references#CD001120-bbs2-0020" title="VanBogaertP , TolsonD , EerlingenR , CarversD , WoutersK , PaqueK , et al. SolCos model‐based individual reminiscence for older adults with mild to moderate dementia in nursing homes: a randomized controlled intervention study. Journal of Psychiatric and Mental Health Nursing2016;23(9‐10):568‐75. ">Van Bogaert 2016</a>). There was a probable slight improvement in favour of the reminiscence intervention, but we could not be sure that this was large enough to be clinically important (SMD 0.29, 95% CI 0.03 to 0.56; I<sup>2</sup> = 0%; moderate quality evidence). </p> <p>Eight studies with 989 participants were carried out in community settings. There was little or no difference in cognition apparent at the end of treatment between reminiscence and control groups (SMD 0.07, 95% CI ‐0.05 to 0.20; I<sup>2</sup> = 8%; high quality evidence). </p> <p>All the community studies with long‐term follow‐up involved a group intervention and all those in care homes involved an individual intervention, and so these results have been detailed under 'Modality' above, with little or no difference for community/group studies, and uncertainty about possible benefit in care home/individual studies. </p> </section> </section> <section id="CD001120-sec-0092"> <h6 class="title">Communication and interaction</h6> <p>(See <a href="#CD001120-fig-0006">Figure 6</a>.) </p> <div class="figure" id="CD001120-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Reminiscence therapy versus no treatment, outcome: 1.7 Communication and interaction post‐treatment." data-id="CD001120-fig-0006" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Reminiscence therapy versus no treatment, outcome: 1.7 Communication and interaction post‐treatment. </p> </div> </div> </div> <p>Six studies with 249 participants, using a variety of different indicators of communication and interaction, were included in the end of treatment analysis (<a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0008" title="HaightB , GibsonF , MichelY . The Northern Ireland life review / life storybook project for people with dementia. Alzheimer's &amp; Dementia2006;2(1):56‐8. [DOI: 10.1016/j.jalz.2005.12.003] ">Haight 2006</a>; <a href="./references#CD001120-bbs2-0011" title="LaiCKY , ChiI , Kayser‐JonesJ . A randomised controlled trial of a specific reminiscence approach to promote the well‐being of nursing home residents with dementia. International Psychogeriatrics / IPA2004;16(1):33‐49. ">Lai 2004</a>; <a href="./references#CD001120-bbs2-0017" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (AD)</a>; <a href="./references#CD001120-bbs2-0018" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (VD)</a>; <a href="./references#CD001120-bbs2-0019" title="ThorgrimsenL , SchweitzerP , OrrellM . Evaluating reminiscence for people with dementia: a pilot study. The Arts in Psychotherapy2002;29(1):93‐7. ">Thorgrimsen 2002</a>). (Note: in this analysis, negative scores indicated <i>improved</i> communication.) There may have been an improvement in communication and interaction following a reminiscence intervention, but, due to inconsistency between studies, we could not rule out a small or negligible effect (random‐effects analysis; SMD ‐0.51 points, 95% CI ‐0.97 to ‐0.05; I<sup>2</sup> = 62%; low quality evidence; <a href="./references#CD001120-fig-0015" title="">Analysis 1.7</a>). </p> <p>Four of the six studies, with 204 participants, also reported data at six to 24 weeks' follow‐up (<a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0011" title="LaiCKY , ChiI , Kayser‐JonesJ . A randomised controlled trial of a specific reminiscence approach to promote the well‐being of nursing home residents with dementia. International Psychogeriatrics / IPA2004;16(1):33‐49. ">Lai 2004</a>; <a href="./references#CD001120-bbs2-0017" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (AD)</a>; <a href="./references#CD001120-bbs2-0018" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (VD)</a>). There was probably an improvement in communication and interaction at longer‐term follow‐up after a reminiscence intervention, but we could not be sure that this was large enough to be clinically important (SMD ‐0.49 points, 95% CI ‐0.77 to ‐0.21; I<sup>2</sup> = 0%; moderate quality evidence; <a href="./references#CD001120-fig-0030" title="">Analysis 1.22</a>). </p> <section id="CD001120-sec-0093"> <p><b>Modality</b></p> <p>Two studies using individual reminiscence reported end of treatment measures of communication and interaction (<a href="./references#CD001120-bbs2-0008" title="HaightB , GibsonF , MichelY . The Northern Ireland life review / life storybook project for people with dementia. Alzheimer's &amp; Dementia2006;2(1):56‐8. [DOI: 10.1016/j.jalz.2005.12.003] ">Haight 2006</a>; <a href="./references#CD001120-bbs2-0011" title="LaiCKY , ChiI , Kayser‐JonesJ . A randomised controlled trial of a specific reminiscence approach to promote the well‐being of nursing home residents with dementia. International Psychogeriatrics / IPA2004;16(1):33‐49. ">Lai 2004</a>). We could not be certain whether there was an improvement as the quality of the evidence was very low, due to imprecision and serious inconsistency (random‐effects analysis; SMD ‐0.74, 95% CI ‐2.38 to 0.89; I<sup>2</sup> = 91%; very low quality evidence). Longer‐term follow‐up data were only available in one study of individual reminiscence (<a href="./references#CD001120-bbs2-0011" title="LaiCKY , ChiI , Kayser‐JonesJ . A randomised controlled trial of a specific reminiscence approach to promote the well‐being of nursing home residents with dementia. International Psychogeriatrics / IPA2004;16(1):33‐49. ">Lai 2004</a>), with effects uncertain due to imprecision. </p> <p>Analysis of the four trials of group reminiscence, including 153 participants, indicated a probable slight improvement for participants receiving reminiscence compared with the control group at end of treatment, although we could not be certain of its clinical importance (SMD ‐0.39, 95% CI ‐0.71 to ‐0.06; I<sup>2</sup> = 0%; moderate quality evidence) (<a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0017" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (AD)</a>; <a href="./references#CD001120-bbs2-0018" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (VD)</a>; <a href="./references#CD001120-bbs2-0019" title="ThorgrimsenL , SchweitzerP , OrrellM . Evaluating reminiscence for people with dementia: a pilot study. The Arts in Psychotherapy2002;29(1):93‐7. ">Thorgrimsen 2002</a>). For group reminiscence, three studies with 138 participants reported data at six months' follow‐up (<a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0017" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (AD)</a>; <a href="./references#CD001120-bbs2-0018" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (VD)</a>). There was a probable improvement after this longer‐term follow‐up (SMD ‐0.63, 95% CI ‐0.97 to ‐0.29; I<sup>2</sup> = 0%; moderate quality evidence). </p> </section> <section id="CD001120-sec-0094"> <p><b>Setting</b></p> <p>Three studies, with 65 participants, were based in the community. There was a probable improvement on communication and interaction in favour of RT although we could not be certain it was clinically important (SMD ‐0.57, 95% CI ‐1.08 to ‐0.06; I<sup>2</sup> = 0%; moderate quality evidence). At longer‐term follow‐up, only two studies, with 50 participants, took place in the community (<a href="./references#CD001120-bbs2-0017" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (AD)</a>; <a href="./references#CD001120-bbs2-0018" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (VD)</a>. There was a probable improvement in favour of RT, although we could not be certain it was clinically important (MOSES withdrawal subscale: MD ‐3.64 points, 95% CI ‐7.21 to ‐0.06; I<sup>2</sup> = 0%; moderate quality evidence). </p> <p>Three studies with 184 participants took place in care homes. Here, we could not ascertain from our results whether there was an important effect on communication and interaction due to imprecision and unexplained variation in results between studies (random‐effects analysis; SMD ‐0.52, 95% CI ‐1.29 to 0.24; I<sup>2</sup> = 83%; very low quality evidence). The two care home studies, with 154 participants, with longer‐term follow‐up of six to 24 weeks used the SES (<a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0011" title="LaiCKY , ChiI , Kayser‐JonesJ . A randomised controlled trial of a specific reminiscence approach to promote the well‐being of nursing home residents with dementia. International Psychogeriatrics / IPA2004;16(1):33‐49. ">Lai 2004</a>). There may have been an improvement; however, imprecision and inconsistency between the studies means we could not be certain of a clinically important effect (random‐effects analysis; MD ‐0.93 points, 95% CI ‐1.77 to ‐0.09; I<sup>2</sup> = 41%; low quality evidence). </p> </section> </section> <section id="CD001120-sec-0095"> <h6 class="title">Quality of relationship</h6> <p>Three studies, with 528 participants, included ratings by the person with dementia of his/her relationship with his/her family carer (<a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0016" title="SubramaniamP , WoodsB , WhitakerC . Life review and life story books for people with mild to moderate dementia: a randomised controlled trial. Aging &amp; Mental Health2013;18(3):363‐75. ">Subramaniam 2013</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). All used the QCPR and reported results separately for its two subscales: warmth and absence of conflict. On both subscales, there was little or no difference between RT and control groups at the end of treatment (warmth: MD 0.16 points, 95% CI ‐0.53 to 0.84; I<sup>2</sup> = 0%; high quality evidence; absence of conflict: MD ‐0.40 points, 95% CI ‐1.09 to 0.29; I<sup>2</sup> = 15%; high quality evidence). </p> <p>Two of the studies, involving 415 participants, both community‐based and using reminiscence groups, reported seven months' follow‐up post‐intervention. Due to the imprecision of the results and inconsistency between the two studies, we were unable to determine whether there was any effect of reminiscence on warmth at follow‐up (random‐effects analysis; MD ‐0.09 points, 95% CI ‐1.82 to 1.63; I<sup>2</sup> = 62%; low quality evidence). There was little or no difference in absence of conflict (MD ‐0.38 points, 95% CI ‐1.28 to 0.51; I<sup>2</sup> = 11%; high quality evidence). </p> </section> <section id="CD001120-sec-0096"> <h6 class="title">Behaviour: function</h6> <p>Six studies, involving 1030 participants, assessed changes in the functional level of the person with dementia at the end of treatment (<a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>; <a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0008" title="HaightB , GibsonF , MichelY . The Northern Ireland life review / life storybook project for people with dementia. Alzheimer's &amp; Dementia2006;2(1):56‐8. [DOI: 10.1016/j.jalz.2005.12.003] ">Haight 2006</a>; <a href="./references#CD001120-bbs2-0011" title="LaiCKY , ChiI , Kayser‐JonesJ . A randomised controlled trial of a specific reminiscence approach to promote the well‐being of nursing home residents with dementia. International Psychogeriatrics / IPA2004;16(1):33‐49. ">Lai 2004</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). In this analysis, a lower score indicated a more positive outcome. Due to imprecision and inconsistency between studies, we were uncertain whether RT improved function at the end of treatment (random‐effects analysis; SMD ‐0.24, 95% CI ‐0.69 to 0.21; I<sup>2</sup> = 90%; very low quality evidence; <a href="./references#CD001120-fig-0016" title="">Analysis 1.8</a>). This uncertainty was present at longer‐term follow‐up (six to 84 weeks) in an analysis that involved five studies and 941 participants (random‐effects analysis; SMD ‐0.31, 95% CI ‐0.66 to 0.03; I<sup>2</sup> = 83%; very low quality evidence; <a href="./references#CD001120-fig-0032" title="">Analysis 1.24</a>). </p> <section id="CD001120-sec-0097"> <p><b>Modality</b></p> <p>Two studies, involving 96 participants, examined the effects of individual reminiscence on level of function (<a href="./references#CD001120-bbs2-0008" title="HaightB , GibsonF , MichelY . The Northern Ireland life review / life storybook project for people with dementia. Alzheimer's &amp; Dementia2006;2(1):56‐8. [DOI: 10.1016/j.jalz.2005.12.003] ">Haight 2006</a>; <a href="./references#CD001120-bbs2-0011" title="LaiCKY , ChiI , Kayser‐JonesJ . A randomised controlled trial of a specific reminiscence approach to promote the well‐being of nursing home residents with dementia. International Psychogeriatrics / IPA2004;16(1):33‐49. ">Lai 2004</a>). There was probably little or no difference in function between RT and control groups at the end of treatment (SMD ‐0.07, 95% CI ‐0.33 to 0.47; I<sup>2</sup> = 0%; moderate quality evidence). Only the <a href="./references#CD001120-bbs2-0011" title="LaiCKY , ChiI , Kayser‐JonesJ . A randomised controlled trial of a specific reminiscence approach to promote the well‐being of nursing home residents with dementia. International Psychogeriatrics / IPA2004;16(1):33‐49. ">Lai 2004</a> study went on to assess participants at later follow‐up time points, with no effect evident at six weeks' post‐intervention. </p> <p>Four studies implementing a group reminiscence intervention reproted a relevant outcome at end of treatment in 934 participants and at follow‐up in 875 participants (<a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>; <a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). From baseline to end of treatment, the difference in change scores between the RT and control groups showed a probable slight benefit of RT (random‐effects analysis; SMD ‐0.40, 95% CI ‐0.99 to 0.20; I<sup>2</sup> = 94%; moderate quality evidence). There was a similar slight improvement at longer‐term follow‐up of six to 21 months (random‐effects analysis; SMD ‐0.38, 95% CI ‐0.78 to 0.03; I<sup>2</sup> = 87%; moderate quality evidence). In both cases, we could not be sure that the improvement noted was large enough to be clinically important; the high inconsistency in each analysis was clearly attributable to the inclusion of the <a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a> study, the only one of the four to be located in a care home setting, and which reported more positive results in this domain than the community‐based group studies. </p> </section> <section id="CD001120-sec-0098"> <p><b>Setting</b></p> <p>Three large group studies, including 846 participants, provided data on the effects of RT on functioning of community residents (<a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>; <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). There was little or no difference in function at the end of treatment between groups (SMD 0.05, 95% CI ‐0.09 to 0.18; I<sup>2</sup> = 0%; high quality evidence), with a slight improvement in favour of RT, of uncertain clinical importance, at longer‐term follow‐up (SMD ‐0.12, 95% CI ‐0.27 to 0.02; I<sup>2</sup> = 0%; high quality evidence). </p> <p>Due to imprecision and inconsistency, we could not be certain of the effect of RT in care home settings (three studies with 184 participants; <a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0008" title="HaightB , GibsonF , MichelY . The Northern Ireland life review / life storybook project for people with dementia. Alzheimer's &amp; Dementia2006;2(1):56‐8. [DOI: 10.1016/j.jalz.2005.12.003] ">Haight 2006</a>; <a href="./references#CD001120-bbs2-0011" title="LaiCKY , ChiI , Kayser‐JonesJ . A randomised controlled trial of a specific reminiscence approach to promote the well‐being of nursing home residents with dementia. International Psychogeriatrics / IPA2004;16(1):33‐49. ">Lai 2004</a>). This was true at the end of treatment (random‐effects analysis; SMD ‐0.53, 95% CI ‐1.87 to 0.80; I<sup>2</sup> = 94%; very low quality evidence) and at longer‐term follow‐up (two studies with 154 participants; <a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0011" title="LaiCKY , ChiI , Kayser‐JonesJ . A randomised controlled trial of a specific reminiscence approach to promote the well‐being of nursing home residents with dementia. International Psychogeriatrics / IPA2004;16(1):33‐49. ">Lai 2004</a>) (random‐effects analysis; SMD ‐0.67, 95% CI ‐1.89 to 0.55; I<sup>2</sup> = 92%; very low quality evidence). The inconsistency in results within these analyses was attributable to the more positive results reported by the one care home study using a group intervention (<a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>). </p> </section> </section> <section id="CD001120-sec-0099"> <h6 class="title">Behaviour: agitation/irritability</h6> <p>Three studies measured irritability and agitation using the MOSES irritability subscale (<a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a>) and CMAI (<a href="./references#CD001120-bbs2-0017" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (AD)</a>; <a href="./references#CD001120-bbs2-0018" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (VD)</a>). A lower score was indicative of improved agitation/irritability. The three studies included 359 participants, with 181 receiving an RT and 178 receiving control conditions, and all implemented a group reminiscence intervention. There was probably little or no difference in outcome between groups at the end of treatment (SMD 0.03, 95% CI ‐0.17 to 0.24; I<sup>2</sup> = 0%; moderate quality evidence; <a href="./references#CD001120-fig-0017" title="">Analysis 1.9</a>). Two studies measured changes in behaviour scores again six months' post‐intervention (<a href="./references#CD001120-bbs2-0017" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (AD)</a>; <a href="./references#CD001120-bbs2-0018" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (VD)</a>). There may have been a slight improvement, although we could not be certain of this, or of its clinical importance, due to imprecision (MD ‐1.52 points, 95% CI ‐4.07 to 1.03; I<sup>2</sup> = 0%; low quality evidence; <a href="./references#CD001120-fig-0033" title="">Analysis 1.25</a>). </p> <p>All the studies were group studies, and in the absence of heterogeneity between studies, analyses by setting were not undertaken. </p> </section> <section id="CD001120-sec-0100"> <h6 class="title">Mood</h6> <p>(See <a href="#CD001120-fig-0007">Figure 7</a>.) </p> <div class="figure" id="CD001120-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Reminiscence therapy versus no treatment, outcome: 1.10 Mood‐related outcomes (depression) post‐treatment." data-id="CD001120-fig-0007" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Reminiscence therapy versus no treatment, outcome: 1.10 Mood‐related outcomes (depression) post‐treatment. </p> </div> </div> </div> <p>Ten studies included a mood scale administered at the end of treatment (<a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>; <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0008" title="HaightB , GibsonF , MichelY . The Northern Ireland life review / life storybook project for people with dementia. Alzheimer's &amp; Dementia2006;2(1):56‐8. [DOI: 10.1016/j.jalz.2005.12.003] ">Haight 2006</a>; <a href="./references#CD001120-bbs2-0013" title="MorganS , WoodsRT . Life review with people with dementia in care homes: a preliminary randomised controlled trial. Dementia: Non‐Pharmacological Therapies2012;1(1):43‐59. ">Morgan 2012</a>; <a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a>; <a href="./references#CD001120-bbs2-0016" title="SubramaniamP , WoodsB , WhitakerC . Life review and life story books for people with mild to moderate dementia: a randomised controlled trial. Aging &amp; Mental Health2013;18(3):363‐75. ">Subramaniam 2013</a>; <a href="./references#CD001120-bbs2-0017" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (AD)</a>; <a href="./references#CD001120-bbs2-0018" title="TadakaE , KanagawaK . Effects of reminiscence group in elderly people with Alzheimer disease and vascular dementia in a community setting. Geriatrics &amp; Gerontology International2007; Vol. 7, issue 2:167‐73. ">Tadaka 2007 (VD)</a>; <a href="./references#CD001120-bbs2-0020" title="VanBogaertP , TolsonD , EerlingenR , CarversD , WoutersK , PaqueK , et al. SolCos model‐based individual reminiscence for older adults with mild to moderate dementia in nursing homes: a randomized controlled intervention study. Journal of Psychiatric and Mental Health Nursing2016;23(9‐10):568‐75. ">Van Bogaert 2016</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). These included self‐report measures such as the HADS and the GDS, but four studies using the CSDD, where the researcher integrated reports from the carer and the person with dementia. In these analyses, negative scores indicated improved mood. </p> <p>For depression, the 10 studies included 973 participants. There was little or no difference in depression between groups evident at the end of treatment (SMD ‐0.03, 95% CI ‐0.15 to 0.10; I<sup>2</sup> = 32%; high quality evidence; <a href="./references#CD001120-fig-0018" title="">Analysis 1.10</a>). At longer‐term follow‐up (six to 84 weeks), six studies, including 747 participants, reported measures of depressed mood. We could not be certain of the effects of RT at follow‐up, as the results were consistent with improvement or with little or no effect, and there was inconsistency between studies attributable to the reminiscence modality (random‐effects analysis; SMD ‐0.16, 95% CI ‐0.43 to 0.11; I<sup>2</sup> = 55%; moderate quality evidence; <a href="./references#CD001120-fig-0034" title="">Analysis 1.26</a>). </p> <p>Two large community‐based studies of group reminiscence, including 436 participants, analysed anxiety (<a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). There was little or no difference in anxiety between groups at the end of treatment (SMD ‐0.03, 95% CI ‐0.22 to 0.16; I<sup>2</sup> = 0%; high quality evidence; <a href="./references#CD001120-fig-0019" title="">Analysis 1.11</a>), and there was probably little or no difference in anxiety at seven months' follow‐up (SMD 0.01, 95% CI ‐0.20 to 0.21; I<sup>2</sup> = 0%; moderate quality evidence; 391 participants; <a href="./references#CD001120-fig-0035" title="">Analysis 1.27</a>). </p> <p>One study with 326 participants evaluated apathy, using a carer‐rated Apathy Index (<a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>). There was probably little or no difference in apathy between groups at the end of treatment assessment or at 21 months' follow‐up. </p> <section id="CD001120-sec-0101"> <p><b>Modality</b></p> <p>The four studies using an individual reminiscence approach included 131 participants. There was probably a slight effect on depressed mood in favour of individual RT, although we could not be sure of its clinical importance (SMD ‐0.41, 95% CI ‐0.76 to ‐0.06; I<sup>2</sup> = 0%; moderate quality evidence). The single study with an individual approach that included a longer‐term follow‐up (six weeks) showed a probable benefit, but the sample size (17 participants) was very small (<a href="./references#CD001120-bbs2-0013" title="MorganS , WoodsRT . Life review with people with dementia in care homes: a preliminary randomised controlled trial. Dementia: Non‐Pharmacological Therapies2012;1(1):43‐59. ">Morgan 2012</a>). </p> <p>Six studies with 842 participants used a group approach. There was little or no difference between group RT and controls (SMD 0.03, 95% CI ‐0.10 to 0.17; I<sup>2</sup> = 27%; high quality evidence). At longer‐term follow‐up of six to 21 months, five studies of group RT reported measures of depressed mood, but all were community based, so the results were confounded with the setting. There was little or no difference related to the RT (SMD ‐0.04, 95% CI ‐0.19 to 0.11; I<sup>2</sup> = 0%; high quality evidence; 730 participants). </p> </section> <section id="CD001120-sec-0102"> <p><b>Setting</b></p> <p>Five studies with 187 participants were based in care homes. There was probably a small benefit of RT, but we could not rule out little or no effect and could not be sure of the clinical importance of any effect (SMD ‐0.19, 95% CI ‐0.48 to 0.10; I<sup>2</sup> = 30%; moderate quality evidence). </p> <p>The five community‐based studies, all involving group interventions, included 786 participants and showed little or no effect of RT (SMD 0.01, 95% CI ‐0.13 to 0.16; I<sup>2</sup> = 31%; high quality evidence). </p> <p>The results for longer‐term follow‐up were discussed in the 'Modality' section above, with all the community studies being group studies, and the single care home study followed up involving individual reminiscence. </p> </section> </section> </section> <section id="CD001120-sec-0103"> <h5 class="title">Outcomes for the carer</h5> <p>For all carer outcomes, lower scores indicated a more positive outcome.</p> <section id="CD001120-sec-0104"> <h6 class="title">Stress related to caring</h6> <p>Seven studies used measures such as the Relative Stress Scale (RSS) and ZBI that evaluated the carer's stress directly related to aspects of caring (<a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>; <a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a>; <a href="./references#CD001120-bbs2-0015" title="SärkämöT , TervaniemiM , LaitinenS , NumminenA , KurkiM , JohnsonJK , et al. Cognitive, emotional and social benefits of regular musical activities in early dementia: randomised controlled study. Gerontologist2013;54(4):634‐50. ">Särkämö 2013</a>; <a href="./references#CD001120-bbs2-0019" title="ThorgrimsenL , SchweitzerP , OrrellM . Evaluating reminiscence for people with dementia: a pilot study. The Arts in Psychotherapy2002;29(1):93‐7. ">Thorgrimsen 2002</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). In six of the studies, the carer was a family member or friend, but in the <a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a> study, the carer was a healthcare assistant or nurse. At end of treatment, these studies involved 1155 participants. Overall, there was probably little or no difference in carer stress related to the reminiscence intervention (random‐effects analysis; SMD ‐0.03, 95% CI ‐0.21 to 0.14; I<sup>2</sup> = 43%; moderate quality evidence; <a href="./references#CD001120-fig-0020" title="">Analysis 1.12</a>). There appeared to be some inconsistency between studies, related to the different settings. Excluding the <a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a> study, so that the 965 participants were all family or friend carers made little difference to the overall results (random‐effects analysis; SMD ‐0.08, 95% CI ‐0.32 to 0.16; I<sup>2</sup> = 59%; high quality evidence). The inclusion of a single care home study, which reported much more positive findings, was responsible for the observed inconsistency (<a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>). </p> <p>Five studies, involving 895 participants, went on to measure carer stress at follow‐up of six to 21 months (<a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>; <a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0015" title="SärkämöT , TervaniemiM , LaitinenS , NumminenA , KurkiM , JohnsonJK , et al. Cognitive, emotional and social benefits of regular musical activities in early dementia: randomised controlled study. Gerontologist2013;54(4):634‐50. ">Särkämö 2013</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). The results were again inconsistent between studies (due to the inclusion of the single care home study) and the result of the meta‐analysis was imprecise being compatible with either improvement or a small or no effect (random‐effects analysis; SMD ‐0.19, 95% CI ‐0.54 to 0.16; I<sup>2</sup> = 82%; moderate quality evidence; <a href="./references#CD001120-fig-0036" title="">Analysis 1.28</a>). </p> <section id="CD001120-sec-0105"> <p><b>Modality</b></p> <p>All the seven studies that measured stress related to caring involved group reminiscence (<a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>; <a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a>; <a href="./references#CD001120-bbs2-0015" title="SärkämöT , TervaniemiM , LaitinenS , NumminenA , KurkiM , JohnsonJK , et al. Cognitive, emotional and social benefits of regular musical activities in early dementia: randomised controlled study. Gerontologist2013;54(4):634‐50. ">Särkämö 2013</a>; <a href="./references#CD001120-bbs2-0019" title="ThorgrimsenL , SchweitzerP , OrrellM . Evaluating reminiscence for people with dementia: a pilot study. The Arts in Psychotherapy2002;29(1):93‐7. ">Thorgrimsen 2002</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). However, an additional aspect of modality that should be considered in relation to carer outcomes relates to whether the family carer was actively involved in the reminiscence group. This joint reminiscence was a key feature of the <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0015" title="SärkämöT , TervaniemiM , LaitinenS , NumminenA , KurkiM , JohnsonJK , et al. Cognitive, emotional and social benefits of regular musical activities in early dementia: randomised controlled study. Gerontologist2013;54(4):634‐50. ">Särkämö 2013</a>; <a href="./references#CD001120-bbs2-0019" title="ThorgrimsenL , SchweitzerP , OrrellM . Evaluating reminiscence for people with dementia: a pilot study. The Arts in Psychotherapy2002;29(1):93‐7. ">Thorgrimsen 2002</a> and <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a> studies, which included 551 participants. There was little or no difference in carer stress between the reminiscence intervention and control conditions at end of treatment in these studies (SMD 0.04, 95% CI ‐0.13 to 0.21; I<sup>2</sup> = 16%; high quality evidence) or at longer‐term follow‐up of six to seven months (SMD ‐0.04, 95% CI ‐0.22 to 0.15; I<sup>2</sup> = 0%; high quality evidence; 3 studies; 481 participants). In contrast, only one study including 88 participants evaluated family carer stress when family carers were not extensively involved in the RT (<a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>). The study used the ZBI and found that there was probably a benefit to carers at the end of treatment (MD ‐4.90 points, 95% CI ‐8.20 to ‐1.60; moderate quality evidence) and at six months' follow‐up (MD ‐7.90 points, 95% CI ‐10.97 to ‐4.83; moderate quality evidence). </p> </section> <section id="CD001120-sec-0106"> <p><b>Setting</b></p> <p>Five studies, including 877 participants, were community‐based (<a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>; <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0015" title="SärkämöT , TervaniemiM , LaitinenS , NumminenA , KurkiM , JohnsonJK , et al. Cognitive, emotional and social benefits of regular musical activities in early dementia: randomised controlled study. Gerontologist2013;54(4):634‐50. ">Särkämö 2013</a>; <a href="./references#CD001120-bbs2-0019" title="ThorgrimsenL , SchweitzerP , OrrellM . Evaluating reminiscence for people with dementia: a pilot study. The Arts in Psychotherapy2002;29(1):93‐7. ">Thorgrimsen 2002</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). There was little or no difference in carer stress between groups at end of treatment (SMD 0.05, 95% CI ‐0.08 to 0.19; I<sup>2</sup> = 0%; high quality evidence) or at longer‐term follow‐up of six to 21 months (SMD 0.02, 95% CI ‐0.12 to 0.16; I<sup>2</sup> = 0%; high quality evidence; 4 studies; 807 participants). </p> <p>There were two care home studies, both using the ZBI (<a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a>; <a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a>). The <a href="./references#CD001120-bbs2-0003" title="AzcurraDJLS . A reminiscence program intervention to improve the quality of life of long‐term care residents with Alzheimer's disease. A randomized controlled trial. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)2012;34:422‐33. [DOI: 10.1016/j.rbp.2012.05.008] ">Azcurra 2012</a> study, which involved family carers, reported probable benefit at both end of treatment and longer‐term follow‐up, but, when combined with the <a href="./references#CD001120-bbs2-0014" title="O'SheaE , DevaneD , CooneyA , CaseyD , JordanF , HunterA , et al. The impact of reminiscence on the quality of life of residents with dementia in long‐stay care. International Journal of Geriatric Psychiatry2014;29(10):1062‐70. [DOI: 10.1002/gps.4099] ">O'Shea 2014</a> study, end of treatment data on staff carers, we could not be certain of any benefits due to inconsistency between the studies and imprecision (random‐effects analysis; MD ‐1.48 points, 95% CI ‐5.43 to 2.47; I<sup>2</sup> = 70%; very low quality evidence; 278 participants). </p> </section> </section> <section id="CD001120-sec-0107"> <h6 class="title">Mood: depression and anxiety</h6> <p>Two large community‐based joint reminiscence group studies with 517 participants used the HADS to evaluate changes in anxiety and depressed mood following carers' participation in joint reminiscence groups with people with dementia (<a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). There was little or no difference between groups on the HADS Anxiety subscale at the end of treatment (MD 0.06 points, 95% CI ‐0.54 to 0.66; I<sup>2</sup> = 0%; high quality evidence; <a href="./references#CD001120-fig-0022" title="">Analysis 1.14</a>). At seven months' follow‐up, there was probably a slight advantage for the control participants, but we could not be certain of the clinical implications of this result, which was also consistent with little or no difference (MD 0.56 points, 95% CI ‐0.17 to 1.30; I<sup>2</sup> = 0%; moderate quality evidence; 464 participants; <a href="./references#CD001120-fig-0038" title="">Analysis 1.30</a>). There was little or no difference between reminiscence and control conditions for the HADS Depression subscale at the end of treatment (MD ‐0.08 points, 95% CI ‐0.59 to 0.44; I<sup>2</sup> = 0%; high quality evidence; <a href="./references#CD001120-fig-0021" title="">Analysis 1.13</a>) and at seven months' follow‐up (MD ‐0.05 points, 95% CI ‐0.71 to 0.60; I<sup>2</sup> = 0%; high quality evidence; <a href="./references#CD001120-fig-0037" title="">Analysis 1.29</a>). </p> </section> <section id="CD001120-sec-0108"> <h6 class="title">Well‐being and quality of life</h6> <p>Four community‐based joint reminiscence group studies, including 530 participants, evaluated aspects of carer psychological well‐being (<a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0015" title="SärkämöT , TervaniemiM , LaitinenS , NumminenA , KurkiM , JohnsonJK , et al. Cognitive, emotional and social benefits of regular musical activities in early dementia: randomised controlled study. Gerontologist2013;54(4):634‐50. ">Särkämö 2013</a>; <a href="./references#CD001120-bbs2-0019" title="ThorgrimsenL , SchweitzerP , OrrellM . Evaluating reminiscence for people with dementia: a pilot study. The Arts in Psychotherapy2002;29(1):93‐7. ">Thorgrimsen 2002</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). Outcome scales included the GHQ‐12, GHQ‐28 and SF‐12 Mental component. There was little or no difference in carer well‐being between groups at end of treatment (SMD ‐0.04, 95% CI ‐0.22 to 0.13; I<sup>2</sup> = 1%; high quality evidence; <a href="./references#CD001120-fig-0023" title="">Analysis 1.15</a>). Three studies provided longer‐term follow‐up data after six to seven months, and there was little or no difference in carer well‐being (SMD 0.01, 95% CI ‐0.18 to 0.19; I<sup>2</sup> = 0%; high quality evidence; 467 participants; <a href="./references#CD001120-fig-0039" title="">Analysis 1.31</a>) (<a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0015" title="SärkämöT , TervaniemiM , LaitinenS , NumminenA , KurkiM , JohnsonJK , et al. Cognitive, emotional and social benefits of regular musical activities in early dementia: randomised controlled study. Gerontologist2013;54(4):634‐50. ">Särkämö 2013</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). </p> </section> <section id="CD001120-sec-0109"> <h6 class="title">Quality of caring relationship</h6> <p>Three studies, including up to 528 participants, evaluated the quality of the relationship between the carer and the person with dementia (as rated by the carer), all using the QCPR with two subscales: warmth and absence of conflict (<a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0016" title="SubramaniamP , WoodsB , WhitakerC . Life review and life story books for people with mild to moderate dementia: a randomised controlled trial. Aging &amp; Mental Health2013;18(3):363‐75. ">Subramaniam 2013</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). There was little or no difference related to RT on the warmth subscale at the end of treatment (MD ‐0.01 points, 95% CI ‐0.77 to 0.76; I<sup>2</sup> = 0%; high quality evidence) or (for the <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a> and <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a> studies) after seven months' follow‐up (MD ‐0.66 points, 95% CI ‐1.59 to 0.27; I<sup>2</sup> = 0%; high quality evidence). Similarly, there was little or no difference on the absence of conflict subscale at end of treatment (MD ‐0.26 points, 95% CI ‐1.01 to 0.48; I<sup>2</sup> = 0%; high quality evidence) or after longer‐term follow‐up (MD ‐0.37 points, 95% CI ‐1.23 to 0.50; I<sup>2</sup> = 0%; high quality evidence). </p> </section> </section> <section id="CD001120-sec-0110"> <h5 class="title">Adverse outcomes</h5> <p>The only outcome identified that probably favoured control participants was carer anxiety at seven months' follow‐up, from an analysis involving two large community studies that involved family carers along with people with dementia in reminiscence groups. The estimated MD was small enough to be of uncertain clinical importance and the evidence was of moderate quality, downgraded due to imprecision. These two studies also reported a few incidences of specific adverse outcomes. The <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a> study recorded 159 'serious adverse events' during the trial, with three of these attributable to the RYCT intervention. Specific details were not given, though it reported that none of these three events led to withdrawal. The <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a> study recorded one adverse event linked to participation in the trial. One participant became upset in one of the intervention sessions relating to marriage. There was a detailed protocol for dealing with distressing events that was implemented. While adverse events are regrettable, it is important to view them in context of the total number of participants and intervention sessions. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD001120-sec-0111" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD001120-sec-0111"></div> <section id="CD001120-sec-0112"> <h3 class="title" id="CD001120-sec-0112">Summary of main results</h3> <p>There has been a welcome increase in the volume of research on reminiscence in dementia care (and an improvement in its quality) since this review was last updated. It has now been possible to include large‐scale multicentre RCTs, using clearly defined interventions and protocols. It has also been possible to exclude studies where the risk of bias was rated as too high, without detracting greatly from the volume of research considered. For several outcomes, meta‐analyses included 800 or more participants. For the first time, it was possible to undertake analyses taking into account different modalities of reminiscence work and different contexts. Individual and group reminiscence work can now be considered separately for several outcomes, and community studies distinguished from those carried out in care homes. </p> <p>The primary finding of the review was that reminiscence work was not associated consistently with improved well‐being and QoL for people with dementia assigned to receive it in research studies. Although its clinical importance was uncertain, in care homes, but not in community settings, there was a probable benefit on QoL measures immediately following the reminiscence intervention. This finding arose from a meta‐analysis of three studies, from different countries, involving 193 people with dementia. Notably, in four of the five community studies in this analysis (and none of the care home studies), the intervention involved <b>joint</b> group sessions, where people with dementia and their family carers participated together. </p> <p>The extent to which reminiscence work would be predicted to improve cognitive functioning is debatable, but this review provides evidence (across 14 studies involving 1219 people with dementia) of a small benefit on cognitive tests evident immediately following the reminiscence work, but not sustained after a longer follow‐up period. The analyses separating individual and group reminiscence work indicated probable slight benefits in cognition related to individual work. There was a probable slight benefit to cognition in care homes but not the community. The overall effect size for cognition at the end of treatment (SMD) was 0.11 (95% CI 0.00 to 0.23); the comparable SMD from the Cochrane Review of cognitive stimulation (<a href="./references#CD001120-bbs2-0126" title="WoodsB , AguirreE , SpectorAE , OrrellM . Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database of Systematic Reviews2012, Issue 2. [DOI: 10.1002/14651858.CD005562.pub2] ">Woods 2012b</a>) was 0.41 (95% CI 0.25 to 0.57). However, a direct comparison of the subset of studies using the MMSE in the two reviews indicated an MD of 1.74 points (95% CI 1.13 to 2.36), from 10 studies of cognitive stimulation involving 600 participants, compared with an MD of 1.87 points (95% CI 0.54 to 3.20) for nine studies of RT involving 437 participants. This suggests the effects may be comparable on the MMSE between the two types of interventions, but with a wider CI for the reminiscence result. </p> <p>The quality of evidence relating to the communication and interaction outcome was lower, but there was probably a benefit of RT at longer‐term follow‐up, albeit of uncertain clinical importance. The number of studies including a relevant outcome measure was smaller (six at end of treatment, four at follow‐up, with 200 or more participants in each case), and the large studies of joint (with carer) reminiscence work were among those without a relevant outcome measure in this domain. Here, a probable effect was evident for community‐based studies at end of treatment and follow‐up, but was even less certain in the care home context. Group reminiscence was associated with a probable slight benefit in communication immediately and a benefit within the clinically important range at follow‐up, whereas (in smaller studies) there was considerable uncertainty in the results for individual reminiscence work. </p> <p>Despite a body of evidence for the effects of reminiscence on depressed mood in older people without dementia (e.g. <a href="./references#CD001120-bbs2-0089" title="BohlmeijerE , SmitF , CuijpersP . Effects of reminiscence and life review on late‐life depression: a meta‐analysis. International Journal of Geriatric Psychiatry2003;18:1088‐94. ">Bohlmeijer 2003</a>; <a href="./references#CD001120-bbs2-0113" title="PinquartM , DubersteinPR , LynessJM . Effects of psychotherapy and other behavioral interventions on clinically depressed older adults: a meta‐analysis. Aging &amp; Mental Health2007;11(6):645‐57. ">Pinquart 2007</a>), only individual reminiscence work was associated with a probable improvement in mood for people with dementia in this review, and the size of the effect (SMD ‐0.41) was relatively small and of uncertain clinical importance. There were no indications of benefits associated with reminiscence work in relation to the other outcomes examined for the person with dementia. These included the person's level of function, extent of irritability and agitation, and their own rating of the quality of relationship with their family carer. Despite the inclusion of several large studies of joint reminiscence work, where family carers were fully involved in the reminiscence sessions, we identified no benefits for family carers in relation to reduced stress related to caring, well‐being and QoL, carer mood or the carer's rating of the quality of their relationship with the person with dementia. The only exception to this was a single care home study, with 88 participants, in which family carers probably experienced less stress after their relative had been involved in reminiscence groups, both immediately after treatment and at six months' follow‐up. Interestingly, this was the only study to examine family carer outcomes that did <b>not</b> have a focus on joint reminiscence work. There were some suggestions from the REMCARE (REMiniscence groups for people with dementia and their family CAREgivers) trial (<a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>) of <i>negative</i> effects on carer anxiety, and this was evident to an extent in the analyses combining data from several studies of joint reminiscence work, where there was slightly higher carer anxiety (a difference of uncertain clinical importance) at the seven months' follow‐up assessment. One qualitative study explored potential factors in increased anxiety among carers taking part in joint reminiscence groups (<a href="./references#CD001120-bbs2-0109" title="MelunskyN , CrellinN , DudzinskiE , OrrellM , WenbornJ , PolandF , et al. The experience of family carers attending a joint reminiscence group with people with dementia: a thematic analysis. Dementia2015;14(6):842‐59. [DOI: 10.1177/1471301213516332] ">Melunsky 2015</a>). It identified issues such as the carer feeling disappointed when improvements in the group setting were not evident at home; the carer seeing people with more advanced dementia, resulting in increased fears for what the future might hold; and increased guilt from not being able to put into practice skills learned in the groups. These negative aspects were in the context of many positive experiences that carers reported from participation in the groups for themselves and the person with dementia. </p> </section> <section id="CD001120-sec-0113"> <h3 class="title" id="CD001120-sec-0113">Overall completeness and applicability of evidence</h3> <p>Although there is now a sufficient body of evidence to enable us to draw conclusions regarding reminiscence work in general, it remains difficult to consider fully different types of reminiscence work. For example, studies of individual reminiscence work have tended to be small‐scale and carried out in care homes, so we could not be certain of any difference in outcomes between individual and group approaches. Related to this, we were unable to draw a distinction in our analyses between simple and integrative reminiscence work. Although some studies have followed a very clear, published treatment protocol, reporting of details of interventions in other studies has been less complete, with even the distinction between individual and group reminiscence not always immediately apparent. </p> <p>Little evidence has emerged regarding the characteristics of people with dementia that might be associated with better outcomes, with the exception of the suggestion that reminiscence has a stronger effect on QoL in a care home context, as opposed to community settings. There clearly are differences between studies in the extent (and direction of changes) demonstrated by the high levels of heterogeneity evident in several analyses. However, many of these differences are yet to be explained. Some studies included only people with AD; others only recruited people with VD; others included any form of dementia. No clear differences in outcomes related to dementia type emerged from the analyses undertaken, and similarly there were few indications of the effects of dementia severity. </p> <p>It is unlikely that there is a simple 'dose' related effect, in that the studies offering the greatest exposure to reminiscence activities were among those with the least positive findings (<a href="./references#CD001120-bbs2-0002" title="AmievaH , RobertPH , GrandoulierAS , MeillonC , DeRotrouJ , AndrieuS , et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. International Psychogeriatrics / IPA2016;28(5):707‐17. ">Amieva 2016</a>; <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>). However, within studies a 'dose' effect may have operated. It is clear that in community settings, a significant proportion of people randomised to receive a reminiscence intervention did not engage with the groups. For example, in <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>, 11% of participants did not attend a single reminiscence session, with over 25% attending three sessions or fewer. An even larger proportion of participants in the <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a> study (43%) did not attend any reminiscence sessions. In line with our protocol, we included the ITT results in our analyses in this review. While it is important to know that these groups may not, for a variety of reasons, be taken up by all people with dementia and their carers, their results must underestimate any actual direct effects of reminiscence. For example, in a compliance analysis, <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a> showed an improvement in cognitive function (AMI‐E PSS) at the end of treatment and improved QoL (European Quality of Life 5 Dimensions; EQ‐5D) and quality of relationship (QCPR) at longer‐term follow‐up, but accompanied by an increase in carer stress (RSS). In contrast, <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a> reported no relationship between attendance and outcomes. </p> </section> <section id="CD001120-sec-0114"> <h3 class="title" id="CD001120-sec-0114">Quality of the evidence</h3> <p>There has been an overall significant improvement in the quality of included studies since the previous version of this review was undertaken. We are now able to include large‐scale studies, overseen by accredited clinical trials units, with quality assurance procedures and well‐developed remote randomisation procedures. </p> <p>However, more generally, under‐reporting of details of trials meant that a number of authors had to be contacted for additional information regarding, for example, randomisation and allocation, and several studies were excluded because of their risk of bias. </p> <p>Some risks of bias arise from the nature of psychosocial interventions such as RT. Participants and carers will be aware of the intervention being received, and, in general single‐blinding is the aim, with assessors being blind to treatment allocation. However, ratings completed by, for example, staff in care homes, may not be blinded, and the blinding of assessors may be compromised by participants and carers providing indications a treatment intervention has been received. Studies such as <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a> asked assessors to indicate which group the participant was in, and their degree of certainty of their judgement so that the extent of bias could be estimated. Expectations of benefit from participation or resentment at not being allocated to the active treatment may occur, and may produce some additional bias. Treatment expectations may be seen in the context of a pragmatic trial as part of the overall 'treatment package,' of course. </p> </section> <section id="CD001120-sec-0115"> <h3 class="title" id="CD001120-sec-0115">Potential biases in the review process</h3> <p>Our search strategy was as comprehensive as possible, and we consulted with experts in the field to identify any further studies. Two review authors (LOP and EF) independently conducted selection of studies, data extraction and risk of bias assessments, and disagreements resolved by contacting authors and consultation with other members of the review author team. The present review included all outcomes detailed in the protocol, irrespective of whether or not the results identified improvements. It must be acknowledged that the included studies could represent a biased sample of the studies undertaken worldwide on RT. It may be the case that trials that are not 'successful' (i.e. do not produce the expected positive findings) are less likely to be published. This may be especially the case with smaller trials. The welcome trend to preregistration of trials, and the publication of trial protocols, makes this less likely to occur in the future in relation to larger, well‐funded trials. The meta‐analyses here have been influenced strongly by larger trials, several of which did not report any positive findings (e.g. <a href="./references#CD001120-bbs2-0005" title="CharlesworthG , BurnellK , CrellinN , HoareZ , HoeJ , KnappM , et al. Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial. Journal of Neurology, Neurosurgery, and Psychiatry2016;87(11):1218‐28. [DOI: 10.1136/jnnp‐2016‐313736] OrrellM , HoeJ , CharlesworthG , RussellI , ChallisD , Moniz‐CookE , et al. Support at Home: Interventions to Enhance Life in Dementia (SHIELD) ‐ evidence, development and evaluation of complex interventions. Programme Grants for Applied Research2017;5:5. [DOI: 10.3310/pgfar05050] ">Charlesworth 2016</a>; <a href="./references#CD001120-bbs2-0021" title="WoodsRT , BruceE , EdwardsRT , ElvishR , HoareZ , HounsomeB , et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technology Assessment2012;16(48):v‐xv, 1‐116. [DOI: 10.3310/hta16480] WoodsRT , OrrellM , BruceE , EdwardsRT , HoareZ , HounsomeB , et al. REMCARE: pragmatic multi‐centre randomised trial of reminiscence groups for people with dementia and their family carers: effectiveness and economic analysis. PloS One2016;11(4):e0152843. [DOI: 10.1371/journal.pone.0152843] ">Woods 2012a</a>), but these were both of a group approach, in community settings. Our care home and individual reminiscence findings could perhaps have been more influenced by publication bias. A funnel plot of cognition at the end of treatment showed some asymmetry (<a href="#CD001120-fig-0008">Figure 8</a>), but this was largely driven by smaller/lower quality community studies having positive findings, with care home studies showing a symmetrical pattern. For most of our outcomes, there are too few included studies for meaningful funnel plots to be plotted. </p> <div class="figure" id="CD001120-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Reminiscence therapy versus no treatment, outcome: 1.5 Cognition (overall) post‐treatment.ADAS‐Cog: Alzheimer’s Disease Assessment Scale for Cognition; AMI‐PSS: Autobiographical Memory Interview ‐ Perceived Stress Scale; AMI‐E‐PSS: Autobiographical Memory Interview Extended Version ‐ Perceived Stress Scale; MMSE: Mini‐Mental State Examination." data-id="CD001120-fig-0008" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-AFig-FIG08.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Reminiscence therapy versus no treatment, outcome: 1.5 Cognition (overall) post‐treatment. </p> <p>ADAS‐Cog: Alzheimer’s Disease Assessment Scale for Cognition; AMI‐PSS: Autobiographical Memory Interview ‐ Perceived Stress Scale; AMI‐E‐PSS: Autobiographical Memory Interview Extended Version ‐ Perceived Stress Scale; MMSE: Mini‐Mental State Examination. </p> </div> </div> </div> </section> <section id="CD001120-sec-0116"> <h3 class="title" id="CD001120-sec-0116">Agreements and disagreements with other studies or reviews</h3> <p>We identified five reviews that overlap with this one.</p> <p><a href="./references#CD001120-bbs2-0094" title="CotelliM , ManentiR , ZanettiO . Reminiscence therapy in dementia: a review [Review]. Maturitas2012;72(3):203‐5. ">Cotelli 2012</a> included seven RCTs, with 218 participants, three of which were included in the current review. They identified some benefits for mood and cognitive function but pointed out that the number of trials 'remains very small and their quality is often poor' (two were excluded from this review on the basis of risk of bias). This review appeared to have predated the recent improvement in quality and size of trials. </p> <p><a href="./references#CD001120-bbs2-0122" title="SubramaniamP , WoodsB . The impact of individual reminiscence therapy for people with dementia: systematic review [Review]. Expert Review of Neurotherapeutics2012;12(5):545‐55. ">Subramaniam 2012</a> focused on individual reminiscence work, identifying five RCTs, three of which were included in the current review. They concluded that there was a consistent pattern emerging, with those studies offering 'individual reminiscence work that includes a life review process, uses specific memory triggers and results in the production of a life story book' having positive psychosocial outcomes for people with dementia. In contrast, where reminiscence was more general, evidence for efficacy was not apparent. Unfortunately, there are still insufficient studies of integrative reminiscence work to confirm this early conclusion. </p> <p><a href="./references#CD001120-bbs2-0108" title="KwonM‐H , ChoB‐H , LeeJ‐S . Reminiscence therapy for dementia ‐ meta analysis. Advanced Science and Technology Letters2013;40:10‐5. [DOI: 10.14257/astl.2013.40.03] ">Kwon 2013</a> reported a meta‐analysis including 10 studies. The studies included are not referenced, so comparisons were difficult. They conclude that reminiscence had a positive effect on cognition, depression and QoL, all with large effect sizes, but not on problem behaviour. </p> <p><a href="./references#CD001120-bbs2-0125" title="TestadI , CorbettA , AarslandD , LexowKO , FosseyJ , WoodsB , et al. The value of personalized psychosocial interventions to address behavioral and psychological symptoms in people with dementia living in care home settings: a systematic review. International Psychogeriatrics / IPA2014;26(7):1083‐98. ">Testad 2014</a> reported a broader review relating to people with dementia in care homes, with RT included as one of several psychosocial interventions. They included six studies involving RT, most of which did not meet the inclusion criteria for the current review (e.g. three were not RCTs). The authors concluded that reminiscence was associated with improved mood, but there was no consistent evidence regarding other outcomes. </p> <p><a href="./references#CD001120-bbs2-0105" title="HuangHC , ChenYT , ChenPY , HuSHL , LiuF , KuoYL , et al. Reminiscence therapy improves cognitive functions and reduces depressive symptoms in elderly people with dementia: a meta‐analysis of randomized controlled trials. Journal of the American Medical Directors Association2015;16(12):1087‐94. ">Huang 2015</a> included 12 studies, with 1325 participants. Cognition and depressed mood were the main outcomes studied, with nine studies contributing to meta‐analyses in each case. As with the current review, they identified a small effect size for cognition (SMD 0.18, 95% CI 0.05 to 0.30) but unlike the current review, there was a moderate‐sized effect for depressed mood (SMD ‐0.48, 95% CI ‐0.70 to ‐0.28). There was evidence that the effect on mood was greater in care home settings than in the community, which is in accordance with our results. Notably the community studies included in the <a href="./references#CD001120-bbs2-0105" title="HuangHC , ChenYT , ChenPY , HuSHL , LiuF , KuoYL , et al. Reminiscence therapy improves cognitive functions and reduces depressive symptoms in elderly people with dementia: a meta‐analysis of randomized controlled trials. Journal of the American Medical Directors Association2015;16(12):1087‐94. ">Huang 2015</a> review were all included in this review, but there were differences in the care home studies included, partly due to different exclusion criteria, but also because they were able to include studies published in Chinese. In general, the current review has adopted stricter quality standards than other reviews, and identified considerably more studies for inclusion, across different modalities and settings. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD001120-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD001120-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/full#CD001120-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD001120-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/full#CD001120-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD001120-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/full#CD001120-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Reminiscence therapy versus no treatment, outcome: 1.1 Self‐reported quality of life post‐treatment." data-id="CD001120-fig-0004" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Reminiscence therapy versus no treatment, outcome: 1.1 Self‐reported quality of life post‐treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/full#CD001120-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Reminiscence therapy versus no treatment, outcome: 1.5 Cognition (overall) post‐treatment." data-id="CD001120-fig-0005" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Reminiscence therapy versus no treatment, outcome: 1.5 Cognition (overall) post‐treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/full#CD001120-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Reminiscence therapy versus no treatment, outcome: 1.7 Communication and interaction post‐treatment." data-id="CD001120-fig-0006" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Reminiscence therapy versus no treatment, outcome: 1.7 Communication and interaction post‐treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/full#CD001120-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Reminiscence therapy versus no treatment, outcome: 1.10 Mood‐related outcomes (depression) post‐treatment." data-id="CD001120-fig-0007" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Reminiscence therapy versus no treatment, outcome: 1.10 Mood‐related outcomes (depression) post‐treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/full#CD001120-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-AFig-FIG08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-AFig-FIG08.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Reminiscence therapy versus no treatment, outcome: 1.5 Cognition (overall) post‐treatment.ADAS‐Cog: Alzheimer’s Disease Assessment Scale for Cognition; AMI‐PSS: Autobiographical Memory Interview ‐ Perceived Stress Scale; AMI‐E‐PSS: Autobiographical Memory Interview Extended Version ‐ Perceived Stress Scale; MMSE: Mini‐Mental State Examination." data-id="CD001120-fig-0008" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-AFig-FIG08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Reminiscence therapy versus no treatment, outcome: 1.5 Cognition (overall) post‐treatment. </p> <p>ADAS‐Cog: Alzheimer’s Disease Assessment Scale for Cognition; AMI‐PSS: Autobiographical Memory Interview ‐ Perceived Stress Scale; AMI‐E‐PSS: Autobiographical Memory Interview Extended Version ‐ Perceived Stress Scale; MMSE: Mini‐Mental State Examination. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/full#CD001120-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-AFig-FIG08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 1 Self‐reported quality of life post‐treatment." data-id="CD001120-fig-0009" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 1 Self‐reported quality of life post‐treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 2 Proxy rated quality of life post‐treatment." data-id="CD001120-fig-0010" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 2 Proxy rated quality of life post‐treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 3 Observed quality of life (post‐treatment)." data-id="CD001120-fig-0011" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 3 Observed quality of life (post‐treatment). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 4 Cognition post‐treatment." data-id="CD001120-fig-0012" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 4 Cognition post‐treatment.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-05.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 5 Cognition (overall) post‐treatment." data-id="CD001120-fig-0013" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 5 Cognition (overall) post‐treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 6 Quality of caring relationship post‐treatment." data-id="CD001120-fig-0014" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 6 Quality of caring relationship post‐treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-07.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 7 Communication and interaction post‐treatment." data-id="CD001120-fig-0015" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 7 Communication and interaction post‐treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 8 Behaviour (function) post‐treatment." data-id="CD001120-fig-0016" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 8 Behaviour (function) post‐treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 9 Behaviour (agitation/irritability) post‐treatment." data-id="CD001120-fig-0017" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 9 Behaviour (agitation/irritability) post‐treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-10.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 10 Mood‐related outcomes (depression) post‐treatment." data-id="CD001120-fig-0018" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 10 Mood‐related outcomes (depression) post‐treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 11 Mood‐related outcomes (anxiety) post‐treatment." data-id="CD001120-fig-0019" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 11 Mood‐related outcomes (anxiety) post‐treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 12 Carer outcomes (stress related to caring) post‐treatment." data-id="CD001120-fig-0020" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 12 Carer outcomes (stress related to caring) post‐treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 13 Carer outcomes (depression) post‐treatment." data-id="CD001120-fig-0021" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 13 Carer outcomes (depression) post‐treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 14 Carer outcomes (anxiety) post‐treatment." data-id="CD001120-fig-0022" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 14 Carer outcomes (anxiety) post‐treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 15 Carer outcomes (quality of life) post‐treatment." data-id="CD001120-fig-0023" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 15 Carer outcomes (quality of life) post‐treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 16 Carer outcomes (quality of caring relationship) post‐treatment." data-id="CD001120-fig-0024" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 16 Carer outcomes (quality of caring relationship) post‐treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 17 Self‐reported quality of life at follow‐up." data-id="CD001120-fig-0025" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 17 Self‐reported quality of life at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 18 Proxy rated quality of life at follow‐up." data-id="CD001120-fig-0026" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 18 Proxy rated quality of life at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 19 Observed quality of life at follow‐up." data-id="CD001120-fig-0027" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 19 Observed quality of life at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 20 Cognition follow‐up." data-id="CD001120-fig-0028" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 20 Cognition follow‐up.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 21 Cognition (overall) at follow‐up." data-id="CD001120-fig-0029" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 21 Cognition (overall) at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 22 Communication and interaction at follow‐up." data-id="CD001120-fig-0030" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 22 Communication and interaction at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 23 Quality of caring relationship at follow‐up." data-id="CD001120-fig-0031" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 23 Quality of caring relationship at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 24 Behaviour (functional) at follow‐up." data-id="CD001120-fig-0032" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 24 Behaviour (functional) at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 25 Behaviour (agitation/irritability) at follow‐up." data-id="CD001120-fig-0033" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.25</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 25 Behaviour (agitation/irritability) at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 26 Mood‐related outcomes (depression) at follow‐up." data-id="CD001120-fig-0034" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.26</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 26 Mood‐related outcomes (depression) at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 27 Mood‐related outcomes (anxiety) at follow‐up." data-id="CD001120-fig-0035" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.27</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 27 Mood‐related outcomes (anxiety) at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 28 Carer outcomes (stress related to caring) at follow‐up." data-id="CD001120-fig-0036" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.28</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 28 Carer outcomes (stress related to caring) at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-29" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-29.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 29 Carer outcomes (depression) at follow‐up." data-id="CD001120-fig-0037" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-29.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.29</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 29 Carer outcomes (depression) at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-29.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-30" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-30.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 30 Carer outcomes (anxiety) at follow‐up." data-id="CD001120-fig-0038" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-30.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.30</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 30 Carer outcomes (anxiety) at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-30.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-31" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-31.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 31 Carer outcomes (quality of life) at follow‐up." data-id="CD001120-fig-0039" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-31.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.31</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 31 Carer outcomes (quality of life) at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-31.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-32" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-32.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 32 Carer outcomes (quality of caring relationship) at follow‐up." data-id="CD001120-fig-0040" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-32.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.32</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 32 Carer outcomes (quality of caring relationship) at follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-32.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-33" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-33.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 33 Mood‐related outcomes (apathy) post‐treatment." data-id="CD001120-fig-0041" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-33.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.33</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 33 Mood‐related outcomes (apathy) post‐treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-33.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001120-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/urn:x-wiley:14651858:media:CD001120:CD001120-CMP-001-34" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_t/tCD001120-CMP-001-34.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reminiscence therapy versus no treatment, Outcome 34 Mood‐related outcomes (apathy) at follow‐up (community)." data-id="CD001120-fig-0042" src="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-34.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.34</div> <div class="figure-caption"> <p>Comparison 1 Reminiscence therapy versus no treatment, Outcome 34 Mood‐related outcomes (apathy) at follow‐up (community). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/media/CDSR/CD001120/image_n/nCD001120-CMP-001-34.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD001120-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Reminiscence Therapy compared to no treatment for people living with dementia</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Reminiscence Therapy compared to no treatment for people living with dementia</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people living with dementia <br/> <b>Setting:</b> Care home and community settings <br/> <b>Intervention:</b> Reminiscence Therapy <br/> <b>Comparison:</b> no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Reminiscence Therapy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of Life (self‐report) at end of treatment<br/> assessed with: QOL‐AD, SRQoL<br/> follow up: range 1 days to 6 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.11 higher<br/> (0.12 lower to 0.33 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1060<br/> (8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A higher score is indicative of improved quality of life. Subgroup analysis by setting likley explains the variation in effect size across the studies. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cognition at end of treatment<br/> assessed with: MMSE, AMI‐PSS, AMI(E)‐PSS, ADAS‐COG<br/> follow up: range 1 days to 6 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.11 higher<br/> (0 to 0.23 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1219<br/> (14 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A higher score is indicative of improved cognition</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Communication and Interaction at end of treatment<br/> assessed with: Social Engagement Scale, Communication Observation Scale, MOSES Withdrawal sub‐scale, Holden Communication Scale <br/> follow up: range 1 days to 2 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.51 lower<br/> (0.97 lower to 0.05 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>249<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> A lower score is indicative of improved communication</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Functional behaviour at end of treatment <br/> assessed with: MDS‐ADL, FIM, ADL, BADLS, ADCS‐ADL, DAD<br/> follow up: range 1 days to 6 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.24 lower<br/> (0.69 higher to 0.21 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1030<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A lower score is indicative of improved functional behaviour</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Agitation/irritability at end of treatment <br/> assessed with: CMAI, MOSES (irritability subscale)<br/> follow up: range 1 days to 6 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.03 higher<br/> (0.17 lower to 0.24 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>359<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A lower score is indicative of improved agitation/irritability</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Depressed mood at end of treatment<br/> assessed with: CSDD, GDS, GDS‐SF,MOSES (depression subscale), HADS (depression subscale), MADRS<br/> follow up: range 1 days to 6 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.03 lower<br/> (0.15 lower to 0.1 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>973<br/> (10 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A lower score is indicative of improved mood</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Stress related to caring (caregiver)<br/> assessed with: ZBI‐SF, RSS, NPI, Modified ZBI, ZBI<br/> follow up: range 1 days to 6 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.03 SD higher<br/> (0.21 lower to 0.14 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1155<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A lower score is indicative of less caregiver stress</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p> *<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded one point for inconsistency due to substantial heterogeneity </p> <p><sup>2</sup> Downgraded one point for imprecision due to small sample size (&lt;400 participants) </p> <p><sup>3</sup> Downgraded one point for imprecision as the confidence interval contains null effect and the lower limit passes ‐0.5 </p> <p><sup>4</sup> Downgraded two points for inconsistency due to considerable heterogeneity </p> <p><sup>5</sup> Downgraded one point for inconsistency due to moderate heterogeneity </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Reminiscence Therapy compared to no treatment for people living with dementia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/full#CD001120-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001120-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Reminiscence therapy compared to no treatment for people living with dementia (modality)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Reminiscence therapy compared to no treatment for people living with dementia (modality)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people living with dementia (modality)<br/> <b>Setting:</b> care home and community settings<br/> <b>Intervention:</b> reminiscence therapy<br/> <b>Comparison:</b> no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with reminiscence therapy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Individual: quality of life (self‐reported)</b> at end of treatment<br/> assessed with: QoL‐AD<br/> Scale from: 13 to 52<br/> follow‐up: range 1 to 7 days </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 7.00 points higher</b><br/> (0.14 lower to 14.14 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score on quality of life measures indicated a more positive outcome. 3.0 points may be the minimum clinically important difference. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Individual: cognition</b> at end of treatment<br/> assessed with: MMSE, AMI‐PSS<br/> follow‐up: range 1 day to 2 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SMD 0.32 higher</b><br/> (0.04 higher to 0.61 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>196<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate<sup>2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score on cognitive measures indicated a more positive outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Individual: communication</b> at end of treatment<br/> assessed with: SES, COS<br/> follow‐up: range 1 day to 2 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SMD 0.74 lower</b><br/> (2.38 lower to 0.89 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low<sup>3,4</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score on communication measures indicated a more positive outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Group: quality of life (self‐reported)</b> at end of treatment<br/> assessed with: QoL‐AD, SR‐QoL<br/> follow‐up: range 1 day to 6 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SMD 0.06 higher</b><br/> (0.15 lower to 0.28 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1037<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score on quality of life measures indicated a more positive outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Group: cognition</b> at end of treatment<br/> assessed with: MMSE, AMI‐PSS, ADAS‐Cog<br/> follow‐up: range 1 day to 6 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SMD 0.07 higher</b><br/> (0.05 lower to 0.20 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1023<br/> (9 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score on cognitive measures indicated a more positive outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Group: communication</b> at end of treatment<br/> assessed with: SES, COS, MOSES Withdrawal subscale<br/> follow‐up: range 1 day to 1 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SMD 0.39 lower</b><br/> (0.71 lower to 0.06 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>153<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate<sup>2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score on communication measures indicated a more positive outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>ADAS‐Cog:</b> Alzheimer's Disease Assessment Scale Cognitive subscale; <b>AMI‐PSS:</b> Autobiographical Memory Interview ‐ Perceived Stress Scale; <b>CI:</b> confidence interval; Communication Observation Scale; <b>MD:</b> mean difference; <b>MMSE:</b> Mini‐Mental State Examination; <b>MOSES:</b> Multidimensional Observation Scale for Elderly Subjects; <b>QoL‐AD:</b> Quality of Life in Alzheimer's Disease; <b>RCT:</b> randomised controlled trial; <b>SES:</b> Social Engagement Scale; <b>SMD:</b> standardised mean difference; <b>SR‐QoL:</b> Self‐Report Quality of Life. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded 2 levels for imprecision due to small sample size (&lt; 400 participants) and including both null effect and an upper limit greater than 0.3. </p> <p><sup>2</sup>Downgraded 1 level for imprecision due to small sample size (&lt; 400 participants). </p> <p><sup>3</sup>Downgraded 2 levels for inconsistency due to considerable unexplained heterogeneity. </p> <p><sup>4</sup>Downgraded 2 levels for imprecision due to small sample size (&lt; 400 participants) and both confidence interval limits crossing 0.5. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Reminiscence therapy compared to no treatment for people living with dementia (modality)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/full#CD001120-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001120-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Reminiscence therapy compared to no treatment for people living with dementia (setting)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Reminiscence therapy compared to no treatment for people living with dementia (setting)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people living with dementia (setting)<br/> <b>Setting:</b> community and care home settings<br/> <b>Intervention:</b> reminiscence therapy<br/> <b>Comparison:</b> no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with reminiscence therapy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Care home: quality of life (self‐reported)</b> at end of treatment<br/> assessed with: QoL‐AD, SR‐QoL<br/> follow‐up: range 1 day to 6 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SMD 0.46 higher</b><br/> (0.18 higher to 0.75 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>193<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score on quality of life measures indicated a more positive outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Care home: cognition</b> at end of treatment<br/> assessed with: MMSE, AMI‐PSS<br/> follow‐up: range 1 day to 2 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SMD 0.29 higher</b><br/> (0.03 higher to 0.56 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>230<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score on cognitive measures indicated a more positive outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Care home: communication</b> at end of treatment<br/> assessed with: SES, Communication Scale for Cognitively Impaired<br/> follow‐up: range 1 day to 2 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SMD 0.52 lower</b><br/> (1.29 lower to 0.24 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>184<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low<sup>2,3</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score on communication measures indicated a more positive outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Community: quality of life (self‐reported)</b> at end of treatment<br/> assessed with: QoL‐AD (self‐report)<br/> Scale from: 13 to 52<br/> follow‐up: range 1 day to 6 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.57 points lower</b><br/> (1.37 lower to 0.22 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>867<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score on quality of life measures indicated a more positive outcome. 3.0 points may be the minimum clinically important difference. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Community: cognition</b> at end of treatment<br/> assessed with: MMSE, AMI‐PSS, AMI‐E‐PSS, ADAS‐Cog<br/> follow‐up: range 1 day to 6 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SMD 0.07 higher</b><br/> (0.05 lower to 0.20 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>989<br/> (8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score on cognitive measures indicated a more positive outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Community: communication and interaction</b> at end of treatment<br/> assessed with: Holden Communication Scale and MOSES (withdrawal subscale)<br/> follow‐up: range 1 day to 7 days </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SMD 0.57 lower</b><br/> (1.08 lower to 0.06 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score on communication measures indicated a more positive outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>ADAS‐Cog:</b> Alzheimer's Disease Assessment Scale Cognitive subscale; <b>AMI‐PSS:</b> Autobiographical Memory Interview ‐ Perceived Stress Scale; <b>AMI‐E‐PSS:</b> Autobiographical Memory Interview ‐ Extended Version ‐ Perceived Stress Scale; <b>MD:</b> mean difference; <b>MMSE:</b> Mini‐Mental State Examination; <b>MOSES:</b> Multidimensional Observation Scale for Elderly Subjects; <b>QoL‐AD:</b> Quality of Life in Alzheimer's Disease; <b>RCT:</b> randomised controlled trial; <b>SES:</b> Social Engagement Scale; <b>SMD:</b> standardised mean difference; <b>SR‐QoL:</b> Self‐Report Quality of Life. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded 1 level for imprecision because of small sample size (&lt; 400 participants). </p> <p><sup>2</sup>Downgraded 2 levels for imprecision because of small sample size (&lt; 400) and the confidence interval including a null effect and a lower limit crossing ‐0.5. </p> <p><sup>3</sup>Downgraded 2 levels for inconsistency due to considerable unexplained heterogeneity. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Reminiscence therapy compared to no treatment for people living with dementia (setting)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/full#CD001120-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001120-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Reminiscence therapy versus no treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Self‐reported quality of life post‐treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1060</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [‐0.12, 0.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 SR‐QoL (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.03, 0.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 QoL‐AD rated by person with dementia (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.08, 0.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 QoL‐AD rated by person with dementia (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>867</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.24, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Proxy rated quality of life post‐treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>763</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [‐1.23, 1.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 QoL‐AD rated by carer (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>577</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [‐1.75, 2.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 QoL‐AD rated by carer (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>186</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [‐1.33, 3.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Observed quality of life (post‐treatment) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.17, 0.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 WIB (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.17, 0.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Cognition post‐treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 MMSE (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [‐0.05, 0.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 MMSE (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [‐0.06, 0.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 AMI‐PSS (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [‐0.08, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4 AMI‐PSS (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [‐0.21, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.5 AMI‐E‐PSS (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>386</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [‐0.09, 0.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.6 AMI‐AIS (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [‐0.52, 0.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.7 AMI‐AIS (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.02, 1.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.8 AMI‐E‐AIS (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>386</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [‐0.16, 0.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.9 ADAS‐Cog (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.31, 0.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Cognition (overall) post‐treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.00, 0.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 MMSE (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [‐0.05, 0.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 MMSE (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [‐0.06, 0.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 AMI‐PSS (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [‐0.08, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4 AMI‐PSS (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [‐0.21, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.5 AMI‐E‐PSS (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>386</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [‐0.09, 0.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.6 ADAS‐Cog (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.31, 0.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Quality of caring relationship post‐treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 QCPR Warmth rated by person with dementia (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [‐0.44, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 QCPR Warmth rated by person with dementia (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>505</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.17, 0.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 QCPR conflict rated by person with dementia (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.67 [‐1.51, 0.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4 QCPR conflict rated by person with dementia (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>500</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.22, 0.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Communication and interaction post‐treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.51 [‐0.97, ‐0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Social Engagement Scale (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.13 [‐0.44, 0.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Communication Observation Scale for Cognitively Impaired (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.62 [‐2.46, ‐0.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 Holden Communication Scale (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.16 [‐1.51, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.4 MOSES Withdrawal subscale (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.64 [‐1.18, ‐0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Behaviour (function) post‐treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1030</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.24 [‐0.69, 0.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 MDS‐ADL (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.52, 0.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Functional Independence Measure (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [‐0.41, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 ADL (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.83 [‐2.33, ‐1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.4 Bristol Activities of Daily Living Scale (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>391</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [‐0.09, 0.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.5 ADCS‐ADL (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.41, 0.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.6 DAD (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.22, 0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Behaviour (agitation/irritability) post‐treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.17, 0.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Cohen‐Mansfield Agitation Inventory (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>304</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [‐0.14, 0.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 MOSES Irritability subscale (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.26 [‐0.79, 0.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Mood‐related outcomes (depression) post‐treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>973</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.15, 0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 CSDD (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>147</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.18 [‐0.50, 0.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 CSDD (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>276</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.38, 0.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3 Geriatric Depression Scale (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐0.90, 0.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.4 Geriatric Depression Scale Short Form (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.53 [‐1.51, 0.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.5 MOSES Depression subscale (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.32 [‐0.85, 0.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.6 HADS Depression (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [‐0.26, 0.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.7 MADRS (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [‐0.05, 0.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Mood‐related outcomes (anxiety) post‐treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>436</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.22, 0.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 HADS Anxiety (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.40, 0.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 RAID (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>307</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.25, 0.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Carer outcomes (stress related to caring) post‐treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.21, 0.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Zarit Burden Interview Short Form (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.61 [‐1.04, ‐0.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 Zarit Burden Interview Short Form (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐0.73, 0.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3 Relatives Stress Scale (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.46 [‐1.82, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.4 NPI (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [‐0.26, 0.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.5 Modified Zarit Burden Interview ‐ care assistant (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.38, 0.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.6 Modified Zarit Burden Interview ‐ nurse report (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [‐0.31, 0.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.7 Zarit Burden Interview</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [‐0.14, 0.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Carer outcomes (depression) post‐treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>517</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐0.59, 0.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 HADS ‐ Depression (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>517</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐0.59, 0.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Carer outcomes (anxiety) post‐treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>517</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.54, 0.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 HADS ‐ Anxiety (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>517</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.54, 0.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Carer outcomes (quality of life) post‐treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>530</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.22, 0.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 GHQ‐12 carer (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.23 [‐0.82, 0.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 GHQ‐28 (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.18, 0.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.3 SF Mental (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.59, 0.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Carer outcomes (quality of caring relationship) post‐treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1051</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.67, 0.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 QCPR Absence of conflict carer (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐5.27, 4.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2 QCPR Absence of conflict carer (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>500</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.27 [‐1.02, 0.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.3 QCPR Warmth carer (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.2 [‐6.07, 3.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.4 QCPR Warmth carer (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>505</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.75, 0.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Self‐reported quality of life at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>874</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [‐0.11, 0.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 SR‐QoL (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.48 [1.00, 1.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.2 QoL‐AD rated by person with dementia (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>786</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.13, 0.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Proxy rated quality of life at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>505</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.15 [‐1.14, 0.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 QoL‐AD rated by carer (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>505</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.15 [‐1.14, 0.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Observed quality of life at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.40 [‐1.34, 0.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1 WIB (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.40 [‐1.34, 0.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Cognition follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1 MMSE (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [‐0.17, 0.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.2 MMSE (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>216</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [‐0.08, 0.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.3 AMI‐PSS (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [‐0.46, 1.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.4 AMI‐PSS (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [‐0.18, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.5 AMI‐E‐PSS (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>328</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.26, 0.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.6 AMI‐AIS (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.25 [‐1.20, 0.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.7 AMI‐AIS (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [‐0.11, 1.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.8 AMI‐E‐AIS (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>325</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.21, 0.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.9 ADAS‐Cog (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.32, 0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Cognition (overall) at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>983</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.09, 0.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.1 MMSE (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [‐0.17, 0.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.2 MMSE (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>216</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [‐0.08, 0.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.3 AMI‐PSS (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [‐0.46, 1.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.4 AMI‐PSS (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [‐0.18, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.5 AMI‐E‐PSS (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>328</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.26, 0.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.6 ADAS‐Cog (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.32, 0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Communication and interaction at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>204</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.49 [‐0.77, ‐0.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.1 Social Engagement Scale (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.46 [‐0.79, ‐0.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.2 MOSES withdrawal subscale (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.56 [‐1.12, 0.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Quality of caring relationship at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.1 QCPR warmth rated by person with dementia (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>415</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [‐0.61, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.2 QCPR conflict rated by person with dementia (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>409</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.38 [‐1.28, 0.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Behaviour (functional) at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>941</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.31 [‐0.66, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.1 MDS‐ADL (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.53, 0.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.2 ADL (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.29 [‐1.75, ‐0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.3 ADCS‐ADL (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.53, 0.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.4 Bristol Activities of Daily Living Scale (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>342</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.35, 0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.5 DAD (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.32, 0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Behaviour (agitation/irritability) at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.52 [‐4.07, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>25.1 MOSES Irritability subscale (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.52 [‐4.07, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Mood‐related outcomes (depression) at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>747</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.16 [‐0.43, 0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>26.1 Geriatric Depression Scale Short Form (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.63 [‐2.77, ‐0.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>26.2 CSDD (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.17 [‐0.43, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>26.3 MOSES Depression subscale (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.26 [‐0.82, 0.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>26.4 HADS Depression (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.48, 0.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>26.5 MADRS (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.11, 0.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 Mood‐related outcomes (anxiety) at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>391</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.20, 0.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>27.1 RAID (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>272</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.25, 0.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>27.2 HADS Anxiety (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [‐0.34, 0.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 Carer outcomes (stress related to caring) at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>895</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.19 [‐0.54, 0.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>28.1 Zarit Burden Interview Short Form (care home)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.07 [‐1.51, ‐0.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>28.2 Zarit Burden Interview Short Form (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐0.74, 0.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>28.3 Relatives Stress Scale (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>327</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.06 [‐0.28, 0.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>28.4 NPI (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.33, 0.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>28.5 Zarit Burden Interview (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.11, 0.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29 Carer outcomes (depression) at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>464</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.71, 0.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>29.1 HADS Depression (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>464</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.71, 0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30 Carer outcomes (anxiety) at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>464</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [‐0.17, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>30.1 HADS Anxiety (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>464</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [‐0.17, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">31 Carer outcomes (quality of life) at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>467</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.18, 0.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.1 GHQ‐12 (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.11 [‐0.78, 0.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.2 GHQ‐28 (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>313</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.15, 0.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.3 SF Mental (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.15 [‐0.54, 0.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">32 Carer outcomes (quality of caring relationship) at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>32.1 QCPR Conflict (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>495</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.37 [‐1.23, 0.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>32.2 QCPR Warmth (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>456</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.66 [‐1.59, 0.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">33 Mood‐related outcomes (apathy) post‐treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.40 [‐1.30, 4.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>33.1 Apathy Index (carer rated) (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.40 [‐1.30, 4.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">34 Mood‐related outcomes (apathy) at follow‐up (community) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [‐1.89, 4.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>34.1 Apathy Index (carer rated) (community)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [‐1.89, 4.39]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Reminiscence therapy versus no treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001120.pub3/references#CD001120-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD001120.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD001120-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD001120-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD001120-note-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="ja#CD001120-note-0003">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD001120-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="th#CD001120-note-0011">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD001120-note-0012">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001120\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001120\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001120\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001120\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001120\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001120\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001120\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001120\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001120\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001120\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001120\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001120\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001120\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001120\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001120\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001120\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001120\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001120\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=kKvAiZoF&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001120.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001120.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD001120.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD001120.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001120.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740717559507"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001120.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740717559511"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001120.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dbae22e919371',t:'MTc0MDcxNzU1OS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 